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Compromised skin barrier function negatively impacts up to 50% of our global population. 
Skin areas with compromised barrier integrity are affected more by environmental triggers 
such as sun exposure and environmental pollution which induce cellular oxidative stress, 
damage skin integrity and promote skin aging. At a sub-cellular level there are accumulative 
strand breaks to mitochondrial DNA (mtDNA). Limited repair mechanisms and proximity to 
the site of superoxide generation, make mtDNA a biomarker of oxidative damage in multiple 
human cell and tissue types.   
This project optimised a long-range qPCR method to compare relative mtDNA damage 
between samples. An application of this methodology tested commercial antioxidants (AOXs) 
tetrahydrocurcumin (THC) and pterostilbene (PTERO) for their capacity to protect skin 
mtDNA from sun exposure in a wide range of human skin models; primary monocultures, skin 
equivalents, and whole skin ex-plants. The assay was also used to detect mtDNA damage 
between donor-matched basal cell carcinoma (BCC) and non-BCC facial skin.  
In skin monolayer experiments, the mtDNA of foreskin-derived adult keratinocytes or 
differentiated keratinocytes was not protected by THC or PTERO. However the mtDNA of 
foreskin-derived adult reticular fibroblasts was protected by THC (but not PTERO), with 
greatest protection provided by a THC + PTERO combination. 
Various technical protocols were developed in this thesis, including an in-house full thickness 
human skin equivalent using CELLnTEC medium. Skin equivalents have donor-matched 
layers and no scaffold material, so fibroblasts secrete and maintain their own dermal 
extracellular matrix. A majority of the skin equivalents were formed with foreskin-derived 
adult keratinocytes and reticular fibroblasts, but some trials were performed using the same 
cell types derived from adult facial skin. In-house (CELLnTEC) and commercial (Labskin™) 
skin equivalents, foreskin and facial ex-plant skin were also tested for mtDNA protection by 
THC/PTERO/combination within topically applied Physiogel™ base formulations. As the 
epidermis can be manually removed from  Labskin™,  the qPCR assay detected a high 64-fold 
range of mtDNA damage in this epidermis and in-house (CELLnTEC) skin equivalents. 
However, the qPCR assay sensitivity was reduced in thicker skin models such as whole 
Labskin™, foreskin and facial ex-plant skin. As such it was difficult to determine conclusive 
results from formulation testing in these models using the mtDNA qPCR assay. 
It is anticipated that the mtDNA assay and human skin equivalent arising from this thesis will 
have wide-ranging applications. The data pertaining to THC/PTERO is indicative that these 
AOXs could enhance the GSK commercial Physiogel™ skin range designed for skin that is 
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HPSF High Purity Salt Free 
H-strand Heavy strand 
H2O2 Hydrogen peroxide 
IDTE Tris-EDTA buffer - 10mM Tris, 0.1mM EDTA 
IF Immunofluorescence 




L-strand Light strand 
MALDI-MS Matrix-assisted laser desorption/ionization mass spectrometry 
mAmp Milliamp 
MEM Modified Eagle Medium 
mtDNA Mitochondrial DNA 
MHz Megahertz 
MTT 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphentyltetrazolium bromide 
MTS 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner salt 
NA Numerical aperture 
nDNA Nuclear DNA 
NAM Niacinamide 
NCR Non-coding region 
NDD Non-descanned detector 
NMR Nuclear magnetic resonance spectrometry 
NRF2 Nuclear factor erythroid-2-related factor 2 
1O2 Singlet oxygen 
O2
- Superoxide anion 
OCT Optimal cutting temperature compound 
OH- Hydroxyl radical 
P Passage number 
PAH Polycyclic aromatic hydrocarbons 
PBS Phosphate buffered saline 
PET Polyethylene terephthalate 
PFA Paraformaldehyde 
PM Particulate matter 
PMMA Poly(methyl methacrylate) 





PSA Penicillin-streptomycin-amphotericin B 
PTERO Pterostilbene 
Q Ubiquinone 
qPCR Quantitative polymerase chain reaction 
RD Reagent diluent 
RHE Reconstructed human epidermis 
RIN RNA integrity number 
RNA Ribonucleic acid 
tRNA Transfer ribonucleic acid 
Redox Reduction-oxidation 
ROCK Rho-associated protein kinase 
ROS Reactive oxygen species 
SCC Squamous cell carcinoma 
SD Standard deviation (of the mean) 
SED Standard erythemal dose 
SEM Standard error of the mean 
SHG Second Harmonic Generation 
SOD Superoxide dismutase 
SPF Sun protection factor 
T Tween 20 
TM Melting temperature (of primers) 
TBS Tris buffered saline 
TE Trypsin-EDTA 
TEAC Trolox equivalent antioxidant capacity 
THC Tetrahydrocurcumin 
TPTZ 2,4,6-Tri(2-pyridyl)-s-triazine 
UVA1 Ultraviolet A1 
UVA2 Ultraviolet A2 
UVB Ultraviolet B 
UVC Ultraviolet C 
UVR Ultraviolet radiation 
VIS Visible light 
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Chapter 1:  Introduction 
The EU Cosmetics Regulation (1223/2009/EEC) prohibits all cosmetic products tested, 
marketed and sold on the backbone of an animal model. Arising from a change in public 
opinion, such guidelines directly affect international industry trade and are beginning to 
influence foreign government policies (Bellas et al., 2012). With academic funding bodies also 
calling for alternatives to animal models, this has influenced the research avenues of university 
institutions. In correlation there is a shift in the commercial availability of human skin 
equivalents, the resources to grow ‘in-house’ equivalents from donor tissue, and development 
of commercial assays for three-dimensional (3D) model systems. An overall precedence has 
been set for the human skin model market to continually evolve. 
Human skin models (3D) are the most developed and understood of all in-vitro engineered 
tissues (Mathes et al., 2014). As Figure 1-1 demonstrates, there are a range of human skin 
equivalent models, ranging in complexity from monoculture to equivalents, explants and 
perfused organ chips. The novel approach of this research project is that it incorporates a multi-
comparative study through several in vitro models of varying biological complexity. 
 
 Relationship between in vitro model complexity and relevance for industrial drug development. RHE - 
reconstructed human epidermis, 3D - three-dimensional. Image source: Mathes et al. (2014) 
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 Skin function 
In its simplest terms, skin is our largest protective organ. It contains a multitude of interacting 
cells types, synergistically maintaining a dynamic homeostatic barrier against our external 
environment (Mathes et al., 2014). As a perceptive interface, it influences responses (e.g. 
immunological) to physical, chemical and biological stimuli (Tobin, 2006; Działo et al., 2016).  
 Skin architecture 
A full thickness skin equivalent aims to recreate human skin structure, spanning core structural 
layers of epidermis and dermis. Physiological skin also contains a hypodermis, and connects to 
the fascial endoskeleton through extensive peripheral components of the neural, immune, 
lymphatic and circulatory systems (Wong et al., 2016). A youthful and ‘defined’ skin 
appearance is synonymous with anchored tethering points, in particular ligaments of the head 
and face that weaken with age (Wong et al., 2016).  
It is important to consider skin architecture when establishing a representative 3D model that 
generates translational data. Skin is not homogenous across the entire body surface area, where 
adipose fat distribution, structure and density of hair, nerve endings and blood supply are highly 
variable (Tobin, 2006). The hands (palmer) and feet (plantar) are particularly adapted to 
enhanced environmental contact through the presence of keratinous nails, a strong and 







 Schematic of human skin anatomy. There are three primary compartment sub-classes: epidermis, dermis, and 
subcutis (hypodermis). Peripheral components of the neural, immune and circulatory system are embedded throughout (e.g. 
sebaceous/sweat glands, capillaries etc.). Image source: Mathes et al. (2014) 
 
 Epidermis  
Epidermal thickness varies across the body but also according to sex, ethnicity and 
environmental impact. However, it shares a common architecture of an outermost stratum 
corneum, followed by granulosum, spinosum and basale (Figure 1-2). Each are permeated by 
specialist cells with a protective function such as pigment producing melanocytes, Langerhans 
cells (immune - dendritic) and Merkal cells (neural - sensory) (Brohem et al., 2011). Without 
vascular support they rely solely on diffusion from the dermal capillary network (MacNeil, 
2007). Keratinocytes progressively differentiate and migrate upwards from a columnar layer of 
self-renewing proliferative cells in the stratum basale (MacNeil, 2007). When at the outermost 
stratum corneum, they have undergone keratinisation to form a protective outermost barrier. It 
is formed of approximately 15 layers of distinctive anuclear corneocytes embedded within a 
high volume of organised multilamellar lipids, such as ceramides and sphingolipids (Brohem 
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et al., 2011). This high lipid content is generated by the stratum granulosum, accounting for the 
firmness of the epidermis (Wong et al., 2016). The stratum corneum continually sheds 
(desquamation), in synergy with keratinocyte proliferation (Mathes et al., 2014).  
 Basement membrane  
The stratum basale of the epidermal barrier layer is attached to the dermis by a specialist 
basement membrane, consisting of several forms of collagen fibre (MacNeil, 2007). These 
mainly include collagen IV, laminin, proteoglycans and glycosaminoglycans, alongside a host 
of growth factors and cytokines (Brohem et al., 2011). Other proteins such as collagen VII 
anchor the dermal reticular lamina to the basal lamina of the basement membrane (Mikesh et 
al., 2013). Key physiological processes such as wound healing, skin regeneration and 
homeostatic maintenance rely on epidermal-dermal interactions through  this membrane 
(Brohem et al., 2011). The culmination is a strong and flexible junction that also acts as a 
mechanical barrier against pathogens (Wong et al., 2016). 
 Dermis 
Like the epidermis, dermal thickness varies across the body, as well as between sexes and 
ethnicities. The dermis provides considerable strength and structural support to skin through its 
upper papillary layer of thin collagen fibres interspersed with elastic fibres, on top of a reticular 
layer composed of thicker collagen fibres (Wong et al., 2016). The reticular layer has a densely 
packed collagenous mesh interlaced with branching elastin fibres, fibronectin and 
proteoglycans (Brohem et al., 2011). Dermal fibroblasts aid synthesis and maintenance of the 
extra-cellular matrix (Brohem et al., 2011). The most abundant collagens are fibril forming type 
I (80-90%), type III (10-20%) and lesser amounts of fibril-associated collagen VI,  XII, and 
XIV (Mikesh et al., 2013). Alongside dermal fibroblasts, the layer is also permeated by hair 
follicles, sweat and sebaceous glands, blood vessels and nerve endings (Tobin, 2006). The 
dermal matrix provides energy and nutrition to the epidermis, but also facilitates cellular 
proliferation and migration in wound healing (Brohem et al., 2011). Sensations of touch, pain, 
itch, temperature and pressure are transmitted from this skin region (MacNeil, 2007).  
 Subcutis  
Also known as the hypodermis, layers of connective tissue and adipose house both nerves and 
larger blood vessels. Like the epidermis, the thickness of this layer varies between individuals 
and is important for both temperature regulation and shock-absorbance (Mathes et al., 2014). 
Relative to the epidermis and dermis, the hypodermis is considered less defined and understood 
(Wong et al., 2016). Indeed, they are generally (if not always) absent from skin equivalents. 
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The cells types include fibroblasts, macrophages and adipocytes, with the overall tissue rich in 
fluid attracting hyaluronan, proteoglycans and glycosaminoglycans (Wong et al., 2016).  
 Skin model systems: ex-vivo skin and in-vitro reconstructed skin equivalents  
There are a host of human skin equivalent models available to purchase commercially or grown 
‘in-house’ from widely published methodologies. Broadly they are divided into epidermal 
(reconstructed human epidermis (RHE)), dermal, or full-thickness (reconstructed human 
dermis, basement membrane, epidermis and stratum corneum) sub-types (Mathes et al., 2014). 
At a cellular level they are primarily composed of human keratinocytes and fibroblasts, but 
additional cell types can be integrated (e.g. melanocytes, stem cells, Langerhans etc.) (Mathes 
et al., 2014). Integration of appendage hair follicles, pores, or sweat/sebaceous glands are also 
a consideration (Mathes et al., 2014).  Nutrition is delivered to equivalents via culture media, 
although perfusion-based methodologies are being developed to replicate vascular input.   
Commercial skin equivalents are widely used in academia, as well as pharmaceutical and 
biotechnological industries. The most commonplace are those produced by SkinEthic™ 
(L’Oréal, France), MatTek™ (MatTek Corporation, USA), Phenion™ (Henkel, Germany), and 
Labskin™ (Innovenn, UK). It is known that the epidermal equivalents of SkinEthic™ and 
MatTek™ use collagen/polycarbonate scaffolds (Groeber et al., 2011). For full thickness 
equivalents, it is not definitively known that SkinEthic™/MatTek™ skin equivalents are 
scaffold-free, but those from Phenion™ incorporate bovine collagen I scaffold (Groeber et al., 
2011) and Labskin™ dermis is formed of polymerised fibrin (Bojar, 2015). Most published 
methodologies develop a viable dermis by seeding fibroblasts into a collagen scaffold or 
hydrogel (Zhang and Michniak-Kohn, 2012; Mathes et al., 2014). Some scaffold/gel materials 
are biodegradable, and can be human- or animal-derived (Mathes et al., 2014), where the 
scaffold degrades as proliferating cells produce an extracellular matrix (Zhang and Michniak-
Kohn, 2012). It would be difficult to determine if the scaffold itself or degraded particulates 
have an effect on the cellular microenvironment (cell signalling etc.).  
CELLnTEC (CnT; Switzerland; www.cellntec.com) have produced a fully defined medium 
range called ‘CnT Prime’ that allows for co-culture of keratinocytes and fibroblasts, and 
eliminates the need for a scaffold. The fibroblast media (product CnT-PR-F) has <1% animal 
serum but a combination of cell-specific growth factors that support fibroblast production of an 
extracellular dermal matrix over 10 days. When keratinocytes are seeded onto the dermis, they 
remain for 3 days in a co-culture ‘airlift’ media (product CnT-PR-FTAL) designed to encourage 
equal growth of both cell types whilst maintaining the correct phenotype. When the 
keratinocytes are raised to the air-liquid interface for 12 days, the equivalents continue to be 
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maintained with the ‘airlift’ medium throughout. The only technical difficulty with this method 
is that it incorporates no antibiotics or antifungals in the cell media, and details not to use them 
in the supplied protocol.   
 Mitochondria  
 Mitochondrial function 
Mitochondria are dynamic, double-membraned organelles that exist in varying quantities per 
cell type (Kandola et al., 2015). They are pivotal to cellular energy (ATP) biogenesis, supplying 
up to 90% of the required quota using electron transport chains (ETC; see Figure 1-4). Energy 
production is maximised by arranging ETC complexes in a densely folded inner membrane 
(cristae) (Oyewole and Birch-Machin, 2015). Mitochondria are integral to multiple cell-
signalling cascades, with certain proteins (GTPases, kinases, phosphatases etc.) co-ordinating 
mitochondrial function with the regulation of metabolism, cell-cycle control, anti-viral response 
and apoptosis (McBride et al., 2006; Panich et al., 2016). They also dynamically interact 
intracellularly, transferring contents through fission-fusion and appropriately cleansing their 
pool through  target-specific mitophagy (Kandola et al., 2015). 
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 Mitochondrial genome (mtDNA) 
Each mitochondrion contains approximately 2 to 10 copies of a 16.5kb mtDNA genome 
(Kandola et al., 2015). It is a double stranded circular molecule with an outer (heavy) and inner 
(light) strand of nuclei acid, which contain genes for two ribosomal RNA (rRNA), 22 transfer 
RNA (tRNA), and sub-units of electron transport chain (ETC) complexes I, III, IV and V 
(Schon et al., 2012; Kandola et al., 2015). The D-loop region contains promotors for the 
initiation and control of mtDNA replication and transcription (Li et al., 2012; Gammage and 
Frezza, 2019)  
Whilst nDNA has histone arrangement and additional protective/reparative mechanisms, 
mtDNA is vulnerable to oxidative stress-induced strand breaks. Due to the polyploid nature of 
mtDNA, damage can accumulate to a threshold before functional decline is seen (Birch-Machin 
and Swalwell, 2010). The mtDNA content, lesions, methylation, deletions and mutations are 
widespread biomarkers of disease and ageing (Wallace, 2010; Tulah and Birch-Machin, 2013). 
This is particularly true of highly metabolic or proliferative tissues (which require more energy 
and have increased numbers of mitochondria and mtDNA), such as the nervous, muscular and 
endocrine systems (Hudson et al., 2016).  
Relative to nDNA, mtDNA has limited repair capacity but both genomes share a 
communicative role in mtDNA replication and maintenance. Wisnovsky et al. (2016) report 
that mtDNA have components of the base excision repair (BER) pathway, but even nDNA 
assistance cannot appear to repair double strand breaks. Mutations in nDNA can therefore affect 
the repair of mtDNA, although mitochondria can be recycled by mitophagy or the entire cell 




 Schematic of human mitochondrial DNA. (A) An electron transport chain (ETC) originates from the nuclear 
and mitochondrial genomes, which together orchestrate the assembly, regulation and expression of its functional components. 
Nuclear encoded proteins are imported through membrane embedded protein translocases in the intermembrane space (IMS) 
adjacent to the mitochondrial matrix. Nuclear encoded components are brown (e.g. complex II), and coloured portions correlate 
to their mitochondrial genome coding region (e.g. complexes I, III, IV, V). (B) The mitochondrial genome has eleven mRNAs 
(grey) which encode 13 ETC polypeptides and are expressed by 22 tRNAs.  Proteins are inserted into the inner mitochondrial 
membrane by mitochondrial ribosomes. The displacement loop (D-loop) contained a non-coding region (NCR) and is expanded 
to show the HSP/LSP promotors for mtDNA transcription of the respective heavy (H-) strand and light (L-) strands, alongside 




 Reactive oxygen species (ROS) and oxidative stress 
ROS are an endogenous bi-product of cellular metabolic processes, with the largest amounts 
arising from mitochondrial driven respiration (Panich et al., 2016). However exogenous 
environmental factors can also drive excessive ROS production, such as ultra violet radiation 
(UVR), air pollutants, and household/agricultural chemical compounds (Poljšak and Fink, 
2014). Examples of ROS include free radicals (superoxide anion - O2
- , hydroxyl radical - OH, 
and non-radicals (singlet oxygen - 1O2, hydrogen peroxide - H2O2) (Panich et al., 2016). Indeed 
ROS aid physiological processes such as phagocytosis (immunity), intracellular signalling 
cascades and general survival of cells such as neurons, fibroblasts, smooth muscle cells, and 
skin keratinocytes (Panich et al., 2016). Paradoxically, the ROS that aid cellular survival, 
ultimately induce senescence via oxidative stress.   
During aerobic respiration (Figure 1-4), electron leakage at the ETC results in mitochondrial 
superoxide (O2
-) formation (Oyewole and Birch-Machin, 2015).Catalysed to H2O2 by 
endogenous SOD enzyme, any H2O2 surplus to cellular function is quenched by GPx enzyme 
to form water. However, Fenton reaction with endogenous metal ions (e.g. Fe2+) produce highly 
reactive radicals that put cells under oxidative stress, inducing damage to intracellular structures 
such as mtDNA (Oyewole and Birch-Machin, 2015). Non-radical H2O2 is membrane permeable 




 Schematic of mitochondrial electron transport chain (ETC) and reactive oxygen species (ROS) generation.  
Within the inner mitochondrial membrane, a series of fuel oxidation stages occur in protein complex I and II which result in 
an electron transfer (e-; blue dotted line) to ubiquinone (Q) and a reduction at complex III. Cytochrome c (Cyt c) carries 
electrons between respiratory complexes III and IV, to the terminal O2 acceptor. Proton motive force (PMT) drives ATP 
synthesis at complex V, thorough use of the generated proton gradient (green lines).  PMT can also induce electron leakage, 
which reacts with O2 to form superoxide anions (O2-). These are catalysed to H2O2 by superoxide dismutase (SOD), which can 
be used in signalling pathways or further catalysed to water by GPx. Unquenched H2O2 can react with metal ions (Fenton 
reaction), resulting in an oxidative stress-induced cellular damage. Image adapted from Kandola et al. (2015) and Mailloux 
and Harper (2012). 
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Oxidative stress is thought to be a major contributor of the mtDNA damage and this tends to 
induce random strand breaks. The mtDNA genome is close to the site of ROS production and 
multiple copies exist within each cell. These factors make mtDNA particularly vulnerable to 
the effects of oxidative stress, exacerbated further by the fact that mtDNA has limited repair 
mechanisms and lacks protective histones (Anderson et al., 2014). Berneburg et al. (2000) 
reported that the mutation frequency of mtDNA is approximately 50-fold higher than nDNA. 
As the integrity of mtDNA is essential for mitochondrial function, the accumulation of 
mutations can result in dysfunctional mitochondrial subunits (Anderson et al., 2014). The 
dysfunctional mitochondria are thought to contribute to increased ROS production, leading to 
further oxidative damage to mitochondria in a continuous cycle illustrated in Figure 1-5 (Birch-
Machin and Bowman, 2016; Naidoo et al., 2018). 
 
 Oxidative stress and mitochondrial theory of ageing.  Oxidative stress arises from an imbalance between an 
increase in reactive oxygen species (ROS) and decrease in antioxidant (AOX) response. These reactive species cause damage 
to both nuclear and mitochondrial genomes but accumulates in the mtDNA due to proximity and limited repair mechanisms. 
Beyond a threshold, mitochondrial becomes dysfunctional which reduces energy production and impacts cellular function and 
repair, as well as increasing the likelihood of cellular senescence. Furthermore, dysfunctional mitochondria produce greater 
levels of ROS. The mitochondrial theory of ageing proposes that this cascade of events at cellular level results in biological 
ageing. Image adapted from Naidoo et al. (2018) 
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 Environmental skin stressors 
Whilst our skin is designed to protect from environmental impact, some stressors (e.g. sunlight) 
remain capable of penetration and individuals with compromised skin barrier integrity are at 
risk of enhanced penetration of environmental stressors such as sunlight/pollutants (Figure 1-
6). Indeed new fields of research are emerging that show a synergistic photoactivation of 
sunlight on environmental stressors such as pollution  (Laurent, 2018).  Sunlight is an 
electromagnetic spectrum of varying wavelengths that include visible light (VIS; ~42-43%), 
ultraviolet (UV; ~3-5%) and infrared radiation (IRR; ~52-55%). UV is subdivided into UVA1 
(320-340nm), UVA2 (340-400nm), UVB (280-320nm), and UVC (100-280nm), where UVC 
is filtered by ozone and does not reach skin. While UVB/UVA2 penetrate the epidermis 
(keratinocytes, melanocytes, Langerhans), UVA1 penetrates deeper to the dermis (fibroblast, 
vascular and connective tissue), and IRR/VIS penetrate even deeper. The effects of IRR, VIS 
and artificial blue light (HEV) from devices are new emerging areas of interest in sun 
protection. Naidoo et al. (2018) reviews the effects of sunlight on photoageing, with emphasis 
on the role of mitochondria as outlined in section 1.4.3. The shorter wavelengths of UV are 
known to cause extensive mutagenic and cytotoxic damage to both genomes and other 
components of skin cells (e.g. lipids, proteins) (Tulah and Birch-Machin, 2013). This can result 
in skin erythema, sunburn and cancers such as localised (non-melanoma) basal/squamous cell 
carcinoma (BCC/SCC), or melanoma. Intermittent sun-exposure (e.g. holidays) is more 
associated with BCC and melanoma, whereas accumulative lifetime sun exposure is associated 
with SCC (Kimlin and Guo, 2012).  
13 
 
 Effect of environmental stressors on skin.  Skin has an increased risk of damage by environmental stressors 
such as ultraviolet radiation (UV) and environmental pollution (PAHs; PM). Areas of compromised barrier obtain deeper 
particle/UV penetration, inducing oxidative stress, inflammation, further dehydration, and overall skin aging. PAHs, 
polyaromatic hydrocarbons; PM, particulate matter; UV, ultraviolet 
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 Antioxidants (AOXs) and chelators 
The continual cellular proliferation/differentiation involved in skin self-renewal is maintained 
by a balance of redox homeostasis and regulation of ROS-mediated signalling (Panich et al., 
2016). Skin epidermis incorporates melanin as an endogenous tissue defence mechanism 
against UV-mediated oxidative stress (Tan et al., 2015). As outlined in Figures 1-3 and 1-7, 
there are also endogenous enzymatic AOXs, non-enzymatic AOX support systems, and iron 
chelators that together maintain an optimal level of intracellular ROS (Panich et al., 2016). 
Indeed AOXs/chelators are used to treat oxidative damage related illnesses, such as 
cardiovascular and neurodegenerative diseases (Rahal et al., 2014).  
 Mechanisms of action 
It has been widely seen in the literature that a combination of plant derived (phyto) AOXs such 
as vitamin E, vitamin C, β-carotene are required to have a biologically relevent effect (Działo 
et al., 2016). This is commonly found in nutritional recommendation of a varied diet, but is also 
of importance to skincare. Strategic combination is based on an understanding of their 
mechanism of action and which cytosolic pathways they influence.  
The mechanism of action and protective effects of cytosolic AOXs have been well derived. 
More recently, mitochondria-targeted antioxidants are gaining traction from their ability to 
cross the mitochondrial phospholipid bilayer and sequester reactive oxygen species at their 
source (Oyewole and Birch-Machin, 2015). Tiron is a potent mitochondria-targeting chelator, 
qualifiying as an ideal experimental positive control (Oyewole et al., 2014).  
 Niacinamide 
Niacinamide (or nicatinamide) is widely used in both clinical dermatology and consumer skin-
care products as a topical (~1-5%) and oral treatment (Forbat et al., 2017). It is a water-soluble 
amide isotype of vitamin B3 (niacin) that is acquired through the diet, and essential for skin, 
oral and digestive health (Forbat et al., 2017). The mechanism of action is well derived, where 
it is an essential catalyst for anti-inflammatory and nDNA repair pathways, and converts to co-
enzymes essential for mitochondrial energy metabolism (Forbat et al., 2017). It has been trialled 





































































































































































 Polyphenolic antioxidants (AOXs) 
The AOXs of interest in this study are polyphenolic compounds tetrahydrocurcumin and 
pterostilbene (Figure 1-7). Polyphenolic compounds are widely found in plants and their 
benefits are extended to humans through diet and herbal medicines. Interestingly both are used 
in traditional Indian ayurvedic medicine, with pterostilbene found in native tree barks used to 
treat diabetes and cardiovascualar ailments (Kosuru et al., 2016). Similarly tetrahydrocurcumin 
is a metabolite of the famous Indian spice tumeric, which is ingested and used topically. They 
are reported to powerfully scavenge free radicals by reducing one electron oxidants and free 
iron (Fe2+) (Tückmantel et al., 1999; Handique and Baruah, 2002). In the food and agriculture 
industries extensive research has been performed on the potent interaction of polyphenols with 
proteins, often forming percipitates of polyphenol-protein complexes that cause haze in clear 
beverages and are the basis of leather tanning (Siebert et al., 1996; Siebert, 2009).  
1.6.3.1  Tetrahydrocurcumin (THC)  
THC is derived from yellow turmeric, where the active ingredient curcumin has a recognised 
role in alleviation of inflammatory skin conditions, enhancement of wound-healing and general 
antimutagenic properties (Kakkar et al., 2018).  The synthesis of THC incorporates 
hydrogenisation that increases physical stability at biological pH, bioavailability, 
hydrophillicity, AOX capacity, and creates a more aesthetically pleasing white colour (Okada 
et al., 2001; Prasad et al., 2014; Kakkar et al., 2018). Unlike curcumin, the role of THC in 
skincare is relatively understudied with available literature advocating a role as a depigmenting 
agent. However a recent study by Kakkar et al. (2018) compared topical hydrogel formulation 
containing ‘free’ or lipid nanoparticles of THC. They applied the gels to the skin of an 
inflammatory wound mouse model and reported enhanced anti-inflammatory/antioxidant 
properties. The role of THC in suncare is relatively unknown, but hairless mice given topically 
applied curcumin had a delaysed onset of smaller and less frequent skin tumours from repeated 
UVB exposure (Phillips et al., 2013). Okada et al. (2001) found that compared to curcumin, 
mice fed with a THC supplemented diet had reduced oxidative stress induced lipid 
peroxidisation and 8-hydroxy-2'-deoxyguanosine (8-OHdG) nDNA products in their kidney.  
1.6.3.2  Pterostilbene (PTERO) 
PTERO is a stilbene class of chemical secreted by various plants (e.g. blueberries, grapes, and 
some tree barks) in response to environmental stressors such as high UV exposure or microbial 
infection (Chen et al., 2017). It is a methoxylated form of the widely studied and utilised 
resveratrol compound, but has a markedly increased bioavailability through enhanced 
lipophilicity, and longer half-life (Sirerol et al., 2015; Yang et al., 2017). Like resveratrol it has 
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proven AOX, anti-inflammatory and anti-microbial qualities, but interest in pterostilbene rose 
when it was reported to drive enhanced rates of autophagy and halt proliferation of cancer cells 
(Chen et al., 2010; Chen et al., 2017; Li et al., 2017). The role of pterostilbene in suncare is 
relatively unknown, but 90% of hairless mice given topically applied pterostilene (delivered 
within liposome) were protected from UVB induction of skin tumour development, whereas all 
mice given resveratrol or placebo developed tumors (Sirerol et al., 2015). In addition, 
pterostilbene treated mice had reduced inflammation and wrinkling at the site of UVB solar 
irradiation (Sirenko et al., 2015). This research group patented the use of pterostilbene for 
prevention or treatment of skin damage (Estrela. J. and Aseni, M. 2009).  
 Antioxidant (AOX) concern surrounding prooxidant activity  
Concern has arisen over certain polyphenolic compounds acting as prooxidants under certain 
conditions, e.g. flavinoid oxidation (Alanko et al., 1999). Metodiewa et al. (1999) postulated 
that the positions and number of hydroxyl groups determined an AOX or proxidant status. It 
has been reported that curcumin (but not THC) had pro-oxidant activity with several cell types, 
including human gingival fibroblasts (Atsumi et al., 2005; Aggarwal et al., 2014). Some studies 
have reported factors such as time (duration), dose, biological age, and even daylight cycles 
influence the pro- or anti-oxidative status of reseveratrol, whereby the potent anticancer effects 
have been attributed to oxidative DNA strand breaks (de la Lastra and Villegas, 2007; Salehi et 
al., 2018). Indeed vitamin E becomes a radical when it interacts with a free radical, and remains 
pro-oxidative if there is insufficient vitamin C to recycle it (Mehta and Gowder, 2015).  
In skin, prolonged exposure to free radicals can overwhelm ROS defence mechanisms 
contributing to general skin aging, and influencing the development of cutaneous diseases or 
skin cancer (Godic et al., 2014). The use of exogenous AOXs to tackle high levels of ROS are 
most beneficial before exposure to environmental stressors (e.g. UV). Incidentally, post-
application may hinder ROS-mediated cell cycle control and apoptosis of damaged cells (with 
significantly mutated DNA) (Godic et al., 2014). Establishing an optimal dosage is important, 
because exogenous AOXs in combination with endogenous AOXs should aim to re-balance 
(but not over-balance) the redox homeostasis of our skin (Kawagishi and Finkel, 2014).  
 Cosmeceutical formulation, skin barrier application and permeation 
Whilst a majority of basic research identifies the interaction of AOXs with skin cells, the 
translation to a final product with appropriate dose and penetrative delivery is largely dependent 
on the formulation (Burke, K., 2018). Furthermore without a standardised measurement of 
efficacy for AOXs, there is concern they are too ‘untargeted’ to significantly reverse oxidative 
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stress (Oyewole and Birch-Machin, 2015). In addition, the economic viability of a product is 
tied to consumer experience of sensory qualities such as absorption, texture, colour and scent.  
To achieve these outcomes, cosmeceutical and sun protection active ingredients have been 
controversially moving towards nanoparticle containing formulations and target driven 
nanocarrier delivery systems which are well reviewed by Kaul et al. (2018). Although concerns 
have arose from the lack of long-term safety data surrounding nanoparticles and how it fits into 
current cosmetic legislation, it is recognised that this is a powerful tool for translating protective 
and synergistic effects seen with phenolic phytochemicals and in vitro cells to real world 
applications (Ganesan and Choi, 2016).  
 Project aims 
GlaxoSmithKline Consumer Healthcare has a portfolio of product brands (e.g. Oilatum™, 
Zovirax™, Physiogel™ etc.) which aim to protect skin health and alleviate symptoms such as 
dryness, itch, and irritation. Topical cosmetic and ‘over the counter’ products contain active 
ingredients of various bio-functions. Understanding how these ingredients interact and behave 
is key to driving product development. 
Human skin is exposed to daily oxidative stress from UV light, environmental pollution, and 
the ozone.  It is therefore beneficial to understand the functional applications of AOX 
ingredients. This project aimed to initially demonstrate if phenolic AOXs tetrahydrocurcumin 
and pterostilbene could protect the mtDNA of keratinocytes and fibroblasts skin cells from 
environmental sun exposure. There are numerous publications relating to curcumin and 
resveratrol, but extremely limited studies on their enhanced synthetic derivatives which are 
likely to have better function in skin due to improved bioavailability and stability. Furthermore, 
there are no studies that use these derivatives in combination, making any findings highly novel.  
This work aimed to optimise a sensitive assay to detect protection of mtDNA, and to develop a 
representative full thickness skin equivalent grown without scaffold and with donor-matched 
layers where the fibroblasts secrete and maintain their own extracellular dermal matrix. Novel 
elements of this project included the transitional approach from pilot data (previously obtained 
in human cell line) to 2D primary cell monoculture, full-thickness skin equivalents, and whole 
skin ex-plants. This transition usually occurs in consecutive projects (and is published in 
consecutive papers), whereas this work proceeded synergistically. 
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Chapter 2:  General Methods 
 Human skin cell culture 
Cell culture medium referred to in the text was supplemented as follows. Unless stated 
otherwise, fibroblast medium was Dulbecco’s Modified Eagles Medium (DMEM) containing 
4.5g/L glucose, L-glutamine, sodium pyruvate and sodium bicarbonate (BE12-604F; Lonza) 
supplemented with 10% foetal bovine serum (FBS; F9665, Sigma) and 1% streptomycin-
penicillin-amphotericin B (PSA; A5955, Sigma). Unless stated otherwise, keratinocyte medium 
was EpiLife™ (MEPI500CA, Thermo Scientific) supplemented with 1% human keratinocyte 
growth supplement (HKGS; S0015, Thermo Scientific) and PSA. The compositions of 
EpiLife™, HKGS and DMEM are included in the supplementary information, under sections 
9.2.1-9.2.3 respectively. Working stock aliquots of all media supplements were stored at -20oC. 
Dulbecco’s phosphate buffered saline (PBS) referred to in the text was 1X concentration and 
without calcium or magnesium. All primary cells were maintained at 37oC, 5% CO2.  
 Human skin processing 
Facial skin was kindly donated in collaboration with the dermatology surgical department of 
the Royal Victoria Infirmary and foreskin from the urology surgical department of the Freeman 
Hospital. All human tissue work adhered to the guidelines outlined by the Newcastle and North 
Tyneside Research Ethics Committee (Ref 08/H0906/95+5_Lovat) and the Newcastle upon 
Tyne Hospitals NHS Foundation Trust (trust approval for R&D project reference 4775). 
Tissue was processed in chilled PBS supplemented with 2% PSA. Dispase enzyme was 
prepared by dissolving a 1g vial of Dispase (neutral protease, grade II; 942078001, Sigma) in 
50ml PBS, and sterile filtered through a 0.22µm membrane before freezing 1ml aliquots at 
-20oC. All surgical equipment was cleaned with 70% ethanol and flame sterilised. Subcutaneous 
tissue and vasculature were removed from skin, before overnight incubation at 4oC with 1ml 
Dispase, 1ml PSA, and 8ml PBS-5% PSA.  
 Isolation and culture of adult skin-derived epidermal keratinocytes 
2.1.2.1  Foreskin source 
After Dispase incubation, epidermis was manually peeled from the dermis with surgical 
tweezers and incubated with Trypsin-EDTA (TE; T3924, Sigma) at 37oC for 5 minutes before 
being neutralised with DMEM, centrifuged (300 RCF, 5 minutes) and resuspended in 
keratinocyte medium. Flask media was changed within 24 hours. Flask size (cm2) were adapted 
to tissue size, with cells from an average size sample seeded into a 175cm2 flask. Cells (≥1x106) 
were cryopreserved at cell passage number 0 or 1 (P0/P1) in 1ml Synth-a-Freeze™ medium 
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(A1254201, Thermo Scientific). Thawed keratinocytes were cultured in EpiLife™ for 
monolayer experiments or CELLnTEC CnT-PR medium for human skin equivalents. 
Keratinocytes were detached with Accutase™ (A1110501, Thermo Scientific) because it was 
gentler than trypsin. They were used experimentally from cell passage number 1 to 3, as the 
proliferative capacity of adult (but not neonatal) skin-derived keratinocytes will reduce from 
passage number 4. Each experiment was performed in at least three independent donors.  
Proliferative basale-like keratinocytes were differentiated into spinosum-like keratinocytes by 
growing the monolayers to 100% confluency in EpiLife™, and then further supplementing the 
medium with 1M CaCl2 (PBS diluent, 0.22µm sterile filtered) to a final calcium concentration 
of 1.2mM. The keratinocytes were in high calcium medium for a further 5 days, with a medium 
change on day 3. Experiments were performed on the fifth day, with antioxidants prepared in 
high calcium medium.   
2.1.2.2  Facial skin source 
Facial skin keratinocytes were isolated and cultured as for foreskin aside from the following 
protocol alterations. A stock of 10mM Y-27632 dihydrochloride (P160 ROCK inhibitor; 1254, 
Tocris) was prepared by sterile filtering ddH2O through a 0.22µm membrane and injecting the 
appropriate volume into the vial. Stock was stored in a screw top vial at 4oC. Prior to each 
medium change EpiLife™ was additionally supplemented with 0.1% ROCK inhibitor. Thawed 
facial keratinocytes no longer required ROCK inhibitor and were cultured in CELLnTEC CnT-
PR medium for skin equivalents. The starting culture of viable keratinocytes from facial skin 
biopsies was very low because of the skin sample size (cm2). As keratinocytes will not grow 
below a certain density, the optimisation in section 5.3.6 outlines how the inclusion of ROCK 
inhibitor was required to obtain a larger starter culture.  
 Isolation and culture of adult skin-derived reticular fibroblasts 
2.1.3.1  Foreskin source 
Small pieces of dermis were attached to a lightly scored 75cm2 flask surface with the reticular 
layer facing downwards, before coated in 1ml 100% FBS and incubated overnight. Media was 
added the following morning. The tissue was fed 3 times weekly for 14 days with DMEM. The 
fibroblasts migrated out of the tissue and were spread out at day 14 by detaching with TE and 
neutralising with DMEM. Once the cells had readhered, the medium was replaced.  Cells were 
cultured in 75cm2 flasks and cryopreserved at P0 or P1 in 1ml freezing medium (90% complete 
DMEM, 10% DMSO). Thawed fibroblasts were cultured in complete DMEM for monolayer 
experiments, or CELLnTEC CnT-PR-F medium for human skin equivalents. In addition, they 
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were expanded and passaged once before seeded for experiments. They were used 
experimentally from cell passage number 2 to 6. 
2.1.3.2  Facial skin source 
Facial skin fibroblasts were isolated and cultured as for foreskin aside from the following 
protocol alterations. Small flasks (25cm2) were coated in sterilised 0.1% gelatine (PBS diluent) 
before small pieces of dermis were attached.  The P0 fibroblasts migrated out of the tissue but 
were not spread out at day 14. They were trypsinized at day 14 for cryopreservation in 1ml 
Synth-a-Freeze™. Additional information is found in section 5.3.6. 
 Induction of DNA damage 
General DNA damage was induced by hydrogen peroxide or irradiation with a solar simulator 
lamp. The purpose was to induce a detectable amount of damage to the mtDNA genome, which 
could be detected by the comparative qPCR assay described in Chapter 3. This allowed for 
screening of antioxidant protection against the damage stimuli, as seen in Chapters 4 and 6.  
 Hydrogen peroxide  
Experimental DNA damage was induced with 150µM hydrogen peroxide (H2O2), diluted from 
30% w/w stock (H1009, Sigma) in non-supplemented cell specific medium. Stock was stored 
light protected at 4oC. All H2O2 dosing was performed on cell monolayers grown in 3.2cm
2 
dishes, which were PBS washed (to remove serum) before light protected incubation for 1 or 2 
hours at room temperature. Cells were trypsinized, pelleted at 300 RCF and frozen at -20oC.  
 Solar irradiation  
Annual calibration of the solar simulator and filters was performed by the regional medical 
physics department of the Newcastle Upon Tyne Hospitals Trust, UK. They Newport solar 
simulator (Model 91282-1000) uses a xenon lamp with associated optics designed to give a 
uniform downwardly directed beam. The calibration report states that this model has been 
retrofitted with an infra-red heat filter and is broadly consistent with the current Newport 
Oriel® Sol-UV-6 model (see Figure 2.1). Calibration is performed to ensure it is spectrally 
compliant with the COLIPA irradiance response curve whereby ~59 seconds is a typical time 
to reach 1 standard erythemal dose (SED) which equates to 10mJ/cm2 weighted (Diffey, 1991) 
at maximum output power. The calibration data in Table 2.1 detected 1.19 SED /min, comprised 
of 0% UVC, 7.8% UVB, and the remainder UVA. For experiments, solar radiation was 
performed with a with SED doses (Diffey, 1991) with the exposure time (seconds) calculated 
using an International Light Technologies radiometer-photometer (Model ILT1400-A serial 
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8524 with UVA sensor serial 867) and UQG optics VIS-IR light filter (Schott UG11 Glass-
Type). This light filter was removed prior to full spectrum solar irradiation. 
 
Measured Irradiance - no filter 
Irradiance 
(mw / 
cm2) % Calibration factor 
Total UV 15.079  1.263 
UVC (250-280) 0.000 0.0 0.000 
UVB (280-315) 1.182 7.8 0.099 
UVA (315-400) 13.897 92.2 1.164 
SED / min 1.191   
 Measured UV Irradiance of Newport solar simulator Measured value of total UV irradiance (and its 
components). The calibration factors are to convert the local broadband meter reading to UV irradiance. The lower portion of 
the table gives the number of standardised erythema (SED) doses (i.e. multiples of 10mJ/cm2) delivered per minute.     
 
  Newport Solar Simulator Online Spectral Irradiance Curve.  
 
Cell monolayers were grown in 3.2cm2 dishes and irradiated in phenol red-free non-
supplemented DMEM with lids removed, because previous work in this research group have 
shown that supplements (e.g. serum) and phenol absorb some of the lamp irradiance and affect 
the dose provided to cells. Human skin equivalent and ex-plant models were irradiated in a 
similar manner except suspended within hanging inserts over medium so the stratum corneum 
remained dry (see sections 5.2 and 6.2). Non-irradiated controls were foil wrapped throughout 
solar irradiation.   
Previous work in this research group has shown that UV solar irradiation increases cell 
monolayer adherence to tissue-culture coated plastic. As a result they require cell scraping as 
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well as trypsinisation immediately after solar irradiation. All non-monolayer experiments were 
rapidly chilled on wet ice (prior to processing) or snap-frozen on dry ice pending storage (see 
sections 5.2 and 6.2).  
 DNA extraction and quantification: ex-vivo tissue, human skin equivalent and cell 
models 
Whole tissue and skin equivalents were thawed to room temperature and cut into small pieces 
with a scalpel before addition of tissue lysis buffer (ATL) and proteinase K of the QiaAMP™ 
DNA mini kit (Qiagen). Tissue homogenisation was performed within a rocking water bath 
(56oC) for 3 hours (human skin equivalents) or overnight (whole tissue, approx. 18 hours). Cell 
pellets were thawed to room temperature before extraction. The extraction continued as outlined 
in the manufacturer’s instructions for the QiaAMP™ DNA mini kit (Qiagen) and DNA 
quantified by NanoDrop ND-1000 spectrophotometer (Thermo Scientific). Isolated DNA was 
of high quality (A260/A280 > 1.8) and stored at -20
oC with minimal freeze-thaw cycles.  
 RNA extraction and quantification: ex-vivo tissue, human skin equivalent and cell 
models 
Whole tissue and skin equivalents were homogenised in chilled Precellys CKMix-50-R 2ml 
tissue lysing tubes with 600µl RLT buffer and 6µl β-mercaptoethanol, using a Precellys 
Evolution tissue homogeniser (Berlin Instruments) at the following settings: 0oC temperature, 
60 seconds at 6000rpm followed by 30 second pause for 6 cycles. The tubes were centrifuged 
at full speed for 30 seconds and the liquid transferred to RNAase-free eppendorfs. For human 
cell pellets, homogenisation was by Qiashredder as per manufacturer’s instructions (Qiagen). 
The remainder of the extraction followed the Qiagen RNeasy mini kit protocol for animal tissue 
(inclusive of DNase I treatment step) and quantified using NanoDrop™ spectrophotometer. 
Isolated RNA was of high quality (A260/A280 > 2.0) and stored at -80
oC with minimal freeze-
thaw cycles. To maintain integrity, RNA was eluted into pre-chilled eppendorfs on wet ice and 
transferred to -80oC for storage as fast as possible. Throughout homogenisation optimisation 
RNA integrity (RIN) was additionally assessed by Agilent RNA 6000 Nano Kit for bioanalyzer, 
whereby RIN>8.0 was of high quality. Protein acetone precipitation from RNeasy mini kit flow-
through was possible, but with a significantly reduced yield to direct homogenisation (see 
section 2.5). 
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 Protein extraction and quantification: ex-vivo tissue, human skin equivalent and cell 
models 
Protein was extracted and stored in chilled RIPA buffer (150mM sodium chloride, 1% Triton 
X-100, 0.5% sodium deoxycholate, 50mM Tris, pH 8.0), freshly supplemented with 150µl 
cOmplete™ protease inhibitor cocktail (Roche) per 1ml RIPA. Protease inhibitor was made by 
dissolving one tablet in 1.5ml dH2O and storing 150µl aliquots at -20
oC. Cell pellets required 
no homogenisation, but whole skin and human skin equivalents were homogenised in RIPA-
protease buffer within pre-chilled Precellys CKMIX-50-R tubes. The settings were as for RNA. 
Samples were incubated on wet ice for 20 minutes before centrifugation at maximum speed for 
15 minutes at 4oC. Supernatant (containing protein lysate) was rapidly aliquoted on wet ice into 
pre-chilled eppendorfs and stored at -80oC with minimal freeze-thaw cycles. A small aliquot of 
protein was kept for quantification, which was performed using a BCA protein assay kit as per 
manufacturer’s instructions with absorbance read at 562nm on SpectraMax 250 (Molecular 
Devices). Protein acetone precipitation from RNeasy mini kit flow-through was possible, but 
with a significantly reduced yield compared to direct homogenisation. The protocol is included 
online as a kit booklet supplement. 
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  Human skin donors 








       Block*** 
2624 RVI Facial Female 56 I-III x1 FFPE 
2625 RVI Facial Female 52 I-III x1 FFPE 
2626 RVI Facial Male 74 I-III x1 FFPE 
2683 RVI Facial Female 65 I-III x1 FFPE 
2720 RVI Facial Female 73 I-III x1 FFPE 
2727 RVI Facial Male 80 I-III x1 FFPE 
2729 RVI Facial Male 77 I-III N/A 
2731 RVI Facial Female 49 I-III N/A 
2732 RVI Facial Female 79 I-III N/A 
2733 RVI Facial Male 46 I-III N/A 
2734 RVI Facial Male 57 I-III N/A 
2735 RVI Facial Male 82 I-III N/A 
2736 RVI Facial Male 69 I-III N/A 
2737 RVI Facial Female 43 I-III N/A 
2742 RVI Facial Male 70 I-III x1 FFPE 
2746 RVI Facial Male 88 I-III N/A 
2747 RVI Facial Male 73 I-III N/A 
2748 RVI Facial Male 72 I-III N/A 
S1009F Freeman Foreskin Male 50 I-IV N/A 
S1013F Freeman Foreskin Male 51 I-IV N/A 
S1026F Freeman Foreskin Male unknown I-IV N/A 
S1052F Freeman Foreskin Male 53 I-IV N/A 
S1054F Freeman Foreskin Male 27 I-IV N/A 
S1057F Freeman Foreskin Male 51 I-IV N/A 
S1058F Freeman Foreskin Male 59 I-IV N/A 
S1073F Freeman Foreskin Male 65 I-IV N/A 
S1074F Freeman Foreskin Male 28 I-IV N/A 
S1075F Freeman Foreskin Male unknown I-IV N/A 
S1076F Freeman Foreskin Male unknown I-IV N/A 
S1082F Freeman Foreskin Male unknown I-IV N/A 
S1083F Freeman Foreskin Male unknown I-IV N/A 
S1141F Freeman Foreskin Male 40 VI x1 FFPE 
S1142F Freeman Foreskin Male 17 I-IV x1 FFPE 
S1144F Freeman Foreskin Male 80 I-IV x1 FFPE 
S1145F Freeman Foreskin Male 51 I-IV x1 FFPE 
S1146F Freeman Foreskin Male 76 I-IV x1 FFPE 
S1147F Freeman Foreskin Male 53 I-IV x1 FFPE 
S1151F Freeman Foreskin Male 35 I-IV x1 FFPE 
S1152F Freeman Foreskin Male 77 I-IV x1 FFPE 
S1153F Freeman Foreskin Male 45 I-IV x1 FFPE 
S1154F Freeman Foreskin Male 44 I-IV x1 FFPE 
S1168F Freeman Foreskin Male 33 I-IV N/A 
S1169F Freeman Foreskin Male 26 I-IV N/A 
S1174F Freeman Foreskin Male 22 I-IV N/A 
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S1175F Freeman Foreskin Male 48 I-IV N/A 
S1192F Freeman Foreskin Male 64 I-IV N/A 
S1193F Freeman Foreskin Male 76 I-IV N/A 
S1194F Freeman Foreskin Male 48 I-IV N/A 
S1196F Freeman Foreskin Male 40 I-IV N/A 
S1197F Freeman Foreskin Male 56 I-IV N/A 
S1202F Freeman Foreskin Male 85 I-IV N/A 
S1215F Freeman Foreskin Male 49 I-IV N/A 
S1216F Freeman Foreskin Male 22 I-IV N/A 
S1223F Freeman Foreskin Male 50 I-IV N/A 
S1224F Freeman Foreskin Male 76 I-IV N/A 
14525 Freeman Foreskin Male 56 I-IV N/A 
14526 Freeman Foreskin Male 48 I-IV N/A 
14527 Freeman Foreskin Male 67 I-IV N/A 
14534 Freeman Foreskin Male 43 I-IV N/A 
14551 Freeman Foreskin Male 41 I-IV N/A 
14552 Freeman Foreskin Male 27 I-IV N/A 
14563 Freeman Foreskin Male 21 I-IV N/A 
14566 Freeman Foreskin Male 77 I-IV N/A 
14567 Freeman Foreskin Male 40 I-IV N/A 
 Demographics of human skin donors obtained in collaboration with Newcastle upon Tyne Hospitals NHS 
Trust. *Newcastle Upon Tyne Hospitals Trust, UK; RVI dermatology and Freeman urology surgical departments **Age at 
time of surgery ***Formalin fixed biopsy stored in Newcastle Dermatology Biobank, UK. Fitz. – Fitzgerald phototyping scale   
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Chapter 3:  Optimised detection of mitochondrial DNA damage  
 Chapter overview and aims 
Intrinsic and extrinsic factors that induce cellular oxidative stress damage tissue integrity and 
promote ageing result in accumulative strand breaks to the mitochondrial DNA (mtDNA) 
genome. Limited repair mechanisms and proximity to superoxide generation make mtDNA a 
prominent biomarker of oxidative damage. Using human DNA, a long-range qPCR 
methodology has been optimised that sensitively detects mtDNA strand breaks relative to short 
mitochondrial and nuclear DNA (nDNA) housekeeping amplicons. The primers used are 
specific to the mtDNA genome, so total DNA (mt- and n-DNA) can be used because the 
housekeeping assay controls for mtDNA copy number variation between samples.  
The assay provides a qualitative comparison of the amount of mtDNA damage relative to a 
control sample. The amount of fluorescence increases with each cycle as it makes more SYBR 
Green-bound mtDNA amplicons. If a sample has damaged regions within its mtDNA, it will 
require additional qPCR cycles to produce the same amount of fluorescent product (Ct). The 
damage detected across the 11kb region is non-specific and screens only for that significant 
enough to halt the DNA polymerase enzyme. 
The reason why primers for 11kb mtDNA amplicons are used instead of covering the entire 
16.5kb mtDNA, is because it is technically challenging to perform l6.5kb long-range qPCR in 
one reaction and robust primers already existed for this 11kb size region. Previous work in this 
research group performed 4 x 4kb qPCR assays to cover the entire mtDNA genome and found 
the amount of extra damage detected was not large enough to justify the extra time and reagents 
to perform multiple amplifications per sample. In addition, this assay amplifies intact 11kb 
regions so screening for a larger amplicon in a highly damaged sample would result in no qPCR 
product, and consequently no Ct data value.  
Portions of this chapter formed a recently published method paper (Hanna et al., 2019).  
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 Chapter specific methods 
 Oligonucleotides 
Primer sequences for all qPCR assays are as outlined in Table 3-1, alongside their respective 
published source. Sequence specificity was additionally verified using Sanger Institute Artemis, 
PrimerBLAST, and UCSC genome browsers. Primers for qPCR were synthesized by Eurofins 
Genomics, and reconstituted to 100µM in IDTE buffer (10mM Tris, pH 8, 0.1mM EDTA). 
Single use aliquots of working primers (10µM) were prepared in IDTE and stored at -20oC.  
 
 Primer pair sequences for qPCR. Product melt temperature (TM), primer efficiency (%) and published source 
are included. *Primer efficiency of 93.5% only within the dynamic linear range (see Figure 3-4). Forward- F, Reverse- R 
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 Amplification of 11kb mtDNA amplicons using qPCR 
Amplicons spanning 11kb of the 16.5kb mtDNA genome (Figure 3-1(A)) were amplified using 
a SYBR Green qPCR assay. This 11kb region spans 11 of the 13 genes encoding functional 
components of the electron transport chain (ETC) and a majority of the D-loop region which 
initiates mtDNA replication and transcription (Li et al., 2012). It is technically challenging to 
perform l6.5kb long-range qPCR in one reaction and robust primers already existed for this 
11kb size region. Previous work in this research group performed 4 x 4kb qPCR assays to cover 
the entire mtDNA genome and found the amount of extra damage detected was not large enough 
to justify the extra time and reagents to perform multiple amplifications per sample. SYBR 
Green I binds to double stranded mtDNA and fluoresces relative to a passive ROX reference 
dye. Fluorescence (ΔRn) increases exponentially to amount of amplicon and is measured at the 
end of each cycle.  As illustrated in Figure 1(B) data is analysed according the comparative Ct 
method (ΔΔCt) whereby a more damaged sample will require more cycles to produce the same 
amount of amplicon product (Santos et al., 2006). The method was performed on a 96 well 
StepOnePlus™ machine (Applied Biosystems), with mastermix composition and settings 
outlined in Tables 3-2 and 3-3. The Expand Long Range PCR System (Sigma) was used 
alongside SYBR Green I DNA dye (10,000X in DMSO; Lonza) and ROX passive reference 
dye (Applied Biosystems). To achieve 5X SYBR Green working concentration, a 1µl frozen 
aliquot was diluted in 2ml IDTE buffer as fluorescent dyes should not have more than two 
freeze-thaw cycles. Each sample was assayed in triplicate with a standard deviation threshold 
of ≤ 0.4 Ct.  Ct threshold was manually adjusted to the linear range on StepOnePlus
™ v2.3 
software and melt curve analysis used to determine product size. The threshold was set at 
1.25ΔRn for all 11kb qPCR experiments. A routine positive control was a previously run 
sample of known Ct value, and negative control was mastermix alone. If the machine was used 
throughout the day, it was important to shut down and reboot it prior to an overnight 11kb assay 





 Summary of 11kb qPCR assay. (A) Schematic of the ~11kb region (green) amplified from each ~16.5kb human 
mtDNA genome.  It is a circular molecule with an inner light (L) strand and outer heavy (H) strand. The 11kb region amplified 
contains 11 of 13 genes (blue arrows) encoding polypeptide components of the mitochondrial electron transport chain.  It also 
covers a large portion of the non-coding D-loop control region. Small housekeeping regions are indicated in orange. (B) 
Amplification plot indicating Ct difference between a highly damaged and low damaged sample. Fluorescent threshold 





 Reagents for 11kb qPCR assay 
 
 
 Amplification settings for 11kb qPCR assay 
 Validation of 11kb mtDNA amplicons  
During initial optimisation, amplified qPCR products were additionally analysed on a Gel-Red 
(Biotium) stained 0.8% w/v agarose gel and visualised using a Li-Cor Odyssey Fc system. 
Positive 11kb bands were cross-referenced with StepOnePlus melt curve analysis whereby each 
amplicon reached peak maximum at the same temperature. To establish the dynamic linear 
range and therefore optimal starting amount of DNA (ng), standard curves were simultaneously 
performed on one qPCR plate using untreated HDFn cell line, primary fibroblast and primary 
keratinocyte DNA. Each sample was serially diluted (1:2) from 100ng/µl to 3.125ng/µl. To 
identify the precise linear range, several smaller ranging standard curves were then performed 
(e.g. 20ng/µl to 5ng/µl). Linear regression analysis was used to calculate primer efficiency 
whereby E = 2(-1/slope) (Yuan et al., 2006). Percentage efficiency (%) was calculated by (E-1) x 
100. 
 Quality Control: Amplification of housekeeping amplicons  
Small regions of mtDNA-specific (83bp or 87bp) and a single copy nDNA-specific β2M gene 
(93bp) were simultaneously amplified using a SYBR Green based qPCR assay. The method 
was performed on a 96 well StepOnePlus™ machine (Applied Biosystems), with mastermix 
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composition and settings outlined in Tables 3-4 and 3-5.  Each sample was assayed in triplicate 
with a standard deviation threshold of ≤ 0.4 Ct. Ct threshold was manually adjusted to the linear 
range on StepOnePlus™ v2.3 software and melt curve analysis used to determine product size. 
The threshold was set at 7.5ΔRn for all housekeeping qPCR experiments.  The standard curve 
for each primer pair were simultaneously performed on one qPCR plate using untreated primary 
fibroblast DNA.  Each sample was serially diluted (1:2) from 100ng/µl to 1.56ng/µl. Linear 
regression analysis was performed as for 11kb standard curve.  
 
 
 Reagents for 83bp/87bp/93bp housekeeping qPCR assay 
 
 




 Validation of the 11kb qPCR strand break assay 
3.3.1.1   Mastermix optimisation  
SYBR Green I 
A direct comparison with SYBR Green I diluted to 5X in 100% DMSO versus IDTE buffer 
(pH8) demonstrated that while both reactions worked, IDTE buffer produced superior melt 
curves and reduced replicate standard deviation (data not shown).  
To determine if the mastermix final concentration of EDTA was low enough to avoid 
magnesium chelation, a direct comparison with commercial 10mM IDTE and Tri-HCL buffers 
was performed. Ultrapure 1M Tris-HCL pH8 (Invitrogen) was diluted to 10mM pH 7.7 using 
PCR grade water. There was no difference between the Ct values generated with either buffer 
(Figure 3-2) so IDTE was selected as a 10mM working buffer is commercially available.  
Finally, a comparison was made between 5X and 10X SYBR Green I diluted in IDTE, and 5X 
in PCR grade water. It was found that SYBR Green was not water stable, and 10X SYBR Green 
was not able to detect Ct changes when DNA concentration was halved (data not shown). The 
DNA concentration standard curve was generated using a mastermix containing 5X SYBR 
Green I in IDTE pH 8 buffer (Figure 3-2).   
 
 SYBR Green I diluent testing for 11kb qPCR assay mastermix. Partial standard curves (6.25-50ng DNA) for 
11kb qPCR demonstrated no difference between Ct values obtained when the reaction mastermix contained SYBR Green I 
diluted in 10mM IDTE or Tris-HCL buffer.  Data obtained from HDFn dermal fibroblast cell line DNA. Mean ± SD, N=1, n=3 




Factors affecting primer integrity were investigated when primer dimer (melt curve temp. ~79) 
would intermittently increase in some plates. 
Custom oligonucleotides from Eurofins Genomics were directly compared in three purification 
forms: ‘optimised PCR primer’, HPSF purified and HPLC purified (Figure 3-3). Whilst all 
primers were reconstituted to 100µM in IDTE buffer, a comparison of 10µM working primer 
diluents was performed using IDTE buffer or PCR grade water. It was found that only 
‘optimised PCR’ and HPLC primers diluted in IDTE buffer detected 1Ct difference when the 
DNA concentration was halved. However only ‘optimised PCR oligos’ could detect the 1Ct 
difference with water diluent. HPSF oligos did not detect the difference in either diluent.  
It was also found that primers were most stable stored as a concentrated 100µM stock, that 50µl 
working aliquots should be single use (to avoid freeze-thaw cycles) and they should be stored 
at -20oC for up to 4 weeks.  
 
 Effect of primer purification and diluent on 11kb qPCR assay. Primers synthesised in three purity forms 
(‘optimised’ PCR (left/grey), HPSF (middle/blue) and HPLC (right/orange)) were simultaneously compared in the 11kb qPCR, 
whereby a doubling of DNA concentration should correspond to a 1 Ct difference. ‘Optimised’ primers detected a 1 Ct 
difference when diluted in IDTE or PCR grade water. HPSF primers failed to detect the difference in both diluents, and HPLC 
detected only in IDTE buffer. Data obtained from adult foreskin-derived reticular fibroblast DNA (donor S1058F – male, age 
59). Mean ± SD, N=1, n=3 per data point.  
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3.3.1.2  Identification of a dynamic linear DNA range 
A series of mean standard curves evaluated the dynamic linear range and primer efficiency 
across a range of 6.25ng-200ng starting total DNA (Figure 3-2). A series of smaller standard 
curves (data not shown) narrowed the linear range too approximately 10-50ng, with 12ng 
selected as an optimal and economical DNA amount. Extending the regression analysis outside 
this range progressively reduced calculated primer efficiency (%) to 62%. However within this 
range (as indicated by dashed box), linear regression analysis determined a correlation 
coefficient (R2) of 0.91 and primer efficiency of 93.5%. There was no difference seen between 




 Mean standard curve for 11kb qPCR assay. The linear range lies between 10-50ng, whereby a doubling of 
DNA concentration corresponded to a 1 Ct difference. Data obtained from adult foreskin-derived reticular fibroblast DNA 
(donor S1057F – male, age 51), adult foreskin-derived keratinocyte DNA (donor S1058F – male, age 59) and HDFn dermal 
fibroblast cell line DNA. There was no variability between the donors, as evidenced by the negligible error bars. Mean ± SEM, 
N=3, n=9 per data point. Image source: Hanna et al. (2019) 
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3.3.1.3  Clarification of the 11kb product amplification 
Positive 11kb bands were determined by StepOnePlus™ melt curve analysis whereby each 
amplicon reached peak maximum at the same temperature of 84oC±1 (Figure 3-5). Agarose gel 
analysis of all standard curve products (6-200ng) demonstrated 11kb bands. For samples with 
starting DNA ≤50ng, positive bands correlated to the correct size with absence of non-specific 
binding or primer- dimers (Figure 3-5). However, for 50-200ng the 11kb bands were 
accompanied by smears of unamplified DNA and bi-peak melt curves (data not shown).  
 
 Melt curve analysis and agarose gel show positive 11kb amplicons. No evidence of non-specific binding or 
primer-dimer. Image source: Hanna et al. (2019)  
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3.3.1.4  Determining equal amounts of starting mtDNA between samples and in relation to a 
nuclear DNA housekeeping gene 
To establish equal starting amounts of mtDNA between samples, small regions of mtDNA 
specific (83bp or 87bp) and a single copy nDNA β2M gene (93bp) were simultaneously 
amplified. The relative amount of mtDNA in treated versus untreated samples, was additionally 
normalised to the amount of β2M (93bp; gDNA) within those samples.  
A comparative Ct method was used to determine the fold difference, whereby 2
ΔΔCt = 2^((Ct, 
mtDNA, untreated – Ct, nDNA, untreated)) - ((Ct, mtDNA, treated - Ct, nDNA, treated). All 
compared samples were between 1 Ct (±0.3) of each other. This is demonstrated in Figure 3-6 
(D) showing equal amounts of starting mtDNA and nDNA in both solar irradiated and non-
irradiated primary skin cells (see 2.2.2). If an experimental treatment increases or reduces the 
amount of intact mtDNA within the sample, the fold difference determines the ratio adjustment 

















































































































































































































































































































































































































































































 Sensitive detection of mtDNA strand breaks in H2O2/solar radiation treated human 
primary skin cells 
Treatment of both human skin derived keratinocytes and fibroblasts by either hydrogen 
peroxide (H2O2) or solar simulated radiation (see 2.2.2) induced mtDNA strand breaks at 
significantly detectable levels, as determined by the modified 11kb qPCR assay. Relative to 
untreated cells there is approximately 16–36 fold (24–26) greater damage and this was not due 
to unequal amounts of starting mtDNA. The simultaneous housekeeping mtDNA and nDNA 
PCR assays not only confirmed equal loading of mtDNA in the assay, but that the treatment did 
not alter mtDNA content in relation to the nuclear gene.  It is of interest that a similar degree of 




 Detection of H2O2 (A) or solar radiation (B) induced mtDNA damage in human primary skin cells. ..Results 
generated from the DNA of three adult foreskin-derived keratinocyte or reticular fibroblast donors (N), treated with 150µM 
H2O2 (A) or 2.16 SED (standard erythema dose) complete solar simulated radiation (B). A dose of 2.16 SED is estimated to be 
the equivalent of 2 hours in the Mediterranean sun at noon during the summer months as an SED is 100 Joules per square 
meter. In addition, detection of mtDNA protection is demonstrated thorough pre-incubation with a mitochondria-permeable 
compound Tiron (PBS vehicle); Graph B). Keratinocytes donors used for H2O2 treatment were S1074F (age 28), S1083F (age 
unknown), and S1082F (age unknown). Keratinocyte donors used for solar irradiation treatment were S1174F (male, age 22), 
S1175F (male, age 48), and S1192F (male, age 64). Reticular fibroblast donors used for H2O2 treatment were S1073F (male, 
age 65), S1076F (male, age unknown), and S1075F (male, age unknown). Reticular fibroblast donors used for solar irradiation 
were S1141F (male, age 40), S1074F (male, age 28), and S1192F (male, age 64). Each sample (N) was performed in triplicate 
(n) and represented as mean ± SEM. Statistical difference determined by one-way ANOVA with Tukey’s post-hoc test. **** 
p <0.0001, *** p = 0.0001, ns p>0.05; N=3, n=9 per cell type. Image source: Hanna et al. (2019) 
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 11kb assay 16-32 times more sensitive than 1kb assay at detecting H202-induced 
mtDNA damage in skin cells 
To determine the increased sensitivity of amplifying an 11kb sized amplicon relative to 1kb, 
the same keratinocyte and fibroblast DNA samples were run on both assays consecutively. 
Figure 3-8 demonstrates there was approximately 4 Ct (16-fold) more damage detected by 
fibroblasts DNA in the 11kb assay, and approximately 5 Ct (32-fold) more in the keratinocyte 
DNA.  
 
 Comparison of 1kb and 11kb sensitivity in mtDNA detection. Detection of H2O2 induced mtDNA damage in 
human foreskin-derived skin cells is enhanced 16-32 fold with 11kb mtDNA amplicon, compared to <2-fold when an 1kb 
mtDNA region is amplified. Mean ± SD data generated from the DNA of adult foreskin-derived keratinocytes (S1075F - male, 
age unknown) or adult foreskin-derived reticular fibroblasts (S1073F - male, age 65).  Each donor was treated with 0 or 150µM 
H2O2 for 1 or 2 hours. Statistical difference determined by one-way ANOVA with Tukey’s post-hoc test. **** p <0.0001, ns 
p>0.05; N=1, n=3 per data point.  
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 Discussion 
This method improved on previously published versions of the 11kb assay arising from the 
Mark Birch-Machin research group (Ray et al., 2000; Passos et al., 2007), whilst adapting the 
method to a new qPCR machine. Firstly, there was a substantial 76% reduction in the amount 
of starting DNA (from 50ng to 12ng (per well)) and 60% reduction in reaction volume (from 
50µl to 20µl). This was verified by standard dilution curves and melt curve analysis (Figures 
3-2 and 3-3).  This benefits applications where clinical samples are small and the DNA amount 
is limiting for multiple analysis, or where the economy of small sample volumes permits larger 
screening. Standard curves were used to determine qPCR efficiency for each primer pair, where 
100% would equate to an amplicon product doubling per cycle (Taylor et al., 2010). The 
dilutions where this occurs lie within the linear dynamic range and determines the optimal 
amount of starting template (ng) to use. Whilst a 10-fold dilution series is favoured in the 
literature, we used a 2-fold approach because the linear range for large amplicons is narrow. 
For this 11kb amplicon, the region of high efficiency (93.5%) spanned only 10-50ng and 
reduced to 62% outside this range. The 11kb standard curve data was indistinguishable when 
performed simultaneously on DNA from different cell types (primary or cell line). Whilst 
primers were reconstituted and diluted in IDTE buffer, the final EDTA concentration supported 
primer integrity without diminishing amplification. A direct comparison with PCR grade water 
was found to disrupt primer integrity over time, causing primer dimerization with melt 
temperatures of 79-80oC. However IDTE buffer produced consistent 11kb products without 
artefact, observed as a single melt temperature peak of 84oC.  
The second improvement ensured equal mtDNA content within the context of total DNA 
samples through the simultaneous amplification of two small mtDNA specific amplicons from 
different regions of the mitochondrial genome as well as one from the single copy nuclear β2M 
gene. The use of these regions and their amplification conditions were verified by appropriate 
standard curves (Figure 3-6). The comparable Ct values obtained from both mtDNA specific 
regions (Fig. 3-6(D)) provided reassurance that the regions are not damaged or co-amplifying 
from nDNA (Malik et al., 2011). Detecting mtDNA relative to nDNA eliminates dilution bias 
and validates Ct changes detected by the 11kb assay. A comparative Ct analysis (2
ΔΔCt) 
determines the fold difference between mtDNA and nDNA levels of untreated and treated 
samples. To avoid dilution error, the same diluted sample is used for sequential runs of 
housekeeping and 11kb assays.  
The method primers can be experimentally used with DNA from any human tissue. An 
application of this methodology is demonstrated in detection of mtDNA damage following the 
separate treatment of human primary skin cells by hydrogen peroxide and solar simulated 
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radiation. Assay sensitivity is demonstrated through a 16–36 fold increase in detection of 
induced mtDNA strand breaks relative to untreated fibroblasts and keratinocytes (Figures 3-7 
and 3-8). Figure 3-8 demonstrates that damage is present throughout the mtDNA genome, 
whereby amplifying an 11kb portion detects a lot more damage than a 1kb portion. Tiron was 
used to demonstrate localised mtDNA protection as it is a potent chelator, free radical 
scavenger, and mitochondrial membrane permeable (Yong et al., 2012). Tiron pre-incubation 
correlated with a significantly reduced Ct value in both cell types, indicative of localised 
protection against solar radiation induced mtDNA damage (Figure 3-7).  
Whilst the use of solar irradiation is an environmental stressor specific to skin, excess H2O2 is 
a bi-product of oxidative stress in an abundance of internal tissues (Halliwell et al., 2000) and 
confirms the application of this optimised assay to study cell types particularly subjected to 
oxidative stress.  
 Summary of findings  
➢ Optimisation of a long-range qPCR assay reduced starting DNA by 76% and reaction 
volume by 60%. Small clinical samples (ng) can now be screened. 
➢ This assay amplifies 11kb of the 16.5kb human mitochondrial genome (mtDNA), and 
required additional cycles to produce the same number of amplicons if there is damaged 
mtDNA in the sample 
➢ Long amplicons greatly increase the sensitivity of damage detection across mtDNA 
➢ Mitochondrial DNA is a wide-ranging biomarker of oxidative stress, and these primers can 
be used in any human cell/tissue type 
➢ The primers are specific to human mtDNA, so a total DNA sample can be used and both 
genomes can be analysed in the same sample (nDNA with a different assay) 
➢ Housekeeping assays were additionally optimised to ensure that there is not mtDNA copy 
number variation between the total DNA samples  
➢ Examples of oxidative stress induced damage detection are shown through H2O2 and solar 
simulated light treatment in human skin cells. Protection against damage was shown by 
pre-incubation with Tiron antioxidant.  
➢ This methodology was published in Mitochondrion journal (Hanna et al., 2019) 
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Chapter 4:  Antioxidant (AOX) testing in acellular and human skin cell 
model systems 
 Chapter overview and aims 
Commercial AOXs tetrahydrocurcumin (THC) and pterostilbene (PTERO) were tested for their 
capacity to protect the mtDNA of human skin cells from solar radiation (see 2.2.2). The aim 
was to investigate if in-house pilot data from Dr Matthew Jackson in human skin cell lines was 
reproduced in primary adult foreskin-derived keratinocytes/reticular fibroblasts, and how 
variable the response was between donors. The effect of solar radiation on acellular AOXs was 
also investigated to determine their photo-stability. These pre-incubation experiments are a 
direct application of the assay developed in Chapter 3, whereby a more damaged population of 
mtDNA will take additional qPCR cycles to amplify a large portion of intact mtDNA genomes. 
The positive control for the qPCR assay (Chapter 3) is a potent AOX/chelator called Tiron, 
which was used in all cell types as it crosses the mitochondrial membrane to act at the site of 
ROS production.  
 Chapter specific methods 
 AOX absorbance of UV-visible light using spectrometry  
Absorbance of AOXs in UV-visible light (190-800nm) was detected using a Varian Cary 300 
Bio UV-visible spectrophotometer with Cary WinUV software (Agilent Technologies). 
Samples were poured into a glass quartz dish for 2.16 SED solar irradiation (or foil protection; 
see 2.2.2), before immediate transfer to cuvette for analysis.  
 Making up AOXs and dosing cells 
Tetrahydrocurcumin (THC; SabiWhite® 96%, SABINSA EUROPE) and pterostilbene 
(PTERO; PteroWhite® 90%, SABINSA EUROPE) were stored as dry powder and light 
protected at 4oC. Tiron (product 89460, Sigma) was stored at room temperature in dry powder 
form. For experimental dosing, AOX stock solutions of 268mM THC and 234mM PTERO 
were made with 100% DMSO solvent, and 300mM Tiron with PBS solvent. All stock solutions 
were mixed by vortex until completely dissolved, and light protected within tinfoil. Working 
AOX solutions were prepared by diluting THC/PTERO 1:4000 or Tiron 1:100 with cell specific 
medium to obtain the experimental concentrations outlined in Table 4.1.  
Cells were seeded into 3.2cm2 dishes and adhered overnight. At 70-80% confluency, they were 
washed twice with PBS and dosed with AOX (Table 4-1), no AOX or 0.025% DMSO vehicle. 
They were incubated for 6 or 24 hours prior to being washed twice with PBS and irradiated as 
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outlined in 2.3.2. The incubation timepoints were recommended by GSK to obtain data 
surrounding the duration of protection, with consideration for future product application.   
 
 AOX compound experimental doses 
 Trolox equivalent antioxidant capacity assay - FRAP 
All buffers and reagents were stored at room temperature unless stated. Sodium acetate buffer 
(0.2M; pH 3.2) was prepared with sodium acetate trihydrate (57670, Sigma) in ddH2O, and 
40mM HCL was diluted from 12M stock in ddH2O. On the day of experiment the following 
were prepared: 10mM TPTZ (4, 6,-tri [2-pyridyl]-s-triazine, Sigma) was prepared in 40mM 
HCL, and dissolved in a 50oC waterbath. 20mM FeCl3 was prepared from ferric chloride 
(FeCl3.6H2O, Sigma) in ddH2O.  
Trolox standards and AOX stocks were prepared at 10X higher concentration, to account for 
the assay dilution factor. Consequently, Trolox (10mM) was dissolved in ddH2O, pH adjusted 
to 7.2, and diluted to the following standards with ddH2O: 0.5, 0.25, 0.125, 0.0625, 0.031, 
0.016mM. As Niacinamide (NAM) is water soluble, 14.3mM (1600µg/ml) was prepared to 
obtain a 1.43mM experimental concentration. However to ensure the final vehicle concentration 
of THC/PTERO was 0.1%, 27mM THC (1mg/ml) and 23.5mM PTERO (600mg/ml) were each 
solubilised in 100% EtOH and then diluted 1:1000 with ddH2O. Unlike the monolayer 
experiments in 4.2.2, EtOH was used instead of DMSO as AOX solvent because it is known to 
not affect the FRAP assay. There have been no historical differences seen in this research group 
between the use of DMSO or EtOH as an AOX solvent, as long as the final concentration is as 
low as possible (≤0.1%). The following combinations were tested simultaneously: THC, 
PTERO, THC+PTERO, NAM, NAM+THC+PTERO, 0.1% EtOH vehicle, and water vehicle. 
In addition, PTERO and NAM+THC+PTERO solutions were made in duplicate with half 
irradiated at 2.16 SED (see 2.3.2).  
To prepare FRAP working solution, 25ml sodium acetate buffer (0.2M) was combined with 
2.5ml TPTZ (10mM) and 2.5ml FeCl3 (20mM). Using a clear, flat bottomed 96 well plate, 30µl 
Trolox standard, AOX or vehicle control were added to each well, followed by 270µl FRAP 
reagent and mixed. A duplicate plate was performed with 270µl ddH2O in lieu of FRAP. Each 
condition was assayed in triplicates per plate (n=3), incubated for 30 minutes at room 
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temperature, and absorbance read at 592nm on a SpectraMax 250 (Molecular Devices).  Three 
technical repeats were performed (N=3).  
Raw data were blank corrected to their water or 0.1% EtOH vehicle control, and the mean of 
condition replicates calculated. Trolox equivalent (µM/ml) was extrapolated from the Trolox 
standard curve on the corresponding 96 well plate (within linear range R2>0.95). The mean ± 
SD Trolox equivalent of three technical repeats was calculated for each AOX. 
 Aqueous One Cell Proliferation Assay (MTS) 
Viability of treated cells were assessed using MTS (Promega) as per manufacturer’s 
instructions. Cells were incubated with MTS in phenol red-free complete DMEM for 4 hours 
at 37oC, 5% CO2. Absorbance was read at 490nm using a SpectraMax 250 (Molecular Devices). 
 Data analysis of mitochondrial DNA protection  
Mitochondrial DNA protection data was generated by the methods outlined in Chapter 3 for the 
11kb and housekeeping assays. All samples for each donor were included on one qPCR plate, 
with housekeeping qPCR performed immediately beforehand to ensure equal starting levels of 
mtDNA across diluted samples.  
Statistical analysis was performed with reference to Yuan et al. (2006) and performed on raw 
Ct values, whereby all non-irradiated controls were first grouped as a control column. Each 
donor was analysed individually. A one-way ANOVA with Tukey’s post-hoc test was used to 
determine significance.  
To generate a graph, Ct differences for each donor were converted to relative fold change ratio 
(2ΔCt) and presented as mean±95% confidence intervals. The mean of controls was first 
subtracted from each treated condition (ΔCt = ΔCt (treated) - ΔCt (control)). In addition, the mean ± 




 AOX photo-stability test post 0, 2, 4, 6 or 8 SED complete solar irradiation: THC, 
PTERO, combination and Tiron 
To determine the effect of solar irradiation on AOX photo-stability, each test compound was 
diluted in distilled water, irradiated in a dose dependent manner (0-8 SED) and analysed 
consecutively with a UV-VIS photo spectrometer (190-800nm; see 4.3.1). THC, PTERO, 
THC/PTERO 1:1 combination and Tiron were solubilized and diluted to the doses used for cell 
monolayer experiments (with water used in lieu of cell medium).  
As seen in Figure 4-1 no AOXs absorbed in the visible light spectrum (400-800nm), and 
irradiation had no effect on Tiron or THC. The Tiron absorbance peak spanned UVB 275-
291nm, and THC at the UVC-UVB border 279nm. However, whilst non-irradiated 
pterostilbene absorbed at the UVB-UVA border 316nm, all irradiated samples had  a different 
absorbance peak at UVC (261nm) with a minimal secondary UVA peak (357nm). The 
irradiated THC and PTERO combination appear to merge/synergise around 279nm, with an 
increase in absorbance from ~0.4Abs to ~0.75Abs. In all cases the absorbance increased with 






















































































































































































































































































 The effect of solar irradiation on AOX capacity using Trolox Equivalent FRAP 
assay  
As PTERO was not photostable (Figure 4-1), the functional capacity of irradiated and non-
irradiated AOXs was tested in a Trolox Equivalent FRAP assay by Miss Agalya Amalanathan 
(undergraduate student). PTERO was tested as non-irradiated and irradiated with 2.16 SED 
solar simulated light. In addition a combination of PTERO, THC and NAM was irradiated, to 
represent the AOXs that would be combined in formulation. NAM was water soluble but lacked 
ferric reducing capacity and tested negative in this assay. PTERO and THC were EtOH soluble, 
but both 0.1% EtOH and water vehicles gave the same 592nm absorbance value of 
approximately 0.1. EtOH was used instead of DMSO because it is known to not affect the assay, 
and no historical difference has been seen in this research group between the use of DMSO or 
EtOH as an AOX solvent, as long as the final concentration is as low as possible (ideally 
≤0.1%). The AOX doses vary between compounds because the goal was not to compare their 
relative scavenging capacities, but rather represent their experimental doses in monolayer 
experiments (Chapter 4) and in test formulation (Chapter 6). NAM was included because GSK 
test formulations (Chapter 6) include this AOX, but this wasn’t known during the design of 
earlier monolayer experiments.  
The purpose of this experiment was to compare non-irradiated and irradiated samples. PTERO 
reducing capacity decreased only marginally upon irradiation. Whilst THC had a high AOX 
capacity, this was not significantly reduced when combined with PTERO and NAM, or when 
irradiated.   
50 
 
 AOX capacity using Trolox Equivalent FRAP assay. A) Trolox Equivalent value was extrapolated for each 
AOX from a Trolox standard curve, where the linear range lay between 0.78-12.5µM. Sample absorbance at 525nm was blank 
corrected to 0.1% EtOH or water vehicle. B) The AOX concentrations are 16µM tetrahydrocurcumin (THC), 39µM 
pterostilbene (PTERO), and 1.3mM niacinamide (NAM).  Irradiation performed as in 2.2.2 with a dose of 2.16 SED, whereby 
1 standard erythemal dose (SED, J.m-2) is equivalent to an erythemal radiant exposure of 100 J.m-2. Mean ± SD, N=3, n=9. 
Statistical difference determined by unpaired two-tail Welch’s t-test, *p=0.03, ns>0.05 
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 NMR of tetrahydrocurcumin (THC) determined stock is stable for years 
When THC protective effects were no longer observed in some fibroblast donors, NMR was 
performed at GSK (Weybridge, UK) to eliminate degradation as a causative factor. When more 
THC stock was required, a comparison was made between the original (3+ year) and new stock 
powders (Figure 4-3). GSK analysis determined minimal difference, with both samples 
representing pure THC. 
 
 Comparative NMR of two tetrahydrocurcumin (THC) dry powder stocks. Samples were analysed at GSK. 
Negligible difference was seen between 3+ year old stock (blue) and a purchased re-supply (red), indicative of stability over 
time when stored light protected at 4oC.  
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 Determination of optimal H2O2 and solar irradiation doses for human foreskin-
derived adult keratinocytes and reticular fibroblasts 
The MTS viability assay was used to determine the optimal H2O2 dose for adult foreskin-
derived keratinocytes and reticular fibroblasts, in order to damage mtDNA without inducing 
apoptosis (Figure 4-4). Previous in-house data demonstrated that 1 hour is an optimal time to 
incubate with H2O2 for the purposes of inducing mtDNA damage that can be detected by qPCR 
assay (chapter 3). For keratinocyte donors, a significant reduction in viability was induced with 
≥300µM H2O2, whereas for reticular  fibroblast donors this was  ≥750µM H2O2. From this data 
a conservative dose of 150µM H2O2 was selected to induce mtDNA damage in both cell types.  
A dose response for solar simulated irradiation was not performed, as 2.16 SED was previously 












































































































































































































































































































































































































































































































































 Determining optimal AOX and vehicle doses for human foreskin-derived adult 
keratinocytes and reticular fibroblasts 
The MTS viability assay was used to determine the optimal AOX and vehicle dose for adult 
foreskin-derived keratinocytes and reticular fibroblasts (Figure 4-5). Dose ranges were based 
around previously obtained GSK data in skin cell lines. Viability was maintained in both cell 
types in all tested conditions except keratinocytes + 6mM Tiron. A dose of 58.5µM PTERO 
and 67µM THC were selected for experiments of both cell types. On the basis of the 
keratinocyte data, fewer conditions were tested on reticular fibroblasts. A 0.025% DMSO 
vehicle was acceptable for both cell types. A positive control of 3mM Tiron was selected for 
its localised mtDNA protection as published by Oyewole et al. (2014), although retrospectively 
a lower dose of ~1-1.5mM would have been preferable for keratinocytes to ensure there was no 
pro-oxidant activity. However the inclusion of Tiron in these experiments is only a control 




 Relative viability of human foreskin-derived adult keratinocytes and reticular fibroblasts after 24-hour 
incubation with AOX or DMSO vehicle. Skin cells were incubated for 24 hours with dose(s) of DMSO vehicle, Tiron, 
pterostilbene (PTERO), tetrahydrocurcumin (THC), or PTERO/THC 1:1 combination. Relative viability of both cell types was 
maintained at all experimental doses except for keratinocytes with 6mM Tiron. Mean ± SEM data generated from three adult 
donors per cell type: A) S1215F – male, age 49, S1223F – male, age 50, S1224F – male, age 76, and B) S1202F – male, age 
85, S1194F – male, age 48, S1196F – male, age 40. Statistical difference to no AOX determined by one-way ANOVA with 
Dunnett’s post-hoc test. *=.002, ns p>.05; N=3, n=9  
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 Determining the capacity of AOX pre-incubation to protect human foreskin-
derived adult cell monolayers from solar light induced mtDNA damage 
The 11kb qPCR assay described in Chapter 3 was used to determine if AOXs 
tetrahydrocurcumin (THC) and pterostilbene (PTERO) could protect human foreskin-derived 
cells from solar simulated radiation induced mtDNA damage. The housekeeping mtDNA qPCR 
assay (Chapter 3) confirmed equal loading of mtDNA, and that the treatments did not alter 
mtDNA content. Adult male foreskin donors of various ages were used to isolate epidermal 
keratinocytes, differentiated keratinocytes and dermal reticular fibroblasts. The cells were 
incubated for 6- or 24-hours with AOXs, with these timepoints recommended by GSK to obtain 
data surrounding the duration of protection, with consideration for future product application. 
 
4.3.6.1  Human foreskin-derived adult keratinocytes pre-incubated with THC or PTERO 
were not protected from solar light induced mtDNA damage  
Human keratinocytes (basale-like) derived from four adult foreskin donors were pre-incubated 
for 6 hours (Figure 4-6) and 24 hours with THC or PTERO and irradiated with 2.16 SED solar 
light. Neither test compound protected mtDNA, but the positive control Tiron protected all 
donors. The mtDNA of non-irradiated cells were unaffected by AOX or vehicle incubation and 
were grouped as controls for data analysis. Protection was also not seen with 24 hours pre-




































































































































































































































































































































































































































































































































4.3.6.2  Human foreskin-derived adult differentiated keratinocytes pre-incubated with THC 
or PTERO were not protected from solar light induced mtDNA damage  
Human differentiated keratinocytes (spinosum-like) derived from four adult foreskin donors 
were pre-incubated for 6 hours (Figure 4-7) and 24 hours with THC or PTERO and irradiated 
with 2.16 SED solar light. Overall neither test compound protected mtDNA, although there was 
significant protection in one donor (S1194F – male, age 48) who had a much larger damage 
baseline than other donors. The method of differentiating keratinocytes means they are no 
longer a monolayer culture, and the mtDNA proportion damaged by 2.16 SED is relatively low 
at ~4-fold. The same results were seen with positive control Tiron, which also showed 
protection only for the S1194F donor. The mtDNA of non-irradiated cells were unaffected by 









































































































































































































































































































































































































































































































































4.3.6.3  Human foreskin-derived adult reticular fibroblasts pre-incubated with THC (but not 
PTERO) were protected from solar light induced mtDNA damage  
Human dermal fibroblasts derived from three adult foreskin donors were pre-incubated for 6 
hours (Figure 4-8), 12 hours and 24 hours with THC or PTERO, and irradiated with 2.16 SED 
solar light. Both THC and positive control Tiron protected 2 of 3 donors, although donor 
S1168F (male – age 33) had a lower damage baseline. Donor S1074F (male – age 28) had 
significant protection for both THC and pterostilbene, but also a high damage baseline. 
Protection for all antioxidants except Tiron was no longer seen at 12 hour and 24 hours (data 
not included). The mtDNA of non-irradiated cells were unaffected by AOX or vehicle 






























































































































































































































































































































































































































































































































4.3.6.4  Human foreskin-derived adult reticular fibroblasts pre-incubated with THC and 
PTERO combination were protected more from solar light induced mtDNA damage  
Human dermal fibroblasts derived from three adult foreskin donors were pre-incubated for 6 
hours (Figure 4-9) with THC or THC+PTERO combination and irradiated with 2.16 SED solar 
light. Both THC, THC+PTERO combination and positive control Tiron protected 2 of 3 donors. 
Both THC+PTERO combination and Tiron gave similarly high levels of protection. The 
THC+PTERO combination protected mtDNA greater than THC alone. The protective effects 
seen with THC were consistent with those seen in Figure 4-8, confirming that this result were 
reproduced in 4 of 6 donors overall. The mtDNA of non-irradiated cells were unaffected by 






















































































































































































































































































































































































































































































































































Curcumin and resveratrol are widely published and recognised AOXs, yet their synthetically 
enhanced derivatives tetrahydrocurcumin (THC) and pterostilbene (PTERO) are significantly 
less investigated. There are no publications on the mtDNA effects of these compounds, a potent 
biomarker of ageing and damage in tissues such as skin. In this chapter commercial AOXs 
tetrahydrocurcumin (THC) and pterostilbene (PTERO) were tested for their capacity to protect 
the mtDNA of human skin cells from solar irradiation. The aim was to investigate if in-house 
pilot data from Dr Matthew Jackson in human skin cell lines was reproduced in primary adult 
foreskin-derived keratinocytes/reticular fibroblasts, and how variable the response was between 
donors. The effect of solar light on acellular AOXs was also investigated to determine their 
photo-stability. These pre-incubation experiments are a direct application of the assay 
developed in Chapter 3, whereby a more damaged population of mtDNA will take additional 
qPCR cycles to amplify a large portion of intact mtDNA genomes. As such, Tiron (a potent 
chelator) was used as an experimental positive control in all cell types.   
THC and PTERO were tested acellularly for AOX scavenging capacity and photo-stability in 
solar simulated light. Throughout the literature, absorbance traces of AOXs in the UV-visible 
light range are commonplace. Sirerol et al. (2015) also report PTERO absorbance in the UVB 
range (275, 290, 305nm; 1mM), yet the effect of solar light on the stability and chemical 
structure of AOXs is rarely reported. This is an important consideration for the efficacy and 
safety of AOXs included in skin products as the consumer will be exposed to daylight. It was 
evident that PTERO irradiated with complete solar light was not photostable (Figure 4-1), 
which supports a similar finding by Silva et al. (2013) who found the amount and rate of trans-
resveratrol degradation was highest after exposure to the combined UV-VIS (200-600nm) 
spectrum, rather than UV (254nm) or VIS (≥365nm) in isolation. In addition, they reported that 
the conversion to intermediates (e.g. cis-resveratrol) was proportionate to the solar light 
intensity, which loosely compares to Figure 4-1 where peak height increased with irradiation 
dose (2-8 SED). To hypothesize the structure of the PTERO photoproduct that absorbed at 
262nm/376nm (Figure 4-1), Dr Robert Lucas of GSK produced a diagram depicting a possible 
chemical reaction in supplementary chapter 9.2.4 which suspects PTERO conversion to a pro-
oxidant via production of ROS. It is extremely likely that the mechanism of action/efficacy of 
PTERO would be reduced, unless formulated encapsulated (e.g. within liposomes (Sirerol et 
al., 2015)) or with sunscreen UV filters. The irradiated AOXs were tested in the FRAP assay 
and no difference between non-irradiated counterparts were found. However Sirerol et al. 
(2015) concurred with others in the literature that resveratrol/pterostilbene are not iron chelators 
and had weak radical scavenging capacity when tested with the 2,2′-Azino-bis(3-
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Ethylbenzothiazoline-6-Sulfonic Acid) (ABTS) enzymatic assay which measures how strongly 
an AOX can quench ABTS radicals. This infers that PTERO functions involve a biological 
mechanism, and therefore the intracellular effect(s) of a photo-modified PTERO remains an 
open question. Nevertheless, it is worth noting that encapsulated antioxidants such as liposome-
PTERO have shown remarkable protective effects against the production of skin cancer 
tumours in UVB treated hairless mice (Sirerol et al., 2015). Further considerations for AOX 
formulation and whole skin application are discussed in Chapter 6.  
To investigate if pilot data AOX pre-incubation could protect foreskin-derived adult skin cells 
from solar light induced mtDNA damage, THC and PTERO were tested with three or four 
donors of basale-like proliferative keratinocytes, spinosum-like differentiated keratinocytes or 
reticular fibroblasts. It wasn’t feasible to donor-match the skin cell types for monolayer 
experiments, although this a prioritised factor for human skin equivalents in chapter 5. The 
experiments were performed at 6- and 24-hour time-points, with protective effects seen at 6-
hours in some donors (Figures 4-6 to 4-9). Although both derivatives are more stable than their 
respective curcumin/resveratrol, it is likely the polyphenol antioxidants had completely 
metabolised by 24-hours through cutaneous phase II metabolic enzymes (Manevski et al., 2015; 
Kosuru et al., 2016).  
No protection was seen with either AOX in foreskin-derived adult keratinocytes (0 of 4 donors; 
Figure 4-6), and protection was seen with both AOXs in 1 of 4 donors of differentiated 
spinosum-like keratinocytes (Figure 4-7). THC (but not PTERO) protected foreskin-derived 
adult reticular fibroblasts from 2 of 3 donors, but a combination gave greater protection in 
reticular fibroblasts from a further 2 of 3 donors (Figures 6-8, 6-9). A study by Trivedi et al. 
(2017) pre-incubated a human foreskin fibroblast cell line (HFF-1) with 0.1-1µg/ml THC and 
found they were protected from apoptosis when stressed with 200mJ/cm2 (20 SED) UVB. 
Whilst the protective effects correlate with our findings, a dose of 20 SED is experimentally 
effective but not translational to real-world skin exposure. As such the biologically targeted 
qPCR assay shows how fibroblasts have protected mtDNA from an equivalent dose of 2-hours 
Mediterranean sun exposure (2.16 SED), without the induction of apoptotic pathways. In 
addition it was surprising that they reported a toxicity dose of 10µg/ml THC for HFF-1 cell 
line, when primary fibroblasts still had ~100% viability when dosed with 268µM (718 µg/ml) 
THC (Figure 4-5). This raises uncertainty about the use of HFF-1 cell line for experiments of 
this nature, suggesting that there are functional differences in HFF-1 and HDF cells. Costa-
Almeida et al. (2015) directly compared the behaviour of HFF-1 and HDF fibroblasts in 
endothelial cell co-culture for their capacity to influence the formation of capillary-like 
structures. Despite both populations being foreskin-derived fibroblasts, HFF-1 fibroblasts failed 
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to secrete extracellular matrix (ECM) proteins (e.g. collagen I) necessary for this purpose. 
However it was interesting that Trivedi et al., (2017) reported that the culture medium of 1µg/ml 
THC-treated HFF-1 cells had higher levels of extracellular matrix proteins (collagen, elastin 
and hyaluronic acid), and enhanced wound healing response to scratch-test.  
The data in Figures 6-8 and 6-9 demonstrate an enhanced protection of mtDNA in skin 
fibroblasts when PTERO was combined with THC (but not alone), which appears indicative of 
two different mechanisms of action in these skin cell types. It suggests that THC may work in 
a manner related to mitochondria, and the effects of PTERO indirectly enhance these effects. 
Kosuru et al. (2016) reviews the proposed mechanisms of action of PTERO, with emphasis on 
its recognised anticancer effects. Although most studies were performed on cancer cell lines or 
mouse models, there are recurrent suggestions that PTERO (like many polyphenols) helps to 
upregulate endogenous antioxidant enzymes via activation of the NRF2 pathway (Kosuru et al., 
2016; Dinkova-Kostova & Abramov, 2015). This pathway is synonymous in skin research for 
its role in the suppression of solar UV photo-damage (Rojo de la Vega et al., 2017). A recent 
study by Zhou et al. (2019) investigated the role of PTERO on the NRF2 pathway in a 
keratinocyte cell line (HaCaT) that they stressed with arsenic. They found a dose of 60µM 
PTERO significantly reduced HaCaT viability using the MTT assay, yet this was not seen in 
foreskin-derived adult keratinocytes from three different donors when dosed with ≥200µM 
PTERO (Figure 4-5). Zhou et al. (2019) reported PTERO increased mitochondrial membrane 
potential and upregulated mitochondrial enzymes, which together decreased cellular ROS 
levels. These findings correlate with the studies outlined in two review articles of PTERO 
mechanisms of action (Kosuru et al., 2016; Chen et al., 2017). A resonating point from Kosuru 
et al. (2016) is that a low concentrations of PTERO drove protective anti-oxidant effects, and 
that high concentrations had a pro-oxidant effect by increasing ROS as a means of inducing 
apoptosis and preventing carcinogenesis. Whilst the doses of AOXs used in Figures 6-5 to 6-9 
were selected for being high (but non-toxic), a lower dose of PTERO was included in Figure 6-
9 to investigate if this in-fact had a greater protective effect. As halving the dose did not enhance 
or diminish the protective effects seen in Figure 6-9, future studies on AOX efficacy should 
aim to find the lowest effective dose.  
Similar to PTERO and resveratrol, much of the mechanistic literature available for THC, 
curcumin and curcuminoids study their role in cancer or ischemic injury. The proposed 
mechanisms of action are similar to PTERO, as well as emphasis on a low dose for AOX effect. 
To investigate the antiproliferative effects of THC in relation to the cell-cycle, Ayli et al. (2010) 
used doses of 50-200µM THC on 18mJ/cm2  (1.8 SED) UVB treated foreskin-derived neonatal 
keratinocytes. Their THC doses roughly correlate with the 67µM THC used in this thesis on 
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foreskin-derived adult keratinocytes. Whilst this study does not address mechanisms outside of 
the cell-cycle, it does confirm that the antiproliferative effects reported in other models also 
extends to skin keratinocytes. It also reproduced some data by Dujic et al. (2007) who reported 
UVA or VIS photoactivation of low level curcumin in HaCaT keratinocyte cell line was 
required to stimulate antiproliferative effects. This is a consideration for product design and 
future work, whereby photoactivation of AOXs would be protected against by the presence of 
UV filters.  
Current literature does not mention mtDNA in relation to either THC or PTERO, nor their 
combination. Whilst some information exists relating to mechanisms of action that affect 
mitochondrial activity and redox pathways, the protection of skin fibroblast mtDNA from solar 
light induced damage is novel and worthy of future study.  
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 Summary of findings 
➢ THC and PTERO absorbed UVB, but PTERO was not photostable upon irradiation with 
solar simulated light (UV-VIS-IR; see 2.2.2) 
➢ The FRAP assay was insufficient at determining the functional difference between intact 
and photo-modulated PTERO 
➢ AOX powders remained stable for years when stored light-protected at 4oC 
➢ Human foreskin-derived adult keratinocytes/reticular fibroblasts had variable levels of 
sensitivity to AOX dose and damage stimulus (e.g. H2O2). Overall, fibroblasts were more 
robust than keratinocytes. 
➢ Human foreskin-derived adult keratinocytes pre-incubated with THC or PTERO for 6 hours 
were not protected from mtDNA damage induced by 2.16 SED complete solar irradiation 
➢ Human foreskin-derived adult differentiated keratinocytes pre-incubated with THC or 
PTERO for 6 hours were not protected from mtDNA damage induced by 2.16 SED 
complete solar irradiation 
➢ Human foreskin-derived adult reticular fibroblasts pre-incubated with THC (but not 
PTERO) for 6 hours were protected from mtDNA damage induced by 2.16 SED complete 
solar irradiation 
➢ Human foreskin-derived adult reticular fibroblasts pre-incubated with THC and PTERO 
combination for 6 hours received greater mtDNA protection than THC alone, when exposed 
to 2.16 SED complete solar irradiation 
➢ Protective effects were not seen for any cell type when pre-incubated with THC and PTERO 
for 24 hours (data not included) 
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Chapter 5:  Development of a full thickness human skin equivalent  
 Chapter overview and aims 
CELLnTEC Advanced Cell Systems AG (Switzerland) produce commercial media for the 
development of full thickness human skin equivalents, with ingredients endogenous to the 
human cellular environment, and elimination of scaffold materials. This system was trialled 
with in-house donor-matched keratinocytes and fibroblasts from adult foreskin donors. The 
primary aim of this chapter was to characterise this model, compare it to a commercial model 
(Labskin™), and assess its suitability for various experiments. Pilots were designed to determine 
where the commercial protocol could be flexible, e.g. scaling model size or tissue site. A 
secondary aim was to investigate the use of facial cells in lieu of traditional foreskin derived 
cells and determine the degree of influence that tissue site has on the models produced.  
 Chapter specific methods 
 Human skin equivalents: full thickness and scaffold-free 
5.2.1.1  Model establishment 
Human skin keratinocytes and fibroblasts were isolated and cultured from foreskin and facial 
skin samples as outlined in section 2.1.  
Skin models were grown according to the CELLnTEC online protocol 
(http://CELLnTEC.com/wp-content/uploads/pdf/FT_Skin_Model_Protocol.pdf)    
using CELLnTEC specialist medium (CnT-PR, CnT-PR-F, and CnT-PR-FTAL) alongside 
ThinCert™ 0.4µm PET transparent hanging inserts (see Table 5-1). Media was thawed at 4oC, 
light protected and aliquoted into 50ml tubes. If surplus to experimental requirements, these 
were stored at -20oC and thawed as required at 4oC. Light protected media aliquots were 
warmed briefly at room temperature before use and free from antibiotics/antifungals.  



















24 well 33.6 350 700 14,000 35,000 662640 
12 well 113.1 1000 2000 50,000 120,000 665640 
6 well 452.4 2000 4000 200,000 840,000 657640 
 




In order to donor-match epidermal and dermal layers, cryopreserved keratinocytes were thawed 
approx. 7-10 days prior to seeding onto the fibroblast dermal layer.  
Models were raised to the air liquid interface using CELLnTEC 12-well spacer plates (CnT-
SP), or single use Greiner ThinCert™ 6 well (657110) or 12 deep well plates (665110). For 24-
well models’ inserts were placed inside 12-well inserts and raised as for 12-well plates. As 
ThinCert™ plates have increased depth (e.g. 4ml volume/12 well), media was reduced to ‘half 
feeds’ (i.e. 2ml was replaced per well). 
At all stages empty wells were filled with the same volume of PBS to prevent unequal 
evaporation.  
5.2.1.2  Model harvest 
Models were generally quartered, with two quadrants embedded in OCT and/or paraffin blocks 
for histology and the others snap-frozen in liquid nitrogen before storage at -80oC.  
 Epidermal skin equivalent  
As cryopreserved keratinocytes are not routinely used for in-house equivalents, they were 
additionally seeded for reconstructed epidermis (RHE) models according to an in-house 
published method (Forrester et al., 2014). Keratinocytes (1x106/model) were seeded into 12mm 
0.4µm PCF inserts (Millipore) placed in 6-well plates. EpiLife™ medium was as outlined in 
section 2.1, but additionally supplemented with 0.22µm sterile filtered 1M CaCl2 (PBS diluent; 
Sigma) to a final calcium concentration of 1.5mM. The equivalents were maintained overnight 
in high calcium medium, before grown at the air-liquid interface for 14 days in high calcium 
medium freshly supplemented with 0.22µm sterile filtered 5µg/ml ascorbic acid (ddH2O 
diluent; Sigma). Media was changed three times weekly. 
 Histology and immunostaining 
Human skin biopsies from adult foreskin or facial sites and human skin equivalent models were 
sandwiched between two biopsy foam pads, placed within tissue embedding cassettes (~1mm2 
holes), and fixed overnight in 10% formalin (Sigma). The small cassette holes ensured tissue 
was not lost during processing/embedding. All tissue processing, paraffin embedding, and 
sectioning was completed at the Newcastle Molecular Pathology Node, UK.  
All OCT embedding and cryosectioning was performed in-house. OCT blocks were stored at -
80oC, and cryosections were air-dried for >1 hour before immediate staining or storage for up 
to 1 month at -20oC.  
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All non-fluorescent images were acquired at 40X magnification with Leica SCN400 Brightfield 
Slide Scanner and Autoloader system at Newcastle University Central Biobank, UK. All 
fluorescent images were acquired at Newcastle Bio-Imaging Unit, UK.  
5.2.3.1  Haematoxylin and Eosin (H&E) 
Some H&E staining was performed at the Newcastle Molecular Pathology Node. In-house 
staining was performed as follows. Paraffin embedded 5µm sections were baked at 60oC 
overnight, cooled and passed through 90%, 100% ethanol, Histoclear™ (15 minutes), 100, 90 
and 70% ethanol. OCT embedded 7µm sections were air-dried at room temperature for 30mins 
and rinsed with distilled water. Paraffin or OCT were then incubated with haematoxylin (30 
seconds) and eosin (10 seconds), washed with tap water, passed through 70, 90 and 100% 
ethanol and mounted with DPX (06522, Sigma).  
5.2.3.2  Oil red O (with optional haematoxylin) 
OCT cryosections (10µm) were air-dried at room temperature for 30 minutes. Initial attempts 
to make Oil red O from powder was time-consuming and provided negative staining. Oil red O 
solution (0.5% isopropanol; Sigma) was then purchased and used as a single use stain. Slides 
were rinsed in distilled water (1 minute), fixed in 10% formalin (1 minute) and rinsed in 60% 
isopropanol before 30-minute incubation in Oil red O solution. They were briefly rinsed in tap 
water before counterstain in haematoxylin (optional; 15 seconds). They were rinsed in tap water 
and mounted with Aquatex™ (108562, Sigma). 
5.2.3.3  Fluorescent staining: collagen I, collagen IV, fibrillin, cytokeratin 14 
OCT cryosections (8µm) were air-dried at room temperature for 30mins, rinsed in PBS, fixed 
in 4% PFA for 10 minutes, and permeabilised in 0.2% Triton X-PBS for 10 minutes. Rabbit 
and mouse antibody co-staining included 30 minutes blocking in PBS-2% BSA (a9647, Sigma) 
supplemented with 2% goat serum (G9023, Sigma) and 2% donkey serum (D9663, Sigma). All 
primary and secondary antibodies were diluted in PBS-2% BSA. For multi-staining rabbit and 
mouse species, primary antibodies were incubated together humidified overnight at 4oC at the 
following dilutions: collagen I (1:1000, rabbit, ab34710, Abcam), collagen IV (1:1000, mouse, 
ab6311, Abcam), fibrillin (1:1000, mouse, mab1919, Millipore), cytokeratin 14 (1:200, rabbit, 
PA5-16722, Invitrogen – kindly gifted by Dr Pawan Gulati of Newcastle University). Slides 
were washed 3 x 10 minutes in PBS-T on a rocker at room temperature. Secondary antibodies 
were incubated together at room temperature for 1 hour as the following dilutions: donkey anti-
mouse-Alexa594 (1:2000, A1203, Thermo) and goat anti-rabbit-Alexa647 (1:2000, A21244, 
Thermo). Slides were washed light protected 3x10minutes in PBS-T, incubated for 15 minutes 
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in 1µg/ml DAPI (PBS diluent), rinsed in PBS and passed through distilled water to removed 
salts before mounting with ProLong Fade Diamond (Thermo). After overnight curing the edges 
were varnish sealed and slides stored light protected at 4oC.   
Imaging was performed at Newcastle Bio-Imaging Unit with Dr Glyn Nelson. Initial studies on 
autofluorescence used Zeiss AxioImager with Apotome, but later changed to Zeiss LSM800 
confocal imaging for labelled staining. Negative controls were performed on all imaged 
samples to test for autofluorescence and non-specific labelling. Zeiss LSM800 images were 
captured with a 20x (0.8 NA) or a 40x (1.3 NA) lens, running Zen Blue v2.3 software (Zeiss). 
For multicolour fluorescence each channel was captured sequentially with the following 
excitation (ex.) /emission (em.) wavelengths: DAPI ex.405nm/em.400-580nm, Alexa Fluor 594 
ex.561nm/em. 580-650nm, and Alexa Fluor 647 ex.640nm/em.546-700nm.  Pixel density was 
maintained at Nyquist resolution for optimal imaging conditions.  Post-acquisition, 3D stacks 
were rendered as maximum intensity projections to show the fluorophore distribution 
throughout the section. 
5.2.3.4  Multiphoton label free imaging of CELLnTEC human skin equivalent  
A 50µm cryosection was rinsed with distilled water and mounted with ProLong Fade Diamond 
with DAPI (Thermo). Images were acquired by Dr Glyn Nelson of Newcastle Bio-Imaging Unit 
on a Zeiss LSM880 confocal microscope equipped with non-descanned detection (NDD) on an 
epi port. For two photon imaging, excitation of DAPI was performed with a Coherent Discovery 
laser (80 MHz, ~100fs pulses) tuned to 760nm whilst sequential second-harmonic generation 
(SHG) signal from collagen and sample autofluorescence were excited using the dedicated 1040 
nm output line. Emissions were detected using a 445-485nm bandpass for DAPI, 515-525nm 
bandpass for SHG and 570-610nm bandpass for autofluorescence using NDD detectors. 
 Protein ELISA: human pro-collagen I, fibronectin and hyaluronan              
Medium collected for ELISA was immediately stored on wet ice before storage at -80oC. 
Samples were thawed on wet ice for protein ELISA analysis of human pro-collagen I (COLA1), 
fibronectin (FN) and hyaluronan (HA). ELISAs were performed in the lab of Dr Lee Borthwick 
at Newcastle University using R&D Systems DuoSet ELISA kits DY6220-05, DY3614-05, and 
DY1918-05. ELISAs were scaled down to half-area 96 well plates (675061, Greiner) with 25µl 
well volumes. The reagent diluent (RD) for COLA1/FN was 1% BSA-PSA and HA was 5% 
PBS-Tween. Capture antibodies were diluted 1:100 in PBS and incubated overnight at 4oC. All 
incubations were on a rocker, and at room temperature unless stated otherwise. All washes were 
performed using PBS-0.05%Tween (PBS-T) on a Wellwash™ microplate plate washer 
(Thermo). Plates were blocked in RD for 1 hour and incubated with samples/standard for 
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2hours. To determine sample dilution, standard curves for each kit standard were performed on 
suspected high protein samples with a serial 1:4 dilution: neat, 1:4, 1:16: 1:256, 1:1024, 1:4096 
and 1:26,382. Sample dilutions were performed in U-bottomed plates and mixed thoroughly on 
a plate shaker. Samples were diluted in RD: 1:2000 (COLA1/FN) and 1:1000 (HA). Detection 
antibody was diluted 1:100 in RD and incubated for 2 hours. Streptavidin-HRP was prepared 
per kit instructions and incubated for 20 minutes in the dark. Substrate Reagent (DY999, R&D 
Systems) was prepared per kit instructions and incubated for maximum 20 minutes in the dark 
(checked visually every 5 minutes for colour gradient). Stop solution (1M H2S04) was rapidly 
applied to prevent saturation, and plates read at 450nm using Filtermax F5 microplate reader 
with Softmax pro 6 software. The Kit standards were used on every ELISA plate, and each 
sample/standard was in duplicate.  
 Western blot: human collagen I 
Cell pellets were lysed and quantified as outlined in 2.6. Protein lysate was thawed on ice, 
prepared with 4X Laemmli sample buffer and denatured at 95oC for 5 minutes. Electrophoresis 
was performed with the XCell SureLock Mini-Cell System (Thermo). Each protein lysate 
sample was run in triplicate (10µg/lane) alongside PageRuler Prestained Protein Ladder (10-
180kDa; Thermo) on NuPage Novex 4-12% BIS-Tris gel(s) for 40 minutes (200v) with 1X 
NuPage MES SDS Running buffer (ddH2O diluent; Thermo) and 500µl NuPage Antioxidant 
(Thermo). Wet-transfer to PVDF membrane was performed for 1 hour (100v) using Bio-Rad 
Mini-PROTEAN Tetra System, and cold 1X NuPage Transfer Buffer (1L: 50ml 20X NuPage, 
1ml NuPage Antioxidant, 100ml 100% Methanol, 849ml ddH2O).  
Unless stated all washes or incubations were performed whilst rocking at room temperature, 
with washes performed in 1X TBS-0.1%Tween (TBS-T) buffer for 15 minutes. Membrane was 
washed and blocked in 5% milk-TBS-T for 1 hour. The blot was cut between 55-70kDa, with 
the top half incubated overnight at 4oC in collagen I primary antibody (ab34710, Abcam, 1:500 
in 1% milk-TBS-T) and the lower half in GAPDH (#2118, Cell Signalling Technologies, 
1:10,000 in 5% milk-TBS-T). HRP goat anti-rabbit (peroxidase) secondary antibody was 
incubated for 1 hour (1:20,000 in 5% milk-TBS-T, Vector Labs). There were three washes in 
TBS-T after each antibody incubation, before development with Supersignal West Dura ECL 




 Pilot study #1: Two donor trial of CELLnTEC full thickness skin model  
In the first pilot study, keratinocytes and reticular fibroblasts isolated from two adult foreskin 
donors (S1073F/S1074F, see Table 2-2) were used to grow donor-matched and scaffold-free 
full thickness models (12 well size, n=2 per donor). Cells were isolated and expanded as 
outlined in section 2.1 and switched to CELLnTEC medium when seeded into inserts. The 
CELLnTEC protocol was followed including omission of antibiotics/antifungals. The 
fibroblasts had not been frozen and were seeded into inserts as passage number 2 cells with 
frequent doublings. The keratinocytes had been cryopreserved to ensure low passage number 
when thawed, expanded in EpiLife™ and seeded onto the dermis layer at day 10 (in Airlift 
medium). As in-house frozen keratinocytes are not generally used for human skin equivalent 
models and this was a new methodology, cells were simultaneously seeded for epidermal 
models according to an in-house established method (supplementary Figure 9.3). The 
keratinocytes successfully formed full thickness models (Figure 5-1). 
Upon completion no contraction was evident and a visible dry stratum corneum was evident. 
Initial histological assessment are shown in Figure 5-1 which visually compare well to the 
CELLnTEC promotional image established with neonatal cells from different donors 
(supplementary Figure 9.3). To determine the layer thickness of online promotional images, 
CELLnTEC were contacted for scale bar information who stated that the PET membrane is 
~10µm (supplementary Figure 9.3). The model histology of both donors shows a keratinised 
stratified epidermis attached to a thicker dermal layer, and a dermo-epidermal junction is visible 
(Figure 5-1). The dermis of S1074F (age 28) was markedly thicker than that of S1073F (age 





 Histological H&E staining of skin equivalents developed using CELLnTEC commercial medium and 
foreskin-derived adult keratinocytes and reticular fibroblasts. Models grown from foreskin-derived and donor-matched 
adult keratinocytes and reticular fibroblasts of S1073F (male – age 65) and S1074F (male – age 28). Models have formed a 
keratinised stratified epidermis attached to a thicker dermal layer. The dermal ECM was secreted by the fibroblasts, without 
use of an artificial scaffold. A dermo-epidermal junction is visible, and fibroblasts are evident within the dermal layer. 
Measurements (mm) of stratum corneum, epidermis and dermis have been calculated using the scale bars for both models, 
alongside the CELLnTEC promotional image (see supplementary Figure 9.3 or CELLnTEC.com) and three ex-vivo whole 
foreskin donors (S1141F – male, ag 40, S1142F – male, age 17, S1145F – male, age 51; see supplementary Figure 9.4). 
Identifying where the dermis met hypodermis in ex-vivo whole skin could not be performed confidently by eye, so they were 
measured together (see 9.2.8). Reference skin from S1073F and S1074F was unavailable. H&E staining was performed on 
three sections per model from each FFPE and OCT block. Images shown are one FFPE section per donor, with FFPE providing 




5.3.1.2 Optimisation of multicolour immunofluorescence staining protocol 
To characterise the biological relevance of human skin equivalent models, skin biomarkers 
were optimised for multistaining. Emphasis was placed on extracellular matrix proteins, as the 
dermal matrix in CELLnTEC models is entirely derived from adult fibroblasts. Optimisation 
was performed in the stages outlined in Figure 5-2. 
 
Control Sample preparation Useful for 
Autofluorescence • Fixation 
• Permeabilization 
• Blocking 
Analyzation of cellular 
autofluorescence. 
Threshold for microscopy in direct IF. 





• Secondary antibody 
• (If desired: nucleus staining) 
Unspecific binding of secondary 
antibody. 
Threshold for microscopy in indirect 
IF. 
Multicolour IF • Fixation 
• Permeabilization 
• Blocking 
• Only 1 first antibody 
• (Indirect IF: secondary antibody) 
• (If desired: nucleus staining) 
Compare single staining to multicolour 
image: 
Check for crosstalk of the selected 
fluorochromes. 
Check if first antibodies affect each 
other in epitope binding. 
 
 Optimisation conditions used for individual and multicolour immunofluorescent (IF) labelling of frozen 
OCT embedded tissue. Table source: https://www.leica-microsystems.com/science-lab/how-to-prepare-your-specimen-for-
immunofluorescence-microscopy/ 
 
As skin is highly autofluorescent, a spectral analysis was performed on frozen sections of 
CELLnTEC models grown from foreskin-derived and donor-matched adult keratinocytes and 
reticular fibroblasts of S1073F (male – age 65) and S1074F (male – age 28). The effect of 
fixative (4% PFA, 100% cold acetone, 100% cold methanol, or cold acetone: methanol) was 
found to have a positive effective on autofluorescence with mild quenching of high signal (data 
not shown). Whilst skin autofluoresces strongly across the spectrum (with a particularly strong 
signal in the green region), green region autofluorescence was not as strong as whole skin and 
could be corrected for with imaging settings. However as seen in Figure 5-3, far red dyes were 
the best option for human skin equivalents, and 4% PFA fixative was selected for its likelihood 
to be suitable for many primary antibodies (see supplementary Figure 9.2 which compares 
fixatives for IF staining). 
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Figure 5-3: Determination of suitable fluorophores for IF labelling of CELLnTEC skin equivalents. A: Schematic of 
excitation (dashed) and emission (solid) spectra for Alexa Fluor -488, -594, -647, and DAPI. Both -488 and DAPI excite in the 
green region of the spectra, where skin autofluorescence emits strongly. Image source: Florescence SpectraViewer on 
ThermoFisher.com. B: CELLnTEC human skin equivalent OCT cryosections (7µm) were 4% PFA fixed and tested for 
autofluorescence in four light channels. Model used was derived from adult skin cells of donor S1074F (male – age 28). 
Autofluorescent signal was negligible in >600nm wavelengths where far right dyes (Alexa Fluor 594 and 647) emission spectra 









S1074F human skin equivalent sections were also used for optimisation in the following 
experimental conditions (performed simultaneously): donkey anti-mouse Alexa-Fluor 594 
secondary antibody (no primary antibody, blocked with donkey serum and BSA), goat anti-
rabbit Alexa-Fluor 647 secondary antibody (no primary antibody, blocked with goat serum and 
BSA), one primary antibody per section with species appropriate secondary antibody, and 
rabbit: mouse combinations of primary antibodies (with both serums and secondary antibodies). 
Starting dilutions were selected from publications and/or company recommendations and 
diluted 1:2 if the signal was strong but with some noise. Concentrations of BSA, serum, Triton-
X, and washing buffers were selected from recommended ranges and published protocols. They 
did not require additional optimisation and worked well for all conditions tested, with no non-
specific binding found. It was recommended by a histology technician that OCT-embedded 
tissue sections mounted onto slides should only be stored at -20oC for 1 month before IF staining 
was performed. Tissue integrity was best preserved for long term storage within the OCT block 
at -80oC. During optimisation Brightfield was used in lieu of DAPI to ensure the channels of 
interest had clean and specific signal. In later imaging it was found that DAPI staining should 
be performed before mounting, as DAPI-containing mountant created substantial background 
artefact. To achieve a wide field of view, images were initially acquired in single plane and 
stitched as tiles. However, as skin models are 3D structures it was necessary to generate images 




Figure 5-4: Optimisation of multi-label immunofluorescence on CELLnTEC method derived human skin equivalents. 
Combinations of single (A/B) and combined (C) collagen I and IV (mouse/rabbit) antibodies were used.  Scale bars 100µm. 
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5.3.1.3  Fluorescent imaging of collagen I, collagen IV, fibrillin and cytokeratin 14 in 
CELLnTEC and Labskin™ models 
CELLnTEC models grown from foreskin-derived and donor-matched adult keratinocytes and 
reticular fibroblasts of S1073F (male – age 65) and S1074F (male – age 28), and Labskin™ 
(batch 190103) were simultaneously multi-stained with rabbit and mouse primary antibodies 
combined as collagen I and IV, or fibrillin and cytokeratin 14. DAPI was included for cellular 
localisation, but the borrowed aliquot used failed to stain some sections and a new stock should 
have been made or purchased. Autofluorescence was quenched sufficiently in CELLnTEC 
models that negligible or no adjustment was required to the DAPI, -594, and -647 channel 
histograms.  
In CELLnTEC models, the amounts of collagen I, IV and fibrillin demonstrated an extensive 
extracellular matrix. Collagen I was abundant (red), and collagen IV was present throughout 




 Multi-labelling of extracellular matrix proteins collagen I and collagen IV on CELLnTEC method derived 
human skin equivalent. Model used donor-matched keratinocytes and reticular fibroblasts derived from adult foreskin (donor 
S1074F – male, age 28). DAPI nuclear staining included for cellular localisation. Abundant collagen I (red) is present in the 
dermis layer, with collagen IV (green) more concentrated around the basement membrane. Scale bars 50µm. 
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Higher magnification (40X) of the collagen and fibrillin demonstrated a structured 3D matrix 




 High magnification (40X) confocal imaging of multi-labelled extracellular matrix proteins Collagen I and 
Collagen IV on CELLnTEC method derived human skin equivalent. Model used donor-matched keratinocytes and 
reticular fibroblasts derived from adult foreskin (donor S1074F – male, age 28). DAPI failed to stain fibroblast nuclei on this 




 Multi-labelling of extracellular matrix protein Fibrillin and epidermal marker Cytokeratin 14 on 
CELLnTEC method derived human skin equivalent. Model used donor-matched keratinocytes and reticular fibroblasts 
derived from adult foreskin (donor S1074F – male, age 28). DAPI failed to stain fibroblast nuclei on this section, but it wasn’t 
a priority to repeat due to time constraints. Abundant fibrillin is present in the dermis layer, with cytokeratin 14 specific to 
epidermis. Scale bars are 50µm. 
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Labskin™ cryosections were cut and stained with CELLnTEC models. Autofluorescence 
extended to the far-red channel -594, particularly in relation to the fibrin gel scaffold (data not 
shown, as corrected for using unstained control sections). This did not extend to the wavelength 
of Alexa-647. Negative controls were used to correct for -547 autofluorescence in stained 
sections. However, after correction no positive signal remained for collagen IV or fibrillin 
extracellular matrix proteins. DAPI revealed sparse fibroblast numbers in the thick dermal 
compartment, but no evidence of secreted extracellular matrix within the fibrin gel scaffold. In 




 Labskin™ immunostaining of collagen I and collagen IV (A), or fibrillin and cytokeratin 14 (B). DAPI 
nuclear staining included for cellular localisation. Extracellular matrix proteins collagen IV and fibrillin were not present, and 
collagen I was in the epidermis instead of dermis. Epidermal cytokeratin 14 stained positive. Scale bars 50µm. 
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5.3.1.4  Label free structural imaging using multiphoton microscopy  
Ex-vivo skin and human skin equivalents are strongly autofluorescent in the green region of the 
spectrum (see Figure 5-3). To determine if this signal was strong enough to enable label free 
imaging, a 50µm cryosection of a CELLnTEC media derived model was mounted with pro-
long fade diamond with DAPI. The model used was formed using donor-matched keratinocytes 
and reticular fibroblasts derived from adult foreskin (donor S1074F – male, age 28). Dr Glyn 
Nelson (Newcastle University) generated some test images with one, two and three photon 
excitations. In addition, he used second harmonic generation to generate label free imaging of 
structures (specifically collagen at 515-525nm), with autofluorescence (570-610nm) 
functioning as a background ‘counter stain’ alongside nuclear stain DAPI (445-485nm).  
 
 
 Label free multiphoton microscopy of CELLnTEC method derived human skin equivalent. One photon 
excitation of autofluorescence produced a strong positive signal at 570-610nm (green region). Two photon excitation identified 
collagen structures, with a strong signal concentrated towards the top of the dermal compartment. DAPI was included as a 
positive control signal and cellular localisation. Scale bars 50µm. 
 
 Pilot study #2: Investigation of CELLnTEC model longevity, XP3 maintenance 
medium trial, and induction of solar light mtDNA damage 
In the second pilot study, keratinocytes and reticular fibroblasts isolated from three adult 
foreskin donors (S1141F – male, age 40, S1142F – male, age 17, S1145F - male, age 51) were 
used to grow donor-matched and scaffold-free full thickness human skin equivalents with 
CELLnTEC medium (12 well size, n=12 per donor). Reference H&E histology for these donors 
is available in supplementary Figure 9.5. To investigate the culture duration of formed human 
skin equivalents (at day 28), twelve were grown per donor to investigate their integrity at four 
harvest time-points (days 0, 4, 8 and 12). There were three skin equivalents at each harvest to 
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investigate model variation. When the skin equivalents were almost formed, there was a 
problem with contraction as illustrated in Figure 5-11 D+E. Whilst almost all had some 
puckering contraction that created a thicker outer ‘roll’ and non-uniform shape (E), 2 of 36 had 
severe contraction that rendered them unusable (D).  
Whilst CELLnTEC medium is used to develop human skin equivalents, the company doesn’t 
recommend a medium to maintain the fully formed equivalents or indicate how long they can 
remain viable for experiments to be performed. When contacted they suggested a trial of 
CELLnTEC CnT-XP3 medium may be suitable as it was designed for extended ex-plant culture 
of up to 10 days. As CnT-XP3 medium contained phenol, the first visual observation was made 
that equivalents formed with the skin cells of  the 17-year-old donor (S1142F) were 
metabolising the medium much quicker than  that of the 40-year-old donor (S1141F). The 
medium would be yellow within 24 hours, as conveyed in Figure 5-10 C. 
 
 
 Photographs of CELLnTEC human skin equivalents pilots #1 and #2. A+B: pilot #1 of skin equivalents 
grown using donor-matched foreskin-derived adult skin cells from donors S1073F (male – age 65) or S1074F (male – age 28), 
which had a dry stratum corneum and no contraction. C: pilot #2 involved the transition of fully formed skin equivalents to a 
culture medium CnT-XP3 that contains. This demonstrated for the first time that metabolic capacity of skin equivalents would 
differ between donors, with the yellow wells showing medium from a 17 year-old donor (S1142F) and  the red wells show how 
the medium from a 40-year-old donor (S1141F) hasn’t changed in the same time-frame (24 hours). D+E: pilot #2 skin 
equivalents had contraction/shrinkage of various distances from the insert edge. Only 2 of 36 skin equivalents were as severe 
as the equivalent shown in ‘D’, which was experimentally unusable.  
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In pilot #1 there was inter-donor variability in established skin equivalents, whereby those 
derived from a younger donor had a thicker dermal layer (Figures 5-1). However, an association 
between skin donor age and ‘better-formed’ skin equivalents was not clearly seen in pilot #2. 
In fact there was a missing or fragmented epidermal layer in the H&E stained FFPE sections of 
most skin equivalents derived from donor S1141F (male – age 40; Figure 5-13) or S1142F 
(male – age 17; Figure 5-14). It was unclear if the epidermis had failed to form correctly or it 
was an artefact of histological processing. S1141F was the only foreskin donor used with a Fitz. 
type V phototype, but it is unclear if this was a contributing factor to sub-optimal skin 
equivalents. 
The largest number of histologically-intact skin equivalents were those developed with 
foreskin-derived cells from donor S1145F (male – age 51; Figure 5-12). However an important 
observation was made that the dermis progressively thinned throughout 12 days in culture, 
whilst the stratum corneum appeared to continue progressively thicken (Figure 5-12). This is 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In pilot #2, an additional two skin equivalents were developed from donors S1141F and S1142F 
to test the induction of mtDNA damage through solar simulated irradiation. The 2.16 SED dose 
given to cell monolayers (see Chapter 4) induced a similar amount of mtDNA damage in the 
3D skin equivalents of both donors. The 11kb assay (Chapter 3) was used to determine a 4 Ct 
or 32-fold (24) induction of mtDNA damage, as seen in Figure 5-14. The DNA yield per 
quadrant of a 12-well skin equivalent was ~7-11µg for S1141F and ~8µg for S1142F.  
 
 
 Detection of solar radiation induced mtDNA damage in CELLnTEC skin equivalents using 11kb qPCR 
assay. Skin equivalents  were irradiated with 2.16 SED (see 2.2.2.). The standard erythemal dose (SED, J.m-2) is equivalent to 
an erythemal radiant exposure of 100 J.m-2. Mean ± SD data from one human skin equivalent per donor (S1141F (male - age 
40), S1142F (male – age 17). Statistical difference determined by one-way ANOVA with Tukey’s post-hoc test. **** p <.0001, 
N=1, n=3 
 
 Pilot study #3: CELLnTEC skin equivalent scaling between insert sizes, 
fresh/frozen medium comparison, and multiphoton live imaging trial  
In the third pilot study, keratinocytes and reticular fibroblasts isolated from one adult foreskin 
donors (S1147F – male, age 53) were used to grow donor-matched and scaffold-free full 
thickness human skin equivalents with CELLnTEC medium in three sizes (24-, 12-  and 6-
well). As each 12-well size skin equivalent requires 120,000 keratinocytes, a 24-well size was 
trialled because it would be an important option for smaller skin samples (e.g. facial) which 
produce reduced numbers of keratinocytes. A 6-well size skin equivalent was trialled only to  
attempt live imaging, so that the microscope objective could be accommodated. A comparison 
was also made between two commercial brands of hanging inserts (Greiner and Millipore) to 
grow 12 well size skin equivalents. This was because CELLnTEC switch between these brands, 
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but report discrepancies between the PET membrane of individual batches. A more critical 
comparisons was made between  ‘fresh’ and ‘frozen’ CELLnTEC medium, because once a 
medium bottle is thawed it is only viable for 6 weeks at 4oC before the nutrients/supplements 
are depleted. The medium was thawed at 4oC protected from light, but some was portioned into 
50ml aliquots and re-frozen. For each size (6-, 12-, 24-well), two skin equivalents was grown 
with the ‘fresh’ medium and two with the ‘frozen’ aliquots. One of each was used for live 
imaging (Figure 5-16), and the other embedded in FFPE and OCT for standard histology.  
In this pilot, both cell types were thawed and expanded in their cell-specific CELLnTEC 
epithelium or fibroblast proliferation medium before seeded into hanging inserts. It was 
observed that cells revived and proliferated very well in this medium, regardless of whether the 
medium had been re-frozen. Countess II Cell Counter (Invitrogen) readings confirmed almost 
identical cell counts and >90% live cells for flasks with ‘fresh’ or ‘frozen’ medium.  
However, after this point it was found that skin equivalents developed compact and well defined 
as 24-well size. Unfortunately the FFPE comparison tissue for ‘24-well size + frozen medium’ 
was lost in processing as a result of the cassette holes being too large. However, an OCT section 
of this skin equivalent was reviewed and was considerably thinner than ‘fresh’ with limited 
dermis. The same pattern was found for the 12-well skin equivalent grown in ‘frozen’ medium, 
although the skin equivalent in OCT had a thicker dermis. No 6-well insert slices looked formed 
in FFPE or OCT sections. From this data it appears that both fresh media and a 24 size are the 
best conditions for skin equivalents, but even that model is not as good as those produced from 




 Histological H&E staining of skin equivalents developed using CELLnTEC commercial medium and 
foreskin-derived adult keratinocytes and reticular fibroblasts from donor S1147F. Skin equivalents were grown in three 
insert sizes (6-, 12-, 24-well) and in fresh or frozen aliquots of CELLnTEC prime medium. One FFPE skin equivalent was lost 
in tissue processing due to the biopsy cassette hole size.  H&E staining was performed on three sections per FFPE-embedded 
skin equivalent. N=1, n=3.  
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As both autofluorescence and second harmonic generation (SHG) signal of the collagen had 
been viewed well in a skin equivalent cryosection (S1074F donor, Figure 5-9), live label-free 
imaging was trialled on these skin equivalents using the multiphoton system (see 5.2.3.4), with 
Dr Glyn Nelson of Newcastle Bio-Imaging Facility.  
The 6-well size inserts could not accommodate any available objectives. If an objective did fit 
within the insert, it would only be able to image the middle portion of the skin equivalent. An 
InverterScope™ was used to invert the objective and attempt to image from underneath, but it 
was difficult to optimise through the PET membrane. We next tired removing the 12-well 
(fresh) skin equivalent from the insert onto a glass slide, with the stratum corneum dry and 
facing upwards. A drop of water was required underneath to keep the skin equivalent from 
dehydrating and curling inwards. Some second harmonic collagen signal was attained, but it 
was very dim, and the structures all appeared to run vertically (Figure 5-16). Given that the 
H&E imaging in Figure 5-18 was acquired after this live SHG trial, the dim signal was likely 
attributed to inadequate model formation from this donor.  
 
 
Figure 5-16: Second harmonic generation of skin equivalent collagen using live label-free multiphoton microscopy.  Live 
SHG multiphoton imaging of dermal pan-collagen in non-fixed skin equivalents developed using CELLnTEC commercial 
medium and foreskin-derived adult keratinocytes and reticular fibroblasts from donor S1147F. Image from a 12-well size skin 
equivalent grown with fresh medium and removed from its insert for imaging.  
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 Pilot study #4: CELLnTEC skin equivalent antioxidant cream application, and 
analysis of equivalents development by ELISA testing media 
Initially a young (S1142F, male – age 17), middle age (S1151F, male – age 35) and older donor 
(S1146F, male – age 76) were selected to establish skin equivalents for a time-scale AOX 
protection study using topical application of test formulations. The fibroblasts proliferated well 
when thawed and were passaged once before seeding into inserts. They grew for 10 days while 
keratinocytes simultaneously proliferated to confluence post-thaw. Accutase™  was used 
instead of Trypsin-EDTA for keratinocyte passaging because it was recommended by 
CELLnTEC, it is a gentler enzyme, and doesn’t require neutralising/centrifugation. However, 
when the keratinocytes were passaged with Accutase™ they did not adhere to the new flask 
surface, and the majority subsequently died by the following morning. When the medium was 
moved to a new flask, some viable cells did adhere but were no longer the correct morphology.  
The study was repeated with remaining donor-matched cell stocks. Donors S1141F (male - age 
40) and S1151F (male – age 35) were used to grow skin equivalents to compare against 
commercial Labskin™. Donor S1154F (male – age 44) was also intended for use but failed to 
thaw viable proliferative fibroblasts. This is a rare phenomenon that occurs with some donors, 
although they are generally always older than 70 years old. Although S1141F and S1151F 
keratinocytes were thawed on the same day, S1141F proliferated twice as fast as S1151F. As 
such S1141F had to be passaged at day 5, but when treated with Accutase™ the same problem 
with flask adherence arose. Another vial of S1141F keratinocytes was thawed which was 
reasonably confluent after 5 days, for seeding onto the dermis. Neither donor was passaged 
between thawing and seeding onto the dermis layer, but it was noted that keratinocytes are 
centrifuged to change medium type so all Accutase™ was removed. Future work should 
therefore also centrifuge the keratinocytes to remove Accutase™ when passaging to new flasks. 
Unfortunately, when histology was performed on PPFE and OCT embedded skin equivalents, 
none had formed into 3D skin models (data not included). In addition when DNA was extracted 
from the skin equivalents for qPCR there was only 0.2-0.8µg, which was considerably less than 
the 8-11µg extracted from previous skin equivalents grown with donor S1141F (Figure 5-13). 
Media was collected throughout skin equivalent development on days 4, 9, 14, 19, 24 and 29 
(Figure 5-17). This was stored at -80oC and used for protein ELISA of pro-collagen I, 
fibronectin and hyaluronan. The ELISA data was used to compare inter-donor and inter-skin 
equivalent variability between two donors, with three skin equivalents per donor as 
demonstrated in Figure 5-17. Over the 29-day period, donor S1141F produced a mean 4.4 times 
more pro-collagen I, 4.5 times more fibronectin, and 3.4 times more hyaluronan than S1151F 
who was similar in age. The inter-skin equivalent reproducibility was much better conserved in 
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S1151F skin equivalents. However, both donors followed the same trend throughout skin 
equivalent establishment with pro-collagen I and fibronectin relatively stable throughout dermis 
establishment, increasing upon the addition of keratinocytes, and stabilising again throughout 
cornification at the air-liquid interface. Hyaluronan had more of a peak and trough pattern for 
both donors, peaking greatly when skin equivalents were first raised to the air-liquid interface.  
However, it was unusual that the medium required only 1:4-1:16 dilution after ELISA standard 
curves were performed. Previously the dilutions were a minimum 1:1000 to fit within the range 
of standard concentrations used. This was an indication that the models were producing much 
less protein, and therefore the cells mustn’t be forming standard skin equivalents. This concern 
was confirmed when histology confirmed this batch of skin equivalents had not formed  into 
3D models (data not included). However this experiment did prove that the ELISA technique 
could be used to sensitively detect inter-donor and inter-skin equivalent variability.  
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Figure 5-17: Mean ELISA quantification of pro-collagen I, fibronectin, and hyaluronan proteins produced by 
developing CELLnTEC full thickness human skin equivalent. Media samples were collected at days 4, 9, 14, 19, 24 and 
29. Skin equivalents were grown with donor-matched foreskin-derived adult keratinocytes and  reticular fibroblasts from donors 
S1141F (male – age 40) or S1151F (male – age 35). Skin equivalent development is grouped in three phases: dermis growth 
(A; 10 days, CnT-PRF medium), addition of keratinocytes in submerged culture (B; 3 days, CnT-FTAL medium), and air-
liquid interface (C; 12 days, CnT-FTAL medium). ELISA was performed to measure inter-donor and inter-skin equivalent 
variability. There is therefore no requirement to normalise for increasing cell number over time. ELISA was performed in 
duplicate for each sample. Mean ± SEM data obtained from three skin equivalents per donor, whereby error bars represent 
inter-skin equivalent variability. N=1, n=3. 
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 Comparison of skin fibroblast ECM production from thick (abdomen) versus thin 
(foreskin) donor sites, using CELLnTEC medium 
It was queried if skin equivalents thickness was a result of the two skin equivalents only 
containing two cell types, or that the fibroblasts of thin skin (i.e. foreskin) produce less 
extracellular matrix (ECM) than thicker skin sites. A pilot comparison was made between skin 
fibroblasts of thick abdomen and thin foreskin. As multisite skin samples were unavailable from 
the same donor, two donors were selected of the same age (56), sex (male), and cell passage 
number (2). The foreskin donor (S1197F) was isolated from dermis in-house, and the abdominal 
donor fibroblasts (RVI07) were kindly provided by Dr Peter Hanson of Newcastle University. 
Initially cells were seeded within hanging inserts to grow into human dermis equivalent (as for 
a full thickness skin equivalent) but visualising and removing them from the membrane was 
ineffective. Cells were then grown in monolayers within a 12-well plate, with six wells per 
donor. To determine if foreskin fibroblasts ECM production could be increased (to make a 
thicker dermis layer), they were treated with CELLnTEC ECM production medium according 
to manufacturer’s online protocol.  
Standard curves for each ELISA kit were performed on high protein samples (supplementary 
Figure 9-6) to determine a working dilution. As Figure 5-16 demonstrates, foreskin fibroblasts 
produced more pro-collagen I, but approximately 50% less fibronectin/hyaluronan than 
abdominal fibroblasts (in CELLnTEC fibroblast proliferation medium (PR-F)).  
The commercial CELLnTEC ECM boost medium did increase pro-collagen I production by 5-
fold in both cell types, but not fibronectin and hyaluronan. A western blot was confirmed the 
collagen I was laid down as extracellular matrix protein (Figure 5-17). Initially a QuickZyme™ 
total collagen kit was used (as per CELLnTEC recommendations), but despite several 








































































































































































































































































































































































































































































































































































































 Five-fold fibroblast collagen increase with  CELLnTEC commercial ‘ECM boost’ medium. Top: Relative 
mean ELISA showing 5-fold pro-collagen I (COLA1) increase in skin fibroblasts after 216 hours incubation with commercial 
CELLnTEC medium designed to increase/’boost’ extracellular matrix (ECM) production (top). Data from reticular fibroblasts 
of one foreskin (S1197F - male, age 56) and one abdominal (RVI07 - male, age 56) skin donor. Bottom: Western blot for 
collagen I (alpha-1/alpha-2 bands; ~129-139kDa), with GAPDH (37kDa) loading control. There were bands at ~70-90kDa, 
which could be mature collagen I (COL1). ELISA performed in duplicate for all samples. ELISA statistical difference 
determined by one-way ANOVA with Tukey’s post-hoc test **** p<.0001, N=1, n=3. 
 
 Optimisation of facial skin cell isolation, culture and cryopreservation 
It was found that performing skin Dispase treatment on the same day as surgical removal 
provided better cell yields than storing overnight in storage medium at 4oC. Eighteen donors 
were used as outlined in Table 2-2. For additional method detail, see section 2.1.  
5.3.6.1  Processing and Dispase treatment 
Flame sterilised surgical scissors were used to remove adipose and a no. 11 shape scalpel was 
used to make 450 angle cuts into the rigid hypodermis to allow for Dispase penetration (which 
was a 1:8 dilution instead of 1:10). The epidermis was easily removed with surgical tweezers 
after overnight Dispase incubation. The hypodermis could not be removed from the dermis.  
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5.3.6.2  Facial keratinocytes  
A direct comparison of keratinocyte culture with and without ROCK (apoptosis) inhibitor 
demonstrated that while some donors could establish a P0 starter culture without it, more donors 
would establish one with it. The use of ROCK inhibitor is discussed further in section 5.4. Due 
to the rapid metabolism of ROCK inhibitor, the media volume per 25cm2 flask was increased 
to 10ml, which was changed at three regularly spaced weekly intervals. For the first 7-9 days 
(longer without ROCK) the morphology appeared as dots before small colonies were observed. 
These would reach confluency between days 10-14, at which point they could be frozen or split 
into two 25cm2 flasks. The keratinocytes came off the flask surface readily with Accutase™. 
Removing ROCK inhibitor at the first passage and/or moving to a 75cm2 flask was detrimental. 
However, if keratinocytes were frozen they could be thawed into CELLnTEC medium that did 
not contain ROCK. They proliferated well in CELLnTEC CnT-PR medium, but this was not 
directly compared to Epi-life™ medium because of limited cell numbers. It was generally 
observed that facial keratinocytes proliferated much faster than foreskin, but this wasn’t 
recorded as quantitative data.  
5.3.6.3  Facial fibroblasts 
Fibroblasts migrated from dermis adhered to the flask surface but would not proliferate from 
these sites when the dermis was removed. To investigate if they required more glucose for 
proliferation, DMEM was additionally supplemented with 1% GlutaMAX™ but this did induce 
proliferation and the fibroblasts looked unhealthy. Having the colony sites closer together in a 
25cm2 flask (instead of the usual 75cm2 flask) did not help proliferation. The thicker dermis-
hypodermis meant that pieces were lost at each media feed as they dislodged very easily from 
the surface. Attempts to readhere them were unsuccessful. A direct comparison between 25cm2 
flask and 6-well plates did not improve the outcome, with the tissue even less adherent to 6 well 
plates with each media change. Moreover, the migrated fibroblasts adhered so strongly to the 
surface that they could not be removed with trypsin-EDTA, Accutase™, or with manual 
agitation. It was found that coating a 25cm2 flask with 0.1% gelatine improved tissue adherence 
and enabled cell removal with Accutase™. Optimised tissue adherence followed dermis 
incubated overnight with 100% FBS (1ml), and the following morning a small ~2ml volume of 
media was added gently to provide some nutrition. On day 3, this was replaced with 5ml media 
which ensured the tissue had firmly adhered. Increasing the media volume above 5ml increased 
the likelihood of tissue lifting off. When adherence was optimised and proliferation remained 
non-evident, the number of dermis adherence sites was increased to maximise overall cell 
number. From donors 2740-2748 (see Table 2-2), the entire dermis was cut into small pieces, 
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which were individually placed onto the 0.1% gelatine coated 25cm2 flask(s) with approx. 1 cm 
spacing between pieces. The dermis was placed with the papillary dermis facing upwards, so 
that reticular fibroblasts were acquired by migration from the tissue onto the coated flask base. 
At day 14 the tissue was removed as it decayed when left attached any longer. Media was 
changed for another 5-7 days (as longer meant the gelatine coating degraded), and Accutase™ 
was used to remove the fibroblasts for cryopreservation. Of the initial pilot (2624-2626), only 
donor 2625 yielded viable proliferating fibroblasts when thawed into CELLnTEC PR-F 
medium within a 25cm2 flask. No donors successfully thawed viable cells until the optimisation 
of 0.1% gelatine coated 25cm2 flasks. However, although all donors 2740-2748 had viable 
thawed cells of correct morphology, they also had a yeast infection of unknown cause and were 
discarded.  
Facial skin fibroblast cryovials were additionally obtained from Public Health England (PHE; 
Oxford, UK), but none of the thawed vials contained viable cells and had a significant amount 
of debris. However the skin donors used by PHE were predominantly geriatric, and these older 
skin cells tend to behave abnormally in culture.  
 Pilot study #5: Full thickness facial skin equivalent using CELLnTEC 
methodology…….. 
Donor 2625 (female, 52yrs) was used for the pilot facial skin equivalent, with both 
keratinocytes and fibroblasts thawing well and proliferating to confluency in cell specific 
CELLnTEC medium. Fibroblasts were passaged once before seeding into 24-well inserts. The 
dermis establishment of 10 days, submerged keratinocyte co-culture of 3 days, and initial 
keratinocyte exposure to the air liquid interface (ALI) were completed.  However, from day 4 
at the interface the medium below some inserts was visibly white and cloudy (Figure 5-19, 
A+B). When swirled and held against a dark surface, the white clouds were visible as deposits 
(Figure 5-19, A). More inserts followed over the next few days, and a medium test proved that 
contact with the skin equivalent was necessary to produce this effect (see Figure 5-19, B). By 
day 12 the media had changed from a cloudy liquid to form a gelatinous consistency, which 
thickened further over the next 6 days (Figure 5-19, C to E). Attempts at harvesting the skin 
equivalents confirmed that a majority had completely degraded (Figure 5-19, D+E) and media 
samples tested negative for mycoplasma infection.  However, some formalin-fixed and fresh-
frozen skin equivalents did have histological remnants, with the most intact shown in Figure 5-
18. It visually confirmed the suspicion that the dermal matrix was degrading, as witnessed by 




 Histological H&E staining of skin equivalents developed using CELLnTEC commercial medium and 
facial skin-derived adult keratinocytes and reticular fibroblasts from donor 2625. Despite signs of ongoing degradation 
whilst at the air-liquid interface (ALI), key skin equivalent components did form. There is a keratinised stratified epidermis 
(~0.019mm), attached to a dermal layer (~0.05mm) which showed some ECM production by the facial reticular fibroblasts. 
Day 12 at the ALI is the standard duration for a completed skin equivalent, with Day 15 ALI representative of three days in 
culture. Histology was comparative in fixed- (PPFE) or frozen- (OCT) skin equivalent sections, with both confirming that the 
ECM was degrading. H&E staining was performed on three sections per FFPE/OCT-embedded skin equivalent. N=1, n=3. 
 
 
 Photographs of facial skin equivalents at air-liquid interface (ALI) days 4, 6, 12, 15 and 18. Skin equivalents 
developed using CELLnTEC commercial medium and facial skin-derived adult keratinocytes and reticular fibroblasts from 
donor 2625. All skin equivalent development stages had been completed until they were raised to the ALI, and four days later 
the media began to present as cloudy-white (A+B). Media incubated in empty wells did not turn cloudy-white (top wells, B).  
At ALI day 12 the media had become a gelatinous consistency (C), which progressively increased in solidity until ALI day 18 
(D+E). Failed attempts to harvest skin equivalents from the wells containing gelatinous material confirmed they had degraded.   
A: Day 4 ALI 
B: Day 6 ALI 
C: Day 12 ALI 
D: Day 15 ALI 
E: Day 18 ALI 
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 Comparative overview of all CELLnTEC skin equivalent pilot studies  
Investigation of the use of CELLnTEC media and methodology with in-house derived adult 
skin cells can be broadly grouped into five pilot studies (see Table 5-2). Overall it was evident 
that cells should be a low passage, with best results seen from seeding passage number 2 
fibroblasts (freshly isolated and not cryopreserved) and passage number 2 keratinocytes 
(cryopreserved at passage number 0, revived and used). However difficulty arose with 
fibroblast transition from DMEM flask media to CELLnTEC proliferation medium (for skin 
equivalent inserts), as this was proposed by CELLnTEC as a causative factor in the pilot 2 skin 
equivalent contraction. Thawing passage number 0 fibroblasts into CELLnTEC proliferation 
medium is an alternative option, where they are expanded once before seeding into inserts as 
passage number 2 cells. In the skin equivalents there was variability in the dermal layer 
thickness, whereby the thickest models came from donors of a young age greater (S1074F – 
age 28 and S1142F – age 17). However not enough donors were tested to conclude this is a 
statistically true association. Skin equivalents could be scaled between insert sizes, but grew 
best in 12-well or 24-well size (possibly best as 24-well). Although there was no difference in 
cell proliferation and viability with frozen aliquots of medium, the histology of skin equivalents 
grown with ‘fresh’ medium showed thicker layers. However this was only tested in one donor 
(S1147F), the fibroblasts were passage number 4 at time of insert seeding, and the fibroblasts 
did not make a thick ECM in any condition tested. Moreover in pilot 4 both donors failed to 
display histology of a fully formed equivalent. Several factors aside from frozen aliquots of 
medium could have contributed to the pilot 4 result. The donor S1141F had also performed sub-
optimally in pilot 2, and S1151F has not been tested before. However these were the last 
remaining donor-matched skin cell cryovials. The fibroblasts of these cells were also passage 
number 4 when seeded into inserts. In monolayer, the prolferation rate decreases rapidly from 
passage number 4 to 6 but they do divide. To lay down enough ECM, it is preferable to prioritise 
younger passage number fibroblasts in optimal proliferative condition, over extending the 




















































The successful growth of a full thickness donor-matched human skin equivalent without the use 
of artificial scaffold is both exciting and highly novel. As previously detailed in section 1.3, 
most in-house methods and commercial skin equivalents incorporate a scaffold material. 
Meloni et al. (2010) and Groeber et al. (2011) describe how a multi-layered skin equivalent is 
a welcomed mediator between conventional cell culture monolayers (lacking physiological 
conditions and complex cell-cell/ECM interactions), skin explants (high variability, difficult to 
obtain/maintain) and in vivo animal models (ethical considerations and anatomical/metabolism 
differences). A primary advantage of in-house skin equivalents is that the cellular composition 
is controlled by the researcher (Groeber et al., 2011). The donor-matched layers, fibroblast-
derived dermal matrix and stratified epidermis of the CELLnTEC skin equivalent implicate 
wide-ranging applications. 
As fibroblasts are critical to wound healing, their natural function of extracellular matrix 
production (Tracy et al., 2016) has been encouraged by the CELLnTEC media. Fibroblasts 
surrounded by their own secreted microenvironment influence epidermal growth (El 
Ghalbzouri et al., 2009). 
It is found throughout the pilots that a well-developed dermis of CELLnTEC derived skin 
equivalents correlated with low passage number fibroblasts. Janson et al. (2013) reported that 
using serially passaged fibroblasts in full thickness equivalents produced thinner dermis, and 
elevated senescence-associated biomarkers. The cells used for their equivalents were extracted 
from healthy surplus skin of female donors (aged 44, 56, 60 years), and their dermal layer 
established without scaffold in CELLnTEC media. They found that several (but not all) 
characteristics of aged skin can be recreated through the fibroblast passage number.  
Deeper analysis of the skin equivalent morphology incorporated immunostaining for epidermal 
and dermal biomarkers. Cytokeratin 14 was used as a general epidermal marker (Figure 5-7) 
and stained positive in the skin equivalent. Skin collagen distribution alters with dermis depth 
(Tracy et al., 2016). To visualise how the fibroblasts had structurally arranged their ECM, 
dermal structural proteins (collagen I and fibrillin) and the epidermal-dermal junction (collagen 
IV) were positively staining (Figures 5-5 to 5-7). Due to the matrix being a 3D structure, it was 
necessary to image several cross-sections and compress the z-stack to generate these figures.  
A comparison was made with antibody labelling of collagen and the label free approach of 
second harmonic generation (SHG) (Figures 5-9 and 5-16). Both were performed on a 
cryosection of the same embedded sample, but consultation of the results with Dr Glyn Nelson 
(Newcastle University) did not find any distinct advantages from visualising collagen with 
SHG. Any advantage would be related to saving time or antibody. Whilst SHG was successful 
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in a section of frozen-embedded skin equivalent, it was much less successful in an attempt to 
generate live signal from a 3D intact skin equivalent (Figure 5-16). However this may benefit 
from being repeated with a well-established skin equivalent, as the one used from donor S1147F 
did not have a good dermis (Figure 5-15).  It was clear that the skin equivalent would have to 
be removed from the hanging insert, so repeat live imaging throughout an extended experiment 
would not be feasible. To generate strong imaging for marketing purposes and localised data 
relating to test compounds, a better approach would be the use of label-free MALDI-MS 
imaging. In the last few years, this method has emerged in the skin literature relating to topical 
AOX penetration and distribution profiles of metabolites, lipids and proteins (Enthaler et al., 
2013; Mitchell et al., 2016; Hochart et al., 2019; Vanickova et al., 2019). Innovenn have 
published using MALDI-MS imaging to assess wound-healing in Labskin™ commercial skin 
equivalent (Lewis et al., 2018). Innovenn kindly supplied some Labskin™ skin equivalents for 
this work. Unfortunately they stained weak or negative for dermal matrix proteins, yet both 
cytokeratin 14/collagen I stained positive in the epidermal layer (Figure 5-8). It appeared that 
suspending fibroblasts within a fibrin gel (Bojar, 2015) had inhibited their capacity to secrete 
matrix proteins into the inter-cell space. It appeared as if the collagen I was pushed out of the 
matrix into the epidermis, sitting atop the fibrin gel. Publications of Labskin™ that include 
immunostaining or MALDI-MS imaging focus on epidermal labelling, and advocate Labskin™ 
for use in skin barrier associated areas such as psoriasis (Harvey et al., 2016), wound-healing 
(Lewis et al., 2018), and microbiome (Bojar, 2015).   
The barrier properties of full thickness skin equivalents are closer to in vivo skin than epidermal 
equivalents, and contain all human skin lipids (Mathes et al., 2014). Whilst a dry stratum 
corneum was visible on CELLnTEC skin equivalents and present in H&E histology sections, it 
was unexpected that a common lipid stain (Oil red O) didn’t have positive stratum corneum 
staining of skin equivalents or control samples of ex-vivo foreskin (data not included). Despite 
various protocol comparisons and amendments, this negative staining could not be explained. 
However a recent publication had positive Oil red O lipid staining of a foreskin cell derived full 
thickness skin equivalent with two key protocol differences: the fixation step was 1 hour and 
the mountant was 50% glycerol (Muresan et al., 2019). Nevertheless, the dry stratum corneum 
of  the CELLnTEC skin equivalent was suitable for formulation application and surface 
irradiation with solar light. After solar irradiation, there was a 16-fold (4 Ct) increase in mtDNA 
damage compared to a foil-protected skin equivalent from the same donor (Figure 5-14).  
The final area of skin equivalent development surrounded the sources of donated skin. A 
majority of commercial skin equivalents, primary cells and cell lines in the literature are sourced 
from adult or neonatal foreskin. Generally these resources are also pooled from multiple donors. 
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A common secondary source of surplus skin is from breast or abdominal surgery, but it is more 
technically difficult to isolate viable cells from these regions. Yet, these three areas are rarely 
exposed to environmental stressors (covered by clothing), are not typical sites for skin diseases 
(e.g. psoriasis, eczema), and are not the intended site of application for cosmetic formulations. 
It is recognised that skin around the body and even within the same region (e.g. face) differs in 
laxity, thickness, topology, pH, temperature, moisture and microbiology (Wong et al., 2016). 
In addition, these factors are also affected by race, age, sex, lifestyle (e.g. obesity), and 
pathologies  (Wong et al., 2016). 
It was observed that foreskin derived skin equivalents were thin, and it was queried if this was 
a result of 1) human skin equivalents containing only two cells types and no accessory 
structures/hypodermis, or 2) that the fibroblasts of thin skin (e.g. foreskin) secreted a reduced 
or different composition of matrix to fibroblasts of thicker skin (e.g. abdomen). To test this 
hypothesis a pilot was designed to compare the fibroblasts of adult foreskin and abdomen in the 
CELLnTEC medium used to support dermal layer formation (Figures 5-18, 5-19). Abdomen-
derived fibroblasts were used because access to facial skin was not available at the time of this 
experiment. In this experiment some fibroblasts were treated with a commercial ‘extracellular 
matrix boost’ medium to see if the secreting capacity could be upregulated, and if this increase 
would lay down as protein (Figure 5-19). Unfortunately, we were unable to obtain two samples 
from the same donor, but two donors were chosen for their matched age, sex, ethnicity, and cell 
passage number. ELISA successfully detected differences between the donor sites, and the 
commercial medium induced 5X more collagen I production (but not fibronectin or 
hyaluronan). Whilst it is not definitive if the differences in this data were a result of donor- or 
site- variability, the techniques used in this pilot were successful at detecting differences. If 
samples were obtained from multiple sites on the same donor, this would be highly novel and 
informative data for the dermatology field. There is one research group that has published on 
the differing mechanical properties of dermal fibroblasts from different sites (Kuang et al., 
2015; Xu et al., 2017). The only other research found on multi-site comparison was a study 
investigating the effect of fibroblast donor site on epidermal differentiation in a full-thickness 
skin equivalent (Konstantinova et al., 1998). They used foreskin derived keratinocytes and 
fibroblasts isolated from the breast, trunk, arm, face, and earlobe of fifteen normal skin donors. 
The fibroblasts were seeded into rat collagen, and keratinocytes seeded onto the gel-based 
dermal layer. In addition, they sourced eyelid fibroblasts from nine donors, and found all 
supported the formation of a well differentiated and stratified epidermis. It is worth noting from 
this study that whilst all facial fibroblast donors supported epidermal development, other 
regions (e.g. breast and arm) had differences between donor capabilities to support this 
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development.  However, beyond this study there is a lack of information understanding the role 
of regional skin cells on skin equivalent function. As a result, there are questions surrounding 
what area of skin we are representing in skin equivalents and the translational impact of this on 
the data generated.   
To address this, a comparison between facial and foreskin derived skin equivalents was 
designed to investigate if the same data was obtained with antioxidant product testing. To our 
knowledge, there has been no data published with 100% facial skin cell-derived skin 
equivalents and it is unknown if a working protocol exists.  
Protocols for isolation and culture of primary skin cells had to be optimised for facial skin (see 
5.3.6). The use of ROCK (apoptosis) inhibitor (Y-27632) to increase the yield of facial-skin 
derived keratinocytes is controversial. The advantage is that it ensures that proliferative 
keratinocytes will be isolated from facial skin, even if the sample is very small. Chapman et al., 
(2014) analysed the gene expression of adult human keratinocytes cultured with or without 
10µM Y-27632 ROCK inhibitor, which is the same compound used in this thesis for facial 
keratinocyte starter culture. The study found that the genes most significantly down-regulated 
are necessary for keratinocyte differentiation, but that this was reversible when Y-27632 was 
removed (Chapman et al., 2014). Mi et al. (2019) showed that addition of Y-27632 for two 
days in the starter culture of primary melanocytes dramatically increased the yield, and that this 
could be attributed to their finding that Y-27632 significantly upregulating keratinocyte stem 
cell factor expression. There is concern that the addition of Y-27632 selects for highly 
proliferative progenitor (stem cell-like) keratinocytes, but that you may be selecting for 
holoclones at the expense of meroclones and paraclones (Barrandon, Y. and Green H. (1985); 
Dellambra et al. (2000); Nanba, D. (2019), Generally it raises the question of keratinocyte 
population functional quality over quantity. However as Y-27632 was only incubated for a short 
duration, it remains an option for isolating keratinocytes from small skin samples that are 
difficult to obtain e.g. face.   
There were observational differences in the culture of foreskin and facial skin cells. Whilst the 
facial site information was requested (e.g. cheek, eyelid etc.), the donor consent form only 
recorded and disclosed the sex and age (Table 2-2). Facial keratinocytes proliferated at a greater 
rate, and facial fibroblasts appeared to prioritise matrix production over cellular proliferation 
as they could not be removed from the flask surface (unless pre-coated with gelatine). There 
was substantial variability between facial donors for the capacity to isolate proliferative primary 
cell cultures, but this doesn’t account for the fact that foreskin samples were more readily 
available than facial skin samples. Therefore the statistical variability between facial and 
foreskin donors may not be as prominent when the sample size is accounted for. Only one facial 
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donor completed the entire skin equivalent process, but there was breakdown of the dermal 
matrix over time (Figures 5-20, 5-21). This had never been seen in-house with foreskin donors, 
but Konstantinova et al. (1998) allude to a similar phenomenon with their skin equivalents 
(facial fibroblast/foreskin keratinocyte-derived) when they describe a short experiment time of 
14 days because ‘the proliferative rate of the cells decreases after 14 days, and by day 21 a 
thick stratum corneum remains but there is no dermis layer’. It is also interesting that eyelid-
fibroblasts produced a skin equivalent almost twice as thick as that from normal skin-fibroblasts 
of other regions (Konstantinova et al., 1998). It is worth noting that this paper describes how 
the stratum corneum thickens over time, which was also observed in pilot #2 (Figure 5-11) of 
this thesis. This is inevitable given that no skin equivalent to date undergoes desquamation. The 
implications of this for time-course experiments in equivalents is to be noted, whereby an 
experiment with repeat topical applications would be affected by the continued thickening of 
the stratum corneum. Indeed, Asselineau et al. (1986) reported that unlike in-vivo epidermis, 
the reconstructed epidermis continues to stratify (and thicken) for as long as 20 days.  
As facial skin samples are typically small and produce limited cell numbers, the skin equivalent 
was successfully scaled down to 24 well size. Relative to the standard 12-well, 24-well foreskin- 
and facial- derived skin equivalents were more compact, slightly thicker and easier to process 
for histology. In addition, having several 24-well skin equivalents produces less artefact than 
separating each 12-well skin equivalent into sections by scalpel. Whilst most commercial 
inserts are available as a 24-well size, corresponding 24-well plates for raising skin equivalents 
to the air-liquid interface are not available from leading companies (Millipore, Greiner, 
CELLnTEC). However, towards the end of this work, Thermo Fisher filled this gap in the 
market with their Nunc™ consumables range. This is a practical option that would save on the 
required volumes of expensive CELLnTEC media.  
To determine the extent of inter-donor and inter-skin equivalent variability, ELISA was used to 
compare levels of secreted proteins in the medium (Figure 5-17). This is a useful technique for 
quality control purposes of skin equivalent batches. This technique could also be used to address 
a limiting factor of this work whereby it was unknown which donors would produce good skin 
equivalents. An overview of all trials (see Table 5-2 and section 5.3.8) determined that the best 
donors were of young biological age and had low passage number cells. However, in this 
research group the consent forms are collected and sent monthly. This means that the donor age 
mightn’t always be accessible before the fibroblasts are ready to be seeded for skin equivalents, 
and successful skin equivalent formation remains unknown until histological analysis. As such, 
considerable time and resources are used inefficiently. For future work I recommend the use of 
protein ELISA to screen fibroblast donors for their secretory capacity of ECM protein (e.g. 
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collagen I) in the proliferative monolayer stage (70% confluent) at passage number 0 or 1. 
Alternatively, as this work was performed in an external ELISA equipped lab, a student project 
could be to find an alternative protein detection assay. Whilst the QuickZyme™ kit was not 
sensitive enough to detect collagen within the provided range of standards, there may be 
alternative options. This would give an indication if the fibroblasts of a donor should be seeded 
into inserts for 3D skin equivalents, frozen for future 3D skin equivalents, or passaged further 
for different experiments. In addition, until the rate of inter-skin equivalent variability is 
established, it is advised to continue with three skin equivalents per condition as throughout 
this thesis and in some literature e.g. Konstantinova et al. (1998).  
Whilst facial fibroblasts were the limiting factor for continuation of this work on facial-derived 
skin equivalents, a large stock of facial keratinocytes were preserved as a result of this work. 
These could be used for reconstructed human epidermis skin equivalents (see 5.2.2. and 
supplementary Figure 9.4) or seeded on top of a foreskin fibroblast derived dermis (of a donor 
similar in biological age).   
Overall, the successful growth of human skin derived skin equivalents that are scaffold-free, 
donor-layer matched, and 100% human derived in <1% serum medium is an exciting and novel 
outcome. Several immunostaining, ELISA, western, and cell culture protocols have been 
generated from this work. Experiments combining the antioxidants introduced in chapter 4, skin 
equivalents outlined in this chapter, and transition to topical applications are discussed in 
chapter 6.   
 Summary of findings 
➢ CELLnTEC commercial medium and protocol for the establishment of full-thickness 
human skin equivalents worked successfully with in-house derived cells 
➢ The CELLnTEC skin equivalents were all scaffold-free, with donor-matched layers, and 
antibiotic/serum-free medium 
➢ Fibroblasts secreted the dermal structural matrix, with the thickness and robustness limited 
by donor biological age and fibroblast passage number  
➢ The keratinocyte passage number should match the fibroblast, with both at P0 or P1 upon 
seeding 
➢ CELLnTEC derived skin equivalents had correct histology (H&E) and stained positive for 
key biomarkers indicative of a fibroblast secreted extracellular matrix 
➢ Immunostaining of commercial Labskin™ determined a lack of extracellular matrix proteins 
in the dermal compartment 
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➢ Label-free imaging of CELLnTEC skin equivalent collagen could be performed on frozen 
sections using second-harmonic-generation (SHG), but not in skin equivalents within their 
inserts 
➢ CELLnTEC skin equivalents were successfully scaled to 24-well insert sizes  
➢ Protein ELISA of collagen, fibronectin and hyaluronan in stored cell medium demonstrated 
differences between donors and anatomical sites 
➢ Western blot confirmed that ELISA data for collagen secretion is laid down in the skin 
equivalent 
➢ A protocol for the isolation and culture of facial skin cells was created 
➢ Facial keratinocytes are highly proliferative in culture, and facial skin equivalents may need 
a reduced number of days stratifying at the air-liquid-interface (ALI) 
➢ A pilot of facial skin cell derived skin equivalents had progressive dermal degradation 
throughout the air-liquid interface phase 
➢ Recommendations for future advancement are outlined in the chapter discussion e.g. 
MALDI-MS imaging, donor screening for skin equivalent suitability etc.   
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Chapter 6:  Antioxidant formulation testing in whole skin ex-plant and full 
thickness skin equivalents…………… 
 Chapter overview and aims 
Antioxidant formulation testing was performed using acellular sun protection factor (SPF) 
testing in response to solar simulated light, alongside topical application to human skin 
equivalents and human ex-plant skin (foreskin and facial). These skin equivalents were tested 
for the antioxidant capacity to protect against solar light induced damage to mitochondrial DNA 
in human skin. This work also aimed to investigate if the protection seen in skin cell monolayers 
with direct antioxidant exposure (Chapter 4) translated through to more complex 3D model 
systems with antioxidants delivered in cream formulation.  
 Chapter specific methods 
 Human skin equivalent culture conditions 
Labskin™ (Innovenn) full thickness human skin equivalents arrived within 24 hours of dispatch 
at room temperature within solidified medium gel. They were transferred to a Greiner 
ThinCert™ 12-well deep culture plate containing 4.5ml/well of Labskin™ maintenance medium 
(supplemented with 1% PSA) and acclimatised overnight at 37oC, 5% CO2. The medium was 
replaced on day 2 (i.e. skin equivalent day 29, see Figure 6-10) immediately prior to formulation 
application. In-house full thickness human skin equivalents were grown using CELLnTEC 
commercial medium and methodology as described in Chapter 5. Experiments were performed 
the day after skin equivalent completion (day 29, see Figure 6-10) with CELLnTEC PR-FTAL 
medium (supplemented with 1% PSA) replaced prior to formulation application.  
  Human ex-plant skin culture conditions 
Tissue was used if collected on the day of surgical removal, where it was stored at 4oC 
submerged in transport media (DMEM with 2% PSA). Subcutaneous tissue and vasculature 
were removed from skin submerged in PBS-2% PSA prior to taking 4mm diameter punch 
biopsies. Individual biopsies were placed “epidermis-up” in 24 well ThinCert™ 0.4µm PET 
transparent hanging inserts (Greiner), suspended above 500µl DMEM, and acclimatised to 
culture conditions overnight at 37oC, 5% CO2.  Experiments were performed the following day. 
  Human ex-plant skin metabolic viability testing 
To detect skin metabolic viability the culture medium underneath the hanging insert was 
replaced with 500µl 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrzaolium bromide (MTT; 
Sigma M2128) at a final concentration of 1mg/ml (diluent: complete DMEM) for 2 hours at 
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37oC, 5% CO2. Formed formazan (purple) was dissolved by free-floating the biopsy in a 15ml 
tube containing 700µl freshly made acidified isopropanol (1µl 37% (12M) HCL per 1ml 
isopropanol). This was parafilmed twice and stored overnight at 4oC. Absorbance was read at 
570nm with SpectraMax™ (Molecular Devices), and blank corrected for acidified isopropanol.     
  Irradiation of human ex-plant skin and full thickness human skin equivalents 
Skin equivalents within hanging inserts were transferred to a standard well plate containing 
room temperature PBS instead of media. They were irradiated with a solar simulator as 
described in section 2.2.2 and immediately placed onto wet ice prior to harvesting (see 6.2.1.6).  
  Confirmation of skin barrier integrity using lucifer yellow stain 
To determine barrier integrity post-solar irradiation, ex-plants were stained with lucifer yellow 
as follows. Lucifer yellow CH salt (L0259, Sigma) was dissolved to 1mM solution in PBS, 
0.22µm sterile filtered, and stored light protected at 4oC. The stain was pipetted onto the stratum 
corneum and incubated for 2 hours at 37oC. The sample was formalin fixed overnight at 4oC 
within a cassette, washed with PBS and OCT embedded. Cryosections (8µm) air-dried for 1 
hour at room temperature in the dark, were briefly rinsed with distilled water and mounted with 
ProLong™ Diamond Antifade with DAPI (Invitrogen). Images were acquired with Dr Glyn 
Nelson at Newcastle Bio-Imaging Unit using a Nikon A1R confocal microscope equipped with 
a 10x 0.45NA objective.  DAPI was excited with 406nm diode laser and lucifer yellow with the 
457nm line from an Argon laser as sequential images with 425-475 and 570-620nm bandpass 
filters respectively. PMT gains, pixel dwell time and density were kept constant for all images. 
 
 Schematic of lucifer yellow excitation and emission spectra, alongside DAPI excitation and excitation 
spectra. To account for skin autofluorescence in the spectrum green region, Lucifer yellow was excited at 457nm whilst DAPI 
was excited at 405nm. Image source: Florescence SpectraViewer on ThermoFisher.com.  
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  Harvesting of human ex-plant skin and full thickness human skin equivalents 
Ex-plant skin equivalents were immediately snap frozen on dry ice and stored at -80oC pending 
DNA extraction as outlined in section 2.3.  
Labskin™ skin equivalents were harvested as outlined in Figure 6-2, whereby half of each 
equivalent had a different cream applied. Therefore the middle quadrants were used for DNA 
extraction because they had the least surface area contact with the opposite testing side (Figure 
6-2). CELLnTEC skin equivalents were also harvested in this manner, but the epidermis was 
not removed. After solar irradiation, individual skin equivalents were removed from their 
inserts by scalpel, divided and peeled into layers (if appropriate) with flame-sterilised fine 
surgical tweezers. Samples were immediately snap-frozen on dry ice and transferred to -80oC. 
Skin equivalents remained chilled on wet ice while individually processed as quickly as 
possible. OCT embedding was performed last over liquid nitrogen, with blocks stored at -80oC.  
 
 
 Schematic of Labskin™/CELLnTEC skin equivalent harvest, whereby half of each skin equivalent was used 
per cream. Whilst Labskin™ epidermis could be removed, CELLnTEC skin equivalents remained as combined layers.  
 
 Formulation composition, storage and dose 
Formulations were synthesized by GSK collaborators (Weybridge, UK), which were stored 
light protected at 4oC. The formulation composition and experimental IDs are summarised in 
Table 6-1. 
Comparative market standards were La Roche Posay Anthelios™ XL Sun Lotion (SPF 50+), 
Olay Total Effects™ Anti-Ageing Moisturiser (SPF 15), and Olay Regenerist™ 3 Point Super 
Age Defying Moisturiser (SPF 0). Creams were used at 2mg/cm2 for SPF testing and 
application to human skin equivalent surfaces, but 20mg/cm2 for ex-plants due to the minute 
surface area and minimum weighing capacity of 1mg. See 6.2.8 for more information.  
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 GlaxoSmithKline formulation composition ingredients. Each contain a base functional antioxidant niacinamide 
(NAM; 4%) alongside test antioxidants of interest tetrahydrocurcumin (THC; Sabiwhite™, 0.25%) and/or pterostilbene 
(PTERO; Pterowhite™, 0.1%). To protect GSK proprietary information, these formulations were given identification codes 
before dispatch to Newcastle University e.g. EXP142169-13.  All values represent percentage composition (% w/w).  
 
  Application to human skin ex-plant 
Creams were weighed (0.00125g per half 4mm biopsy) by dipping sterile 200µl pipette tips 
into formulation and transferring into small plastic weigh boats on a KERN analytical balance 
(model: ABT 100-5M). They were immediately applied by placing the biopsy onto the cream 
with the stratum corneum (SC) facing downwards. Using fine surgical tweezers, the biopsy was 
rotated in a circular motion ten times in each direction with applied pressure. The biopsy was 
turned SC-upwards, returned to the insert and left for 10 minutes to allow for permeation of the 
formulation before returned to culture conditions. 
 
  Application to human skin equivalents 
Formulation spreaders were prepared by rapidly rotating each glass pasteur pipette (between 
hands) over a blue flame to create a rounded bulb end. These were sterilised by oven baking at 
100oC for 24 hours within a metal container. A Gilson Microman M25 (3-25µl) positive 
displacement pipette (with Gilson CAP PISTONS CP25 tips) was used to transfer creams onto 
the stratum corneum, after establishing the volume (µl) equating to 2.2mg on a KERN analytical 
balance (model: ABT 100-5M). For 12-well size skin equivalents (Labskin™ and CELLnTEC), 
half a skin equivalent (1.1cm2) was dosed with 4µl GSK formulations, 3.5µl La Roche Posay, 
or 4.5µl Olay. Once applied, it was immediately rubbed in circular motions with the spreader. 
After 10 minutes skin equivalents were returned to culture conditions.  
Function Ingredient EXP142169-13 EXP142169-14 EXP142169-15 EXP142169-16
Water Aqua 75.63 75.78 75.53 75.88
Functional ingredient Sabiwhite 0.25 0 0.25 0
Functional ingredient Pterowhite 0 0.1 0.1 0
Functional ingredient Niacinamide 4 4 4 4
Humectant IPD 1.5 1.5 1.5 1.5
Humectant Glycerin 5 5 5 5
Humectant Panthanol 1.5 1.5 1.5 1.5
Humectant / Stabiliser Pentylene Glycol 5 5 5 5
Stabiliser Hydroxyacetophenone 0.5 0.5 0.5 0.5
Emulsion Lipids Isostearyl Isostearate 0.256 0.256 0.256 0.256
Emulsion Lipids Cetyl Alcohol 0.426 0.426 0.426 0.426
Emulsion Lipids Behenic Acid 0.256 0.256 0.256 0.256
Emulsion Lipids Behenic Alcohol 1.207 1.207 1.207 1.207
Emulsion Lipids Dicapryl Carbonate 4 4 4 4
Emulsion Lipids Hydrogenated Lecithin 0.355 0.355 0.355 0.355
Polymer Sepimax Zen 0.12 0.12 0.12 0.12
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 Schematic of Labskin™/CELLnTEC skin equivalent cream application, whereby half of each skin 
equivalent was used per cream. Cream formulations were pre-incubated on skin equivalents for 0, 1.5, 3 or 6 hours prior to 
solar irradiation with 2.16 SED (CELLnTEC), 5 SED (Labskin™) or foil protection (0 SED). The standard erythemal dose 
(SED, J.m-2) is equivalent to an erythemal radiant exposure of 100 J.m-2. Labskin™ required the same irradiation dose as 
whole skin due to its physical thickness (See Table 6.2). A niacinamide base (C16) was compared to niacinamide + 
tetrahydrocurcumin (C13), pterostilbene (C14), or both (C15). Market controls included 50+ or 15 SPF. 
 
  Acellular formulation solar irradiation (broad spectrum SPF testing) 
Formulations were applied at 2mg/cm2 onto Transpore surgical tape coated quartz dish or 
PMMA plate. This was evenly spread in circular motion with a gloved finger, and immediately 
irradiated with a Newport solar simulator as previously described (see 2.2.2). To determine if 
the formulations could absorb/physically block some of the UV, live irradiance data (mAmp) 
was recorded from the radiometer directly underneath the quartz dish/PMMA plate. Test 
formulations were compared to market standards of known SPF (0, 15 and 50+). 
118 
 
 Schematic/photographs of in-vitro solar protection factor (SPF) testing method. Solar simulated light from a 
Newport simulator is passed through a quartz dish onto a spectroradiometer. The quartz dish is coated with Transpore surgical 
tape (with negligible blocking capacity), which topical applications can be applied across the surface area at a recommended 




 Data analysis of mitochondrial DNA protection 
Formulations applied to human skin equivalents or ex-plant skin were testing for mitochondrial 
DNA damage using the qPCR methods outlined in Chapter 3. The formulations were not 
removed prior to DNA analysis because the application method chosen (see 6.2.8-6.2.9) 
ensured it was absorbed (‘rubbed’ in) and therefore was not sitting on the surface. Data for each 
donor (CELLnTEC skin equivalents or ex-plant biopsies) was generated from one qPCR plate, 
with housekeeping qPCR run immediately beforehand to ensure equal starting levels of mtDNA 
in diluted samples. Labskin™ was the one experiment where the number of samples did not fit 
onto one qPCR plate. As it  required three qPCR plates, one DNA control sample was re-run 
on all plates to determine inter-run variation, and controls from all plates were grouped for 
analysis.   
Statistical analysis was performed with reference to Yuan et al. (2006) and performed on raw 
Ct values, whereby all non-irradiated controls were first grouped as a control column. Each 
donor was analysed individually. A one-way ANOVA with Dunnett’s post-hoc test was used 
to determine significance between the mean treated and control Ct values.  
To generate a graph, Ct differences for each donor were converted to relative fold change ratio 
(2ΔCt) and presented as mean±95% confidence intervals. The mean of controls was first 
subtracted from each treated condition (ΔCt = ΔCt (treated) - ΔCt (control)). In addition, the mean ± 




 Optimisation of whole skin ex-plant model system 
6.3.1.1  Whole skin ex-plant experiments are best performed at their metabolic peak (day 1), 
after overnight acclimatisation to culture conditions 
Ex-plant biopsies were taken from two foreskin and one facial skin sample on the day of 
surgical removal. As whole foreskin is a shared departmental resource and facial skin is a small 
sample, with 8 punch biopsies required per donor this was the minimum number of samples 
required to confirm that the biopsies acclimatise to culture conditions overnight and are 
therefore viable for experimentation. Each were maintained in hanging inserts as outlined in 
6.2.2, with metabolic viability determined by the tissue capacity to reduce MTT to formazan 
(see 6.2.3). Viability was calculated relative to the day 0 baseline metabolic capacity of each 
donor, with metabolic peak maintained at day 1 for all tissues tested. After day 1, two foreskin 
donors metabolism decreased by approximately 25% every 24 hours until a plateau at around 
day 5. Although they shared the same trend (%), individual raw data demonstrated that the 27-
year-old donor (14552) produced more formazan than the 41-year-old (14551) from days 0-2.  
The facial donor maintained metabolic capacity in culture for the entire 7 days.  
 
 Mean skin metabolic viability over 7 days in culture. Viability relative to a day 0 baseline performed on the 
day of surgical removal. Whole skin explant 4mm punch biopsies from two foreskin (14551 – male, age 41, 14552 – male, age 
27) and one facial (2736 – male, age 69) donors were maintained in culture, with one punch biopsy tested every day for its’ 
capacity to reduce MTT to formazan. Data presented as mean ± SD; N=1, n=3 per donor. 
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6.3.1.2  Foreskin explant (4mm) obtained significant mtDNA damage from ≥4 SED complete 
solar irradiation 
Ex-plants from three foreskin donors were acclimatised to culture conditions overnight and 
irradiated as described in 6.2.4 (and 2.2.2) in a dose dependent manner of 0, 2, 4, 6, and 8 SED, 
whereby 1 standard erythemal dose (SED, J.m-2) is equivalent to an erythemal radiant exposure 
of 100 J.m-2. The 2 SED dose routinely used for monolayer and thin human skin equivalents 
did not induce a detectable amount of mtDNA damage in whole skin ex-plants. However, a 
mean 2.2 Ct (5-fold) was detected at 4 SED, with a marginal increase to 2.5 Ct (5.7-fold) at 6 
SED. Only 2 of 3 donors were able to detect damage at 8 SED as one donor (14526 – age 46) 
was particularly susceptible to solar irradiation and did not have enough intact mtDNA to 
produce 11kb amplicons in the qPCR assay of Chapter 3 (as demonstrated by melt product 
temperature). To account for donor variability in damage susceptibility as well as a 




 Dose response of solar irradiation (0-8 SED) on mtDNA damage to whole skin foreskin ex-plants. Significant 
damage was detected from 4 SED, with the maximum damage capacity for one donor reached by 8 SED. A dose of 5 SED was 
determined an optimal solar irradiation dose, for detection by 11kb qPCR assay. The standard erythemal dose (SED, J.m-2) is 
equivalent to an erythemal radiant exposure of 100 J.m-2. Total DNA was analysed for mtDNA damage by the housekeeping 
and 11kb qPCR assays of Chapter 3. Mean ± SEM generated from three adult male foreskin donors (14525 – age 56), 14526 
(age - 46), 14527 (age 67) for 0-6 SED (N=3, n=9) or 8 SED (N=2, n=6). Significant difference to 0 SED detected by one-way 
ANOVA with Dunnett’s post-hoc test **** p<.0001 ns p>.05 
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6.3.1.3  A solar simulated dose of 5 SED does not damage skin barrier integrity or diminish 
metabolic viability 
Ex-plants from three adult male foreskin donors (14525 – age 56, 14526 – age 46, 14527 – age 
67) were acclimatised to culture conditions overnight and irradiated in a dose dependent manner 
of 0, 2.5, 5, and 7.5 SED (see 6.3.2 and 2.2.2). The standard erythemal dose (SED, J.m-2) is 
equivalent to an erythemal radiant exposure of 100 J.m-2. These were tested for barrier integrity 
with lucifer yellow stain and metabolic viability with MTT assay. An experimental dose of 5 
SED solar irradiation did not disrupt barrier integrity or reduce metabolic viability of the skin 
(Figure 6-7).  
 
 
 Solar irradiation does not damage barrier integrity or diminish metabolic viability. A+B) Adult foreskin 
donor 14527 (age 67) irradiated with 0 SED (A) or 5 SED (B) both maintained Lucifer yellow within intact stratum corneum. 
Scale bar 50µm, nuclei stained with DAPI. C)  Dose response solar irradiation (0 - 7.5 SED) on whole skin foreskin ex-plants 
did not reduce metabolic viability (as determined by MTT conversion to formazan). Significant damage was detected by 1% 
SDS positive control.  The standard erythemal dose (SED, J.m-2) is equivalent to an erythemal radiant exposure of 100 J.m-2. 
Total DNA was analysed for mtDNA damage by the housekeeping and 11kb qPCR assays of Chapter 3. Mean ± SEM generated 
from three adult foreskin donors (14525 - age 56, 14526 - age 46, 14527 – age 67y). Significant difference to 0 SED detected 






6.3.1.4  Solar irradiation variation across surface area does not largely affect the 
experimental dose (SED) 
A UV-photometer was used to measure solar irradiation (mAmps) over each well of a 24 well 
plate, which was placed in the central solar radiation area (see 2.2.2). Solar radiation readings 
were taken with/without a VIS-IR filter, as the filter is used to determine solar irradiation dose 
but removed for the irradiation treatment. Raw data obtained by Miss Maria Zakhour 
(undergraduate student). The solar irradiation values without a filter (Figure 6-8, A) 
demonstrate a mean of 16.82mAmps, which range between 16.25-17.52mAmps reaching each 
well. Negligible difference (0 – 0.06 mAmps) was found when the UV-VIS filter was washed 
before the repeat on a different day. The mean plate solar irradiation data (with filter, 8.87 
mAmps; n=24) was used to represent 5 SED, whereby 1 standard erythemal dose (SED, J.m-2) 
is equivalent to an erythemal radiant exposure of 100 J.m-2 Relative variation was calculated 
where the lowest dose relatively equated to 4.81 SED and the highest dose relatively equated 
to 5.17 SED (Figure 6-8, B).  
 
 Solar irradiation over surface area. A: Solar irradiation (mAmps, without VIS-IR filter) of each well on 
standard 24 well plate in centre of irradiation area (see 2.2.2). The surface area is not homogenous as it ranges between 16.25-
17.53mAmps, with a mean of 16.81mAmps (n=24).  B: Solar irradiation dose (SED) calculated from data (mAmps) with VIS-
IR filter, demonstrating range between 4.81 - 5.17SED, whereby 1 standard erythemal dose (SED, J.m-2) is equivalent to an 
erythemal radiant exposure of 100 J.m-2. Mean well values calculated from two independent repeats, N=2, n=1.   
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 AOX formulation testing 
6.3.2.1  Test formulations did not physically block live solar light irradiance  
AOX and placebo test formulations did not physically block complete solar simulated light 
(Figure 6-9). Raw data obtained by undergraduate student Miss Maria Zakhour. The relative 
data did not change when filters where used to eliminate UV or visible and infrared components 
of solar light (data not shown). There was no difference to the data obtained through a quartz 
dish or industry standard PMMA plate for SPF testing (PMMA data not shown). Experimental 
controls demonstrated that covering the test system with foil blocked all irradiance, and 
Transpore surgical tape itself blocked only minimal light (<2 mAmp; data not shown). Market 
standards of known broad spectrum SPF significantly blocked irradiance by 85-90%. Both GSK 
placebo cream and Olay Regenerist™ SPF 0 contain niacinamide with no UV filter ingredients.  
Olay Regenerist™ offered marginally more protection than placebo alone (<10%). The addition 




 SPF testing of AOX formulations against market standards. Formulations with/without AOX(s) and SPF 
0/15/50+ market standards were tested for their ability to physically block solar light transmission to a radiometer (mAmp). 
Mean ± SEM from three independent repeats. Significant difference relative to placebo determined by one-way ANOVA with 
Dunnett’s post-hoc test **** p<.001, *p<.05, N=3, n=1 per condition 
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 Human skin equivalent formulation testing 
6.3.3.1  Comparative summary of commercial Labskin™ and in-house CELLnTEC skin 
equivalents technical characteristics 
The primary difference between in-house and commercial skin equivalents is the ability to 
control the source of keratinocytes and fibroblasts used. Labskin™ uses adult fibroblasts derived 
from one donor foreskin, but pools keratinocytes from several neonatal foreskin donors. In-
house skin equivalents can use donor-matched keratinocytes and fibroblasts. The second key 
difference is that the CELLnTEC skin equivalent uses no dermal scaffold, whereas Labskin™ 
uses a fibrin gel which fibroblasts are seeded into. This makes Labskin™ skin equivalents 
approximately 10X thicker. A third relevant difference is that Labskin™ epidermis can be 
manually removed, whereas CELLnTEC skin equivalents have a robust basement membrane. 
Labskin™ is available in 6-well and 12-well sizes, whereas one in-house pilot found 
CELLnTEC was best grown as 12- or 24-well size skin equivalents (see Chapter 5).  
 
 
 Comparative summary of Labskin™ and CELLnTEC full thickness skin equivalent characteristics. 
Labskin™ data taken from company website, certificate of analysis (batch 190103) and first-hand technical experience. 
CELLnTEC skin equivalents derived in-house with media and technical protocol obtained from company website. *ALI – air 
liquid interface 
 
Asides from Labskin™ maintenance medium containing phenol, all other characteristics such 
as establishment time/method remain as standard for these skin equivalent types. Labskin™ 
construction timeline information was sourced from a publicly available presentation slide, 
which has since been taken offline (supplementary Figure 9-3).  
Model Characteristics Labskin
1.1 CELLnTEC





Insert permeable membrane pore size 3.0µm 0.4µm








Insert brand Greiner Greiner/Millipore
Insert sizes 6 or 12 well 12 or 24 well
Human foreskin-derived keratinocytes Pooled donors: neonatal epidermis Single donor: adult epidermis
Human foreskin-derived reticular fibroblasts Single donor: adult dermis Single donor -   adult dermis
Donor matched layers No Yes
Dermal layer scaffold Fibrin gel No
Days at air-liquid interface (ALI) 7-12 (two shipping dates) 12
Media serum Serum-free <1% FBS or serum-free
Antibiotics/Antifungals during growth No No
Antibiotics/Antifungals were added post ALI Yes Yes
Phenol containing medium Yes No
Histology confirms one dermal & four epidermal layers Yes Yes
Epidermis can be manually removed Yes No (robust basement membrane)
Formulation can be applied to stratum corneum Yes Yes
Solar irradiation to induce 4-fold mtDNA damage 5 SED (500J/m
2




There are two key differences in the timelines of Labskin™ and CELLnTEC construction, 
although both take the same total time of approximately 6 weeks. Labskin™ grows its dermal 
equivalent in 6 days, compared to CELLnTEC 10 days. In addition, Labskin™ completes 
cornification by air-liquid interface (ALI) day 7, though CELLnTEC protocol takes ALI 12 
days (+5 days). Both skin equivalents decrease in viability over time in culture (1-10 days), 
although CELLnTEC was tested for 12 days after air-liquid interface completion. 
 
 
 Comparative schematic of CELLnTEC and Labskin™ construction timeline. K- Keratinocytes, F – 
Fibroblasts, SUB-M – submerged co-culture, S – shipping date, A – arrival/acclimatisation, E – experiment day.  
 
6.3.3.2  Labskin™ skin equivalents pre-incubated (0, 1.5, 3 & 6 hours) with AOX or SPF 
formulations demonstrated sensitive time-dependent protection in the epidermis 
(limited in dermis or combined layers)  
A comparison was made between the sensitivity of the 11kb qPCR assay (see Chapter 3) at 
determining mtDNA damage (and protection) in commercial human skin equivalent Labskin™ 
with combined layers and manually separated epidermis and dermis (Figures 6-11, 6-12). A 
solar dose of 5 SED was chosen because this skin equivalent is ~5-6mm mm thick and this had 
proven sufficient in whole skin (Figure 6-6). Two NAM base creams were applied per skin 
equivalent and grouped as: THC/PTERO, SPF 50+/15+, placebo/combination (see Figure 6-3). 
All samples were tested for homogenous mtDNA content immediately prior to 11kb testing, 
with 18/24 dermis samples requiring normalisation (additional total DNA) to equate to the 
mtDNA content of the epidermis and combined samples. Only 3/24 epidermis and 3/24 
combined samples required marginal normalisation.                               
Overall there was greater sensitivity in the amount of damage detected in the epidermis, 
compared to dermis and combined layers. However, the epidermis 3-hour data for placebo and 
combination was not obtained because the epidermis of one skin equivalent (of x12) did not 
adequately separate and minimal DNA was extracted (~1ng/µl). In the combined epidermis and 
dermis, the distinctive trend seen with epidermis is visibly diluted when the multi-layer mtDNA 
is pooled together.  
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The epidermis trend demonstrated that all test formulations had the lowest amount of damage 
at 0 hour (immediate application), and this increased with time. Whilst PTERO had the highest 
amount of damage at each time-point, in combination with THC this was reduced. The addition 
of test AOXs did not improve the protection seen with NAM base cream.   
In the epidermis only one market control (SPF 15) protected against mtDNA damage induced 
by solar light, and this was also seen in the combined sample. However, this was reversed in 
the dermis sample, whereby SPF 50 protected and SPF 15 did not. Nevertheless, the overall 
amount of damage detected in the dermis samples was very low, as the qPCR fold change range 
lay predominantly between 1 to 3-fold (Figure 6-12, B). 
 Labskin™ H&E histology. H&E histology of Labskin™ batch 190103, demonstrating stratum corneum, 




 Labskin™ commercial skin equivalents were tested for mtDNA protection from 5 SED solar light, after 
pre-incubation (0-6 hours) with AOX formulations. Formulations contained 4% niacinamide (NAM), NAM+0.25% 
tetrahydrocurcumin, NAM+0.1% pterostilbene, or NAM+combination. Market controls of known SPF 15/50 were included, 
where the SPF 15 formulation contains NAM. A comparison was made by adjacent portions of skin equivalent whereby 
separated epidermis (A) and dermis (B) were compared to combined (C) layers. In graph A, the 3-hour data for NAM and 
NAM+combination was not obtained because the epidermis of one skin equivalent did not adequately separate and minimal 
DNA was extracted. Total DNA was analysed for mtDNA damage by the housekeeping and 11kb qPCR assays of Chapter 3.  
The standard erythemal dose (SED, J.m-2) is equivalent to an erythemal radiant exposure of 100 J.m-2. Statistical difference 
from controls determined by one-way ANOVA with Dunnett’s post-hoc test on raw Ct value data. ****p<.0001, ***p<.001, 
**p>.001, *p>.01, ns p>.05, N=1, n=3 per sample 
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6.3.3.3  Labskin™ experiment repeated on CELLnTEC skin equivalents produced 
incomparable data due to inadequate batch formation  
As outlined in section 5.3.4, it became apparent after the formulation application experiment 
that this batch of skin equivalents had not formed into layers and produced significantly less 
DNA when compared to previous pilot studies. However, a dry stratum corneum surface was 
available for topical application. Total DNA was analysed for mtDNA damage by the 
housekeeping and 11kb qPCR assays of Chapter 3. The housekeeping assay amplified 83bp 
amplicons for all skin equivalents from both S1141F and S1151F donors, and they all had equal 
mtDNA content. However 2.16 SED solar irradiation induced such significant damage in 
S1151F donor skin equivalents that 11kb amplicons of intact mtDNA could not be amplified 
from any irradiated samples using long range qPCR assay. However they did amplify in DNA 
samples from S1141F donor skin equivalents (Figure 6-13). Although all irradiated samples 
had significant difference to non-irradiated controls, the SPF 15 and 50 control formulations 
did demonstrate a reduced damage than other samples. 
 
 CELLnTEC skin equivalents were tested for mtDNA protection from 2.16 SED solar light, after pre-
incubation (0-6 hours) with AOX formulations. Skin equivalents were derived from foreskin-derived adult keratinocytes 
and reticular fibroblasts from donor S1141F (age 40). Formulations contained 4% niacinamide (NAM), NAM+0.25% 
tetrahydrocurcumin, NAM+0.1% pterostilbene, or NAM+combination. Market controls of known SPF 15/50 were included, 
where the SPF 15 formulation contains NAM. Total DNA was analysed for mtDNA damage by the housekeeping and 11kb 
qPCR assays of Chapter 3.  The standard erythemal dose (SED, J.m-2) is equivalent to an erythemal radiant exposure of 100 
J.m-2. Statistical difference from controls determined by one-way ANOVA with Dunnett’s post-hoc test on raw Ct value data. 
****p<.0001, N=1, n=3 per sample 
  
2.16 SED solar irradiation 
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 Ex-plant skin formulation testing 
It was investigated if the 11kb assay (see Chapter 3) could sensitively determine mtDNA 
damage (and protection) in ex-plant foreskin and facial skin. It was not possible to remove the 
epidermis (as for Labskin™, Figure 6-12), without risking further damage caused by an enzyme 
or heat treatment separation methods. Each 4mm biopsy was manually cut in two, with one 
formulation applied per half biopsy (see 6.2.8). The AOX formulations tested contained 4% 
niacinamide (NAM) base cream with/without a combination of 0.25% tetrahydrocurcumin 
(THC) and 0.1% pterostilbene  (PTERO). All samples per donor were analysed on one qPCR 
plate, having been tested for homogenous mtDNA content immediately prior to 11kb testing.  
6.3.4.1  Adult foreskin pre-incubation with AOX formulations indicated a protective trend in 
some donors from solar light induced mtDNA damage 
Four adult male foreskin donors were used to compare a 4% NAM base cream with/without a 
combination of 0.25% THC and 0.1% PTERO (Figures 6-14, 6-15). Six pre-incubation time 
points ranged from 0 to 6 hours. Three of these donors had enough tissue to perform three time 
points (0, 2, 4 hours) on niacinamide base creams containing tetrahydrocurcumin or 
pterostilbene (Figure 6-15).  
Consistent with Figure 6-6, there was an induction of ~5-fold mtDNA damage in all four donors 
irradiated with 5 SED and no cream formulation.  
There was a protective trend that increased with pre-incubation time in donors 14567 (NAM 
base), 14563 and 14566 (NAM base ± combination) (Figure 6-14). In some instances the 
amount of mtDNA damage was almost as low as the non-irradiated controls,  and these were 
indicated as non-significant (ns) or only marginally different (*). There was not a clear 
improvement to mtDNA protection with the addition of THC and PTERO to NAM base. 
Donors 14566 (age 77)  and 14563 (age 21) had an immediate protection with NAM base ± 




 Protection against solar induced mtDNA damage of ex-plant foreskin with AOX formulations. Total DNA 
was analysed for mtDNA damage by the housekeeping and 11kb qPCR assays of Chapter 3. Solar irradiation (5 SED) induced 
a detectable window of mtDNA damage within a DNA pool of all skin layers. The standard erythemal dose (SED, J.m-2) is 
equivalent to an erythemal radiant exposure of 100 J.m-2. Pre-incubation (0-6 hours) of ½ 4mm skin biopsies with 4% 
niacinamide (NAM) base formulation ± 0.25% THC/0.1% PTERO combination gave variable mtDNA protection (A-D; mean 
± 95% CI). Statistical difference from controls determined by one-way ANOVA with Dunnett’s post-hoc test on raw Ct value 





 Protection against solar induced mtDNA damage of ex-plant foreskin with AOX formulations. Total DNA 
was analysed for mtDNA damage by the housekeeping and 11kb qPCR assays of Chapter 3. Solar irradiation (5 SED) induced 
a detectable window of mtDNA damage within a DNA pool of all skin layers. The standard erythemal dose (SED, J.m-2) is 
equivalent to an erythemal radiant exposure of 100 J.m-2. Pre-incubation (0-6hours) of ½ 4mm skin biopsies with 4% 
niacinamide (NAM) base formulation±0.25% tetrahydrocurcumin, 0.1% pterostilbene or a combination gave variable mtDNA 
protection (A-C; mean ± 95% CI). Statistical difference from controls determined by one-way ANOVA with Dunnett’s post-
hoc test on raw Ct value data. ****p<.0001, ***p<.001, **p>.001, *p>.01, ns p>.05, N=1, n=3 per sample 
  
133 
6.3.4.2  Adult facial skin pre-incubated with AOX formulations indicated inconclusive 
protection against solar light induced mtDNA damage  
Three adult male donors were used to compare a 4% NAM base cream with/without a 
combination of 0.25% THC and 0.1% PTERO (Figures 6-16, 6-17). Six pre-incubation time 
points ranged from 0 to 6 hours. Two of these donors had enough tissue to perform three time 
points (0, 2, 4 hours) on NAM base creams containing THC or PTERO (Figure 6-17).  
There was insufficient facial skin to perform a dose-response solar irradiation experiment as 
with foreskin in Figure 6-6. As facial skin is markedly thicker than foreskin, 5 SED solar 
irradiation induced approximately half the mtDNA damage in all donors irradiated without 
cream formulation.  
 
 Protection against solar induced mtDNA damage of ex-plant adult facial skin with AOX formulations.  
Total DNA was analysed for mtDNA damage by the housekeeping and 11kb qPCR assays of Chapter 3. Solar irradiation (5 
SED) did not induce a detectable window of mtDNA damage within a DNA pool of all skin layers. The standard erythemal 
dose (SED, J.m-2) is equivalent to an erythemal radiant exposure of 100 J.m-2.  Pre-incubation (0-6 hours) of ½ 4mm skin 
biopsies with 4% niacinamide (NAM) base formulation ± 0.25% THC/0.1% PTERO combination gave variable mtDNA 
protection (A-C; mean ± 95% CI). Statistical difference from controls determined by one-way ANOVA with Dunnett’s post-
hoc test on raw Ct value data.. ****p<.0001, ***p<.001, **p>.001, *p>.01, ns p>.05; N=1, n=3 per sample 
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 Protection against solar induced mtDNA damage of ex-plant facial skin with AOX formulations. Total 
DNA was analysed for mtDNA damage by the housekeeping and 11kb qPCR assays of Chapter 3. Solar irradiation (5 SED) 
did not induce a detectable window of mtDNA damage within a DNA pool of all skin layers. The standard erythemal dose 
(SED, J.m-2) is equivalent to an erythemal radiant exposure of 100 J.m-2. Pre-incubation (0-6 hours) of ½ 4mm skin biopsies 
with 4% niacinamide (NAM) base formulation±0.25% tetrahydrocurcumin, 0.1% pterostilbene or a combination gave variable 
mtDNA protection (A-B; mean ± 95% CI). Statistical difference from controls determined by one-way ANOVA with Dunnett’s 




6.3.4.3. Grouped donor analysis of foreskin or facial skin protection against solar induced 
mtDNA damage by AOX formulations.  
Although statistics were performed on raw Ct comparisons between samples of the same donor, 
raw data was grouped in Figure 6-18. Although donor variation is evident by large standard 
deviation bars, statistical difference could not be calculated on mean Ct values of multiple 
donors (see 6.2.11). In Figure 6-18 the lower dashed line indicates the mean Ct value of non-
irradiated controls, whereas the higher dashed line indicates the mean Ct value of irradiated 
skin without any cream application. The distance inbetween represents the ‘window of damage’ 
to visually identify which conditions showed some mtDNA protection from solar irradiation. 
This window is markedly smaller for facial skin (Figure 6-18, B), where 5 SED solar irradiation 
didn’t induce as much damage as thinner foreskin. There are some trends seen with foreskin 
(Figure 6-18, A)  that are indicative of protection e.g. THC + 0 hour, but more donors are 
required to draw strong conclusions. 
 
 
 Mean protection against solar induced mtDNA damage of ex-plant foreskin or facial skin with AOX 
formulations. Total DNA was analysed for mtDNA damage by the housekeeping and 11kb qPCR assays of Chapter 3.  Pre-
incubation (0-6 hours) of adult foreskin (A) or facial skin (B) ½ 4mm skin biopsies with 4% NAM base formulation ± 0.25% 
THC , 0.1% PTERO or a combination. Data is mean raw Ct values ± SD for the foreskin and facial donors of Figures 6-14 to 
6-17. The lower dashed line indicates the mean Ct value of non-irradiated controls, whereas the higher dashed line indicates 
the mean Ct value of irradiated skin without any cream application. The distance inbetween represents the ‘window of damage’ 
to visually identify which conditions showed some mtDNA protection from solar irradiation. The standard deviation bars 
represent donor variability. Statistical difference could not be calculated on mean Ct values of multiple donors (see 6.2.11). 




This chapter investigated if the protection seen in skin cell monolayers with direct antioxidant 
(AOX) exposure (Chapter 4) was reproduced in 3D skin model systems with AOXs delivered 
in cream formulation. The human skin equivalents outlined in Chapter 5 were used for 
formulation testing and compared to whole skin ex-plant from foreskin and facial sources. 
These skin equivalents were tested for the AOX capacity to protect against solar light induced 
damage to mitochondrial DNA in human skin, using the qPCR method (Chapter 3). In 
accordance with international cosmetic protocols (e.g. COLIPA), a formulation dose of 
2mg/cm2 was applied in experiments (Lionetti and Rigano, 2017).  
Initial acellular experiments were performed on the emulsion formulations provided by GSK, 
that have a Physiogel™ (Stiefel) chassis/base formulation inclusive of a core AOX ingredient 
(niacinamide) and test antioxidants tetrahydrocurcumin, pterostilbene, or combination (Table 
6-1). Although niacinamide was not included in monolayer experiments (chapter 4), it would 
be included in a cosmetic product due to its established efficacy and popularity with consumers.  
As such, two Olay products that contain niacinamide (0 or 15 SPF) were included as market 
controls, alongside a high SPF positive control (La Roche Posay sun cream). The test 
formulations contain no UV filters, and neither the chassis nor AOX ingredients provided any 
physical blocking capacity of simulated sunlight (Figure 6-9). As outlined in the chapter 4 
discussion, it was expected that phenolic antioxidants would offer protection by biological 
mechanisms over physical absorbance of UV wavelengths. Sirerol et al. (2015) also found that 
while pterostilbene compound has an absorbance peak in the UVB range, the pterostilbene 
formulation had a very low in-vitro SPF rating. However, this knowledge is useful for two 
reasons. It confirms that any protection seen in model systems has a biological basis and avoids 
a delayed product launch as a result of the legal requirement for sun protection product testing 
(e.g. Cosmetics Regulation (EC no. 1223/2009)).  
 
To optimise an organ culture method for ex-plant skin, biopsies from three donors were 
incubated at air-liquid interface for 1-7 days and tested for their capacity to metabolise MTT 
(Figure 6-5).  Facial skin was better sustained over time than foreskin, but it is unclear if this is 
attributed to donor or site variability. Whilst all tissue was used for experiments on day 1 (after 
overnight acclimatisation), the tissue viability could perhaps be extended for longer studies with 
a different medium. For long term organ culture of human scalp skin, Lu et al. (2007) compared 
supplemented serum-free William’s E medium with a commonplace serum-containing MEM 
medium. They found that serum-free medium allowed prolonged and enhanced human skin and 
hair follicle survival beyond three weeks, with one donor reported to survive 88 days. Zhou et 
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al. (2018) reviews human skin organ culture and the approach in this thesis (DMEM+10% FBS, 
air-liquid interface) is concurrent with culture conditions for the majority of skin sites. However 
they advocate the use of a serum-free or human-serum approach in lieu of bovine-serum.  
It was reassuring that an environmentally relevant dose of 5 SED (500 J/m2) induced a level of 
mtDNA damage in ex-plant foreskin that could be detected by the qPCR method (chapter 3). 
Whilst this equates to a relatively intense dose of 5 hours Mediterranean summer sun, it is not 
outside the feasibility of a single or accumulative dose to human skin. As seen in Figures 6-6 
and 6-7, this dose did not disrupt the skin barrier or reduce metabolic activity in the cultured 
skin. The solar irradiation dose was optimised using foreskin, but it was unexpected that 5 SED 
would only induce half the amount of mtDNA damage in facial biopsies (Figures 6-16, 6-17, 
6-18(B)). This narrowed the detection window for AOX protection to the limit of qPCR assay 
sensitivity (1 Ct), making it difficult to draw conclusions from Figure 6-18 (B). In addition, the 
facial skin had a rigid hypodermis that made it technically difficult to divide biopsies evenly in 
half and sit upright on the insert membrane. The unequal division of facial biopsies likely 
explains the viability peaks and troughs in Figure 6-5, whereby a slightly smaller piece would 
produce less formazan.  
 
The final chapter area pertains to AOXs formulation testing using the human skin equivalents 
characterised in chapter 5. These include the in-house derived CELLnTEC skin equivalent 
(Figure 6-13) and commercial Labskin™ (Figure 6-12). Technical characteristics of these skin 
equivalents are compared in Figure 6-10 and Table 6-2. Unlike the CELLnTEC skin equivalent, 
Labskin™ epidermis could be manually separated from the dermal compartment. However the 
Labskin™ fibrin hydrogel dermis ruptured  and released liquid when divided with a scalpel. To 
investigate where most of the solar light induced mtDNA damage was located, a comparison 
was made between separated and combined Labskin™ epidermis-dermis (Figure 6-12). The data 
confirmed the theory that a limiting factor for qPCR assay mtDNA damage detection is 
comparative sample size. A standardised surface area and thickness of tissue sample is required. 
Relative to pooled mtDNA from all skin layers, a higher proportion of damage would be 
detected in pooled mtDNA from the thinner epidermis. In Figure 6-12 the same trend is found 
in epidermis and combined, but the level of damage (bar height) has been reduced (or ‘diluted’). 
This ‘dilution’ effect is not as prevalent in Labskin™ as other human skin equivalent/ex-vivo 
skin because there are few fibroblasts in the dermal compartment, and a thickened stratum 
corneum. The skin equivalent is substantially thicker than physiological skin and it was unclear 
if 5 SED simulated solar light had penetrated through the dermis. The ‘dilution’ effect was more 
evident in the foreskin and facial skin studies (Figures 6-14 to 6-18) and the qPCR assay could 
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not distinguish clear trends between test conditions. To increase sensitivity, epidermal 
separation of ex-plant skin would be feasible by Dispase (enzyme) or heat treatment methods 
(Zou and Maibach, 2018). However, it is more likely that DNA/RNA/protein quality would be 
preserved through the separation method of a 30-minute epidermis-up (free-floating) incubation 
in ice-cold 0.5M ammonium thiocyanate phosphate buffer (Baris et al., 2011). The intention 
was to repeat the ex-plant/Labskin™ AOX formulation studies with CELLnTEC skin 
equivalents, but they failed to establish (see 5.3.8). It was expected that as these in-house skin 
equivalents were of a similar thickness to thin physiological skin (but without additional cell 
types/organ structures), that the qPCR assay would be suited to distinguish between conditions. 
 Summary of main findings 
➢ Organ culture of human foreskin and facial skin punch-biopsies were maintained at the air-
liquid interface 
➢ A dose-response solar irradiation of ex-plant foreskin determined 5 SED induced mtDNA 
damage detectable with the qPCR assay 
➢ A dose of 5 SED did not disrupt the skin barrier integrity or skin metabolic function 
➢ GSK test formulations tested as SPF 0 in acellular in-vitro assay 
➢ Formulations were topically applied at 2mg/cm2 to commercial Labskin™ and in-house 
CELLnTEC skin equivalents. Formulations were topically applied at 2mg/cm2 to 
commercial Labskin™ and in-house CELLnTEC skin equivalents 
➢ Labskin™ could be manually separated and a greater sensitivity of mtDNA was detected in 
isolated epidermis.  
➢ CELLnTEC skin equivalents failed to establish correctly for this experiment, but some 
DNA was attained and it had a sensitive detection of mtDNA damage 
➢ An organ culture system, solar irradiation, formulation application and isolation techniques 
(DNA/RNA/protein etc.) were optimised for whole skin, making it suitable for other 
analytical methods 
➢ Pooled mtDNA from whole skin ex-plant provided a damage range detectable by the qPCR 
assay in foreskin, but not the thicker facial skin 
➢ Separation of the epidermis from whole skin (by enzyme or heat treatment) should provide 
a pool of mtDNA that the qPCR assay can sensitively detect damage within 
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Chapter 7:  Detection of mtDNA damage in donor-matched BCC and non-
BCC facial skin……………………….. 
 Chapter overview and aims 
Mitochondria are becoming increasingly associated with human cancers whereby cellular 
metabolic reprogramming is thought to have a key role in tumour initiation and  progression 
(Hosseini et al., 2017). Environmental stressors such as UV result in accumulative damage to 
mtDNA in human skin, and skin cancer rates of incidence are rising. However, it remains 
unclear why only portions of environmentally exposed skin become cancerous, and the adjacent 
skin remains physiologically intact. A proof of concept study was designed to see if the qPCR 
assay (Chapter 3) could be applied to the detection of mtDNA damage in donor-matched basal 
cell carcinoma (BCC) and non-BCC tissue. The effect of simulated solar radiation on these 
tissues was also investigated. In collaboration with Dr Sarah Felton of Oxford University 
Hospital NHS Trust and Public Health England (PHE; Oxford, UK), 21 donors were included 
in this pilot study.  
 Chapter specific methods 
Skin samples were sourced from Mohs micrographic surgical patients of Dr Sarah Felton. Total 
DNA samples were sourced in collaboration with Dr Ken Raj and Dr Graham Holliman of PHE. 
Skin processing, solar irradiation, and DNA extractions were performed by Dr Holliman at PHE 
on donor-matched whole skin from excised facial BCC and its non-cancerous standing cone 
(see Table 7-1 footnote for definition). Donor information is summarised in Table 7-1 whereby 
21 donors (16 females, 5 male) were analysed for mtDNA damage with sequential 
housekeeping and 11kb mtDNA assays, as outlined in Chapter 3. Housekeeping was used to 
check donor-matched BCC and non-BCC samples had equal mtDNA copy number (Ct values).  
Data from the 11kb assay was analysed as outlined in 6.3.3, except for the following 
differences. Data was grouped into two categories per donor, whereby non-BCC represents                
Ct (control) and the BCC represented Ct (treated) in the 2
ΔCt (treated-control) formula calculating 
relative fold change. Welch’s t-test was performed on the raw Ct values of all samples per donor 
(Fagerland and Sandvik, 2009). 
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190717-58M M Back 58 Yes Yes Fig 7-3 
190717-61F F Cheek 61 Yes Yes Fig 7-3 
190717-69F F Nose 69 Yes Yes Fig 7-3 
190717-86F F Nose 86 Yes Yes Fig 7-3 
260717-56F F Chin 56 Yes Yes Fig 7-3 
260717-82F F Forehead 82 Yes Yes Fig 7-3 
260717-62F F Nose 62 Yes Yes Fig 7-3 
260717-47F F Lip 47 Yes Yes Fig 7-3 
260717-79M M Temple 79 Yes Yes Suspected SCC+, Fig 7-3 
260717-92F F Chin & Forehead 92 Yes - both Yes - both Figs. 7-1, 7-3 
300817-85FA F Nose 85 Yes Yes Fig 7-3 
300817-85FB F Nose 85 Yes Yes non-BCC may be scar 
tissue, Fig 7-3 
181017-81F F Nose, lip/cheek, 
and eyelid 
81 Yes - nose Yes - nose, 
lip/cheek, eyelid 
Figs. 7-1, 7-3 
181017-91F F Nose 91 Yes Yes Fig 7-3 
181017-82M M Nose 82 Yes Yes Fig 7-3 
181017-87F F Eyelid 71 Yes Yes non-BCC was not 
supplied so manually 
separated, Fig 7-3 
041017-76F F Lip 76 Yes Yes Fig 7-3 
011117-70F F Nose & lip 70 Yes - both Yes - both ≠ Figs. 7-1, 7-3 
011117-61F F Nose 61 Yes Yes ≠ Fig 7-3 
131217-79M M Ear 79 Yes Yes Fig 7-3 
131217-88M M Cheek 88 Yes Yes Fig 7-3 
Excluded samples 
041017-71M M Ear 71 Yes No  
131217-51M M Nose 51 Yes No  
300817-70M M Neck 70 No Yes  
011117-XXF F Ear ? No Yes ≠ 
011117-61F F Nose 61 Yes No  
 Demographics of donor DNA samples provided in collaboration with Public Health England and Oxford 
University Hospital NHS Trust. Two donors were excluded from analysis as no comparative material was available. *Age 
on date of surgery, **BCC – basal cell carcinoma excised by Mohs surgery, ***non-BCC – Mohs surgical standing cone or 
‘dog ears’ are skin adjacent to the excision site that are removed for smooth wound closure, +SCC - squamous cell carcinoma 




 Sensitive detection of relative mtDNA damage across multiple facial sites.… 
There were three female donors who had multiple excisions from different facial sites (260717-
92F, 181017-81F, 011117-70F, see Table 7-1). Total DNA was analysed for mtDNA damage 
by the housekeeping and 11kb qPCR assays of Chapter 3. The non-BCC samples were 
compared to determine if mtDNA damage had accumulated to the same extent across their face. 




 Sensitive detection of mtDNA damage across multiple facial sites in three female donors. Total DNA was 
analysed for mtDNA damage by the housekeeping and 11kb qPCR assays of Chapter 3. Statistical difference determined by 
two-tailed unpaired t-test with Welch’s correction. Mean Ct ± SD, ****p<.0001, **p=.026, *p=.01; N=1, n=3 per sample. 
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 Solar irradiation methods did not induce detectable differences in mtDNA 
damage…….. 
To determine if there was a difference in BCC susceptibility to solar light induced mtDNA 
damage, Dr Graham Holliman (PHE) manually divided all donor samples (BCC and non-BCC) 
exposing half to irradiation using a Hönle solar simulator. Various solar irradiation doses were 
used but mtDNA damage was not induced (data not included). A PHE spectroradiometer was 
sent to Newcastle University and various traces of the Newport Solar Simulator were captured 
using SpectraSuite software. The equipment was returned to PHE and repeated on their solar 
simulator. The data was analysed at PHE by Dr Holliman and showed that the Newport model 
represented ‘summer’ sunlight compared to the ‘winter’-like sun of the Hönle solar simulator. 
This is represented in Figure 7-2 where the Newport model has a much higher amount of UV, 



































































































































































 Detection of differences in donor-matched BCC and non-BCC mtDNA 
damage........... 
Total DNA was analysed for mtDNA damage by the housekeeping and 11kb qPCR assays of 
Chapter 3. The mtDNA damage fold change (2ΔCt) of BCC relative to non-BCC per donor is 
illustrated in Figure 7-3. Of the 22 donors analysed, a majority were from the nose (n=9), 
followed by lip (n=3), cheek/chin/forehead (n=2/region), and eyelid/ear/temple/back 
(n=1/region). The BCC had less mtDNA damage than non-BCC in 8/22 donors, but more than 
non-BCC in 5/22. The levels were within 2-fold of one another in 9/22 donors.  
 
 Detection of mtDNA damage in donor-matched BCC and non-BCC skin samples. Total DNA was analysed 
for mtDNA damage by the housekeeping and 11kb qPCR assays of Chapter 3. The skin sites are grouped by colour, and all but 
one sample are facial skin. The relative fold change of BCC mtDNA damage to non-BCC control are graphed as mean ± 95% 




Traditionally nuclear DNA (nDNA) has been widely studied in cancer research, and the 
carcinogenic effect of UVR on skin nDNA is well defined in the skin cancer field (Schallreuter 
et al., 2002; Fajuyigbe et al., 2018). However, mitochondria are becoming increasingly 
associated with human cancers because cellular metabolic reprogramming is thought to have a 
key role in tumour initiation and  progression (Penta et al., 2001; Giampazolias and Tait, 2016; 
Zong et al., 2016; Hosseini et al., 2017). To date a majority of the research pertaining to 
mitochondria and epithelial carcinomas have focused on other organ systems such as renal, 
gastric, and colorectal (Penta et al., 2001; Hosseini et al., 2017). Yet skin cancer rates of 
incidence are rising, and environmental stressors such as UV cause accumulative damage to 
mtDNA in human skin cells (Hosseini et al., 2017). Basal cell carcinoma (BCC) is the most 
common skin tumour, although squamous cell carcinoma (SCC) is more aggressive (Fajuyigbe 
et al., 2018). There are established associations between intermittent sun-exposure (e.g. 
holidays) causing BCC and melanoma, whereas accumulative lifetime sun exposure is 
associated with SCC occurrence (Kimlin and Guo, 2012). It is hypothesized that BCC arises 
from mutation(s) to epidermal basal stem cells (Fajuyigbe et al., 2018), yet it remains unclear 
why only portions of environmentally exposed skin become cancerous and the perilesional skin 
is comparatively unaffected. Eshaghian et al., (2005) used long range PCR to investigate  
mtDNA in BCC/tumour-free skin margins and found a lower frequency of deletions in the 
tumours. Long range PCR can be biased to preferentially amplify smaller products (Eshaghian 
et al., 2005), which the qPCR assay (chapter 3) ameliorates through amplification of intact 
mtDNA. A proof of concept study was designed to see if the qPCR assay could be applied to 
the detection of mtDNA damage in donor-matched BCC and non-BCC tissue. The effect of 
simulated solar radiation on these tissues was also investigated.  In collaboration with Dr Sarah 
Felton of Oxford University Hospital NHS Trust and Public Health England (PHE; Oxford, 
UK), 21 donors were included in this pilot study. 
 
As three patients had multiple excisions, it was an opportunity to first investigate whether the 
qPCR assay could detect differences in the amount of mtDNA damage between their individual 
(non-BCC) facial regions. As well as confirming the suitability of the qPCR assay to detect 
acquired damage, it was interesting to review differences across the face where skin thickness 
is highly variable. Even in the context of this small study, it was clear that the incidence of nose 
BCC was more prevalent than other areas (Table 7-1). However, nose had significantly less 
mtDNA damage than thinner skin such as the eyelids and lips (Figure 7-1). Of the donors 
analysed, a majority were from the nose (n=9), followed by lip (n=3), cheek/chin/forehead 
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(n=2/region), and eyelid/ear/temple/back (n=1/region) (Figure 7-3). Pratt et al. (2017) describe 
how 70-90% of BCCs develop on sun-exposed head and neck regions, but 5-10% of all skin 
cancers are on the eyelids. Their study in Liverpool (UK) used UV imaging to show that facial 
areas prone to skin cancer are those missed during sunscreen application (particularly around 
the eyes and lips).   
To investigate the effect of solar irradiation on BCC and non-BCC skin, each skin sample was 
divided in half and treated with 2 SED solar simulated light. This dose was chosen by Dr 
Holliman of PHE, but this did not induce any differences to mtDNA that could be detected by 
the qPCR assay (data not included). Calibration equipment was sent from PHE to compare solar 
irradiation equipment (Figure 7-2), which indicated that 2 SED from the Newport ‘summer’ 
solar simulator would induce much more damage than a Hönle ‘winter’ sun simulator. Later 
studies determined that 2 SED is an insufficient dose for induction of damage in whole skin 
(Chapter 6). It would perhaps be better to focus on repeated dosing in an organ culture system 
(Chapter 6), but as this was a secondary question focus was shifted towards the primary 
objective of comparing mtDNA damage (Figure 7-3). 
 
As seen in Figure 7-3, BCC had less mtDNA damage than non-BCC in 8/22 donors, but more 
than non-BCC in 5/22. The levels were within 2-fold of one another in 9/22 donors.  
Whilst it is not unexpected that a cohort could stratify in groups, concerns arose around this 
data. It became apparent with the transition from cell (chapter 4) to more complex human skin 
models (chapter 6), that the qPCR assay comparative nature requires consistency between the 
volume of sample used to isolate DNA. Whilst the housekeeping protocol ensures equal 
mtDNA content between samples, the tissue surface area and depth require standardisation. In 
a cell or skin swab experiment, sample standardisation is more naturally embedded in the 
methodology. In this collaboration there were additional logistical factors relating to sample 
collection, transport and processing, that could have affected mtDNA damage. In future studies 
it is recommended to create robust protocols that detail consistency in sample storage 
method/duration, processing, and DNA isolation. Whilst surface area is easily standardised by 
a punch biopsy of chosen diameter (mm), excision depths vary between procedures. To control 
for this, reference material could be embedded so data can be grouped by histological depth 
measurements and/or facial region mapping. The non-uniformity of facial skin suggests an 
approach that groups  donor data by region so that thin skin (e.g. lip/eyelid) is not grouped with 
thicker cheek or nose. It is also necessary to group by skin phototype (Fajuyigbe et al., 2018).  
Overall, this area of research using donor-matched BCC/non-BCC skin is novel and worth 
developing. As the qPCR assay was scaled down in Chapter 3, a small punch-biopsy of donor 
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tissue provides enough DNA for mtDNA screening. This allows for several further 
investigations to be performed on the DNA/RNA/protein of remaining tissue from an extremely 
valuable resource.  
 Summary of findings 
➢ The qPCR assay (chapter 3) can detect mtDNA damage in human skin 
➢ The Newport Solar Simulator has a different spectral profile than PHE lamps. This is a 
consideration for future collaborative project protocols incorporating solar irradiation 
➢ To induce a detectable level of induced solar light damage in facial skin, a very high single 
dose or repeated dosing of organ cultured skin are most likely to be effective 
➢ Collaborative protocols should be standardised for future studies pertaining to sample 
storage, transport, DNA isolation, sample punch-biopsy size (surface area), sample biopsy 
depth, and facial location mapping 
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Chapter 8:  Discussion 
 Overview 
To drive development of skin products, it is essential to understand how AOX ingredients 
interact and behave. Human skin is exposed to daily oxidative stress from environmental 
stressors. This project aimed to demonstrate if phenolic AOXs tetrahydrocurcumin (THC) and 
pterostilbene (PTERO) could protect skin mtDNA from environmental sun exposure. There are 
numerous publications relating to curcumin and resveratrol, but extremely limited studies on 
their enhanced synthetic derivatives. Furthermore, there are no studies that use these derivatives 
in combination.  
To accomplish this, a sensitive assay was optimised to detect protection of mtDNA, and a 
representative full thickness skin equivalent was developed that comprised donor-matched 
layers and no scaffold material. In addition, an organ culture method was optimised for human 
skin.  
A limiting factor in scientific research is the capacity for basic research to translate to clinical 
or commercial application. To investigate, this project incorporated a novel transitional 
approach from previously obtained human cell line data to 2D primary cell monoculture, full-
thickness skin equivalents, and whole skin ex-plants. Applications of the qPCR assay were 
tested in models of different complexities and its use for detection of acquired mtDNA damage 
was investigated by novel comparison of donor-matched basal cell carcinoma (BCC) and non-
BCC facial skin.  
8.1 AOX stability: THC and PTERO 
Acellular investigations of THC and PTERO photo-stability in solar simulated light, revealed 
PTERO (but not THC) sustained dose dependent photo-degradation. Although AOX 
absorbance data in UV-visible light are commonplace, the effect of solar light on AOX stability 
and chemical structure is infrequently reported. This data concurs with studies by Sirerol et al. 
(2015) who reported PTERO absorbance in the UVB range (275, 290, 305nm; 1mM), and Silva 
et al. (2013) who found the amount and rate of trans-resveratrol degradation was highest after 
exposure to the combined UV-VIS (200-600nm) spectrum, rather than UV (254nm) or VIS 
(≥365nm) in isolation. Dr Robert Lucas of GSK hypothesized that the photo modulated PTERO 
may be pro-oxidative (see supplementary chapter 9.2.4). Moreover it was a patented liposome 
encapsulated PTERO that was found to confer remarkable protective effects against the 
production of skin cancer tumours in UVB treated hairless mice (Estrela, J. and Asensi, M. 
2009; Sirerol et al., 2015). Yet a study by Dujic et al. (2007) reported UVA or VIS 
photoactivation of low level curcumin in HaCaTs was required to stimulate antiproliferative 
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effects. These simple experiments provide valuable information relating to strategic 
combinations of AOXs (or other AOX ingredients) and give considerations for vehicles in 
formulation design. While THC and PTERO had positive UV absorbance data, this was not 
translated to a physical blocking (SPF) capacity within a Physiogel™ formulation. Sirerol et al. 
(2015) also found that while PTERO compound has an absorbance peak in the UVB range, the 
PTERO formulation had a very low in-vitro SPF rating. A low SPF rating can sometimes be 
viewed positively because legislation (e.g. Cosmetics Regulation EC no. 1223/2009) requires 
extensive testing for a cosmetic to be classified with sun protection status. It is preferable for 
the AOX ingredients to achieve protection or repair via biological mechanisms. 
8.2 Optimisation of the qPCR assay to assess AOX protection of mtDNA 
The comparative qPCR assay optimised in this project effectively scaled down the required 
amount of DNA (by 76%) and reaction volume (by 60%). This meant that more sample types 
could be economically screened, and smaller samples could be included. This method has been 
published (Hanna et al., 2019) and applied to other studies which are intended for publication.   
This assay is a powerful screening tool for assessing AOX protection of mtDNA from solar 
simulated light. However, some instances have been detected where this assay is not 
appropriate.  
If a sample contains so much mtDNA damage that intact copies cannot amplify, then a shorter 
mtDNA amplicon should be chosen. An example of this would be a skin swab (where 
considerable damage is in the top layers of skin), or where monolayers are excessively damaged 
by high or repeated dosing of solar irradiation. In this instance primer dimer will amplify instead 
of 11kb mtDNA amplicons, which has a characteristic lower melt temperature of 79-80oC.  
The second instance relates to sample standardisation if the experimental model is tissue. As a 
comparative assay, the housekeeping protocols compare relative mtDNA content (irrespective 
of damage). However, the proportion of mtDNA damage within the total mtDNA pool is 
influenced by the volume of original sample. Relative to pooled mtDNA from all skin layers, a 
higher scale of damage would be detected in pooled mtDNA from the thinner epidermis. 
Therefore they could not be directly compared with this assay. An example of this was in the 
whole skin studies where a solar dose of 5 SED induced a higher range of mtDNA damage in 
foreskin, than thicker facial skin. In a cell or skin swab experiment, sample standardisation is 
more naturally embedded in the methodology. In a collaborative pilot study with Public Health 
England (PHE), this qPCR method was used to compare the mtDNA damage of donor-matched 
BCC/non-BCC skin. Whilst this research is highly novel, recommendations were made in the 
Chapter 7 discussion that would improve sample standardisation for future use with this 
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sensitive assay. This would add confidence to this preliminary data ahead of any publications. 
In order to induce a detectable amount of mtDNA damage in models of various thickness, the 
solar irradiation dose varied in this thesis, e.g. a 2.16 SED dose was used for monolayers, but 5 
SED was required for whole skin. The standard erythemal dose (SED, J.m-2) is equivalent to 
an erythemal radiant exposure of 100 J.m-2 and equates to one hour of Mediterranean summer 
sun. The doses used were therefore not outside the remit of a physiological dose acquired over 
one or multiple accumulative sunlight exposures.  
8.3 Protective capacity of THC and PTERO in primary human skin cells exposed to solar 
simulated light 
Foreskin-derived adult keratinocytes, differentiated keratinocytes and fibroblasts were pre-
incubated with THC and PTERO to test their protective capacity when irradiated with solar 
simulated light. Human skin cell lines are widely used to assess the protective capacity of 
AOXs, but the findings do not always translate with the same potency or mechanism in primary 
cell cultures. In addition, there is often variability in donor response which is more 
representative of the diverse consumer population. As such, information can be acquired from 
primary cell data pertaining to efficacy for market demographics such as sex, age, or skin-type. 
Although given that the most widely used and available resource of human skin is foreskin, this 
can skew these demographics. Each AOX was pre-incubated with three or four different adult 
foreskin donors. THC (but not PTERO) protected mtDNA in 2 of 3 fibroblast donors, and a 
combination gave greater protection in a further 2 of 3 different fibroblast donors. This is 
indicative of the previous point where not all donors respond in the same way, or to the same 
degree. However, it can be difficult to economically test enough donors to draw clear 
conclusions. With this in mind, it would be beneficial to incorporate design of experiments 
(DOE) statistical methods in order to identify the minimum number of donors to test and 
standardise study design. Mignon et al. (2018) advocate this approach after demonstrating how 
variations in technical parameters and cell culture protocols affect fibroblast response to solar 
irradiation.  
There are some skin cell studies with THC or PTERO that propose mechanisms for their AOX 
and anticarcinogenic properties, such as upregulation of endogenous AOX enzymes (via NRF2 
pathway), and increasing mitochondrial membrane potential (Ayli et al., 2010; Kosuru et al., 
2016; Chen et al., 2017; Trivedi et al., 2017; Zhou et al., 2019). A resonating point from Kosuru 
et al. (2016) is that low concentrations of PTERO drive protective AOX effects, and high 
concentrations have a pro-oxidant effect by increasing ROS as a means of inducing apoptosis 
to prevent carcinogenesis. Whilst AOX doses used in this thesis were selected for being high 
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(but non-toxic), a lower dose of PTERO was included in the later fibroblast experiments to 
investigate if this in-fact had a greater protective effect. Halving the dose did not enhance or 
diminish the mtDNA protection, so future studies on AOX efficacy should aim to find the 
lowest effective dose.  
There is limited evidence in current literature in relation to the protective capacity of THC, 
PTERO or their combination against mtDNA damage. The protection of skin fibroblast mtDNA 
from solar light induced damage is novel and worthy of future study.  
8.4 AOX formulation testing in 3D human skin models 
To investigate whether the mtDNA results from skin cell monolayers could be replicated in 
more complex 3D model systems, AOXs were delivered in a Physiogel™ (Stiefel) moisturising 
cream formulation. The skin equivalents developed in Chapter 5 were used for formulation 
testing and compared to whole skin ex-plant from foreskin and facial sources. In accordance 
with international cosmetic protocols (e.g. COLIPA), a formulation dose of 2mg/cm2 was 
applied (Lionetti and Rigano, 2017). A technical difficulty relating to ≤4mm skin punch 
biopsies is that they can be difficult to dose with minute volumes of formulation. However, this 
was overcome by using a positive displacement pipette.  
It was not anticipated during the initial monolayer experiments that later formulations would 
contain niacinamide. As this is a core ingredient of future products, it would be worthwhile to 
investigate the impact of niacinamide with THC, PTERO, and THC/PTERO combination in 
monolayer experiments. The incorporation of two Olay positive control products (Chapter 6) 
worked well, as both contain ~4% niacinamide but vary in SPF status (0 or 15 SPF).  
The formulations and market controls were tested on the in-house derived CELLnTEC skin 
equivalent and commercial Labskin™. Both skin equivalent types were simultaneously 
characterised with immunostaining, to compare the volume and organisation of extracellular 
matrix. Whilst the in-house skin equivalent stained positively, the Labskin™ dermis was not as 
physiologically representative. There was a low fibroblast density and it appeared that 
embedding fibroblasts within a gel limits their ability to secrete extracellular matrix. Klicks et 
al. (2017) refer to the use of hydrogel-based scaffolds in their review of 3D in-vitro skin 
equivalent systems, but don’t comment on the functional capacity of fibroblasts embedded 
within it. It is unclear how readily fibroblasts can communicate with each other in this 
environment, or with keratinocytes. As collagen I stained within the Labskin™ epidermis, it 
appeared to visually suggest that the fibroblasts had pushed it out of the gel. In immunostaining 
and western blots, this antibody has proved highly specific and it is not expected to be non-
specific binding. In published literature, Labskin™ is marketed towards epidermal studies 
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surrounding wound-healing or skin microbiome but fails to disclose thorough characterisation 
data. In addition, the model is substantially thicker than physiological skin and raises concerns 
about the translation of data relating to the dermis or whole skin. One advantage of the dermis 
design was that the epidermis could be manually removed. To investigate where most of the 
solar light induced mtDNA damage was located, a comparison was made between separated 
and combined Labskin™ epidermis-dermis. The same trend was found in epidermis and 
combined, but the level of damage (bar height) in the latter has been reduced (or ‘diluted’). It 
was unclear if 5 SED simulated solar light had penetrated through the dermis.  
This study used one batch of Labskin™ but data relating to inter-model and inter-batch 
variability is currently unavailable. Mitchell et al. (2016) tested the lipid distribution of 
Physiogel™ on Labskin™ skin equivalents using MALDI-MS imaging. It would be interesting 
to use this method to investigate the distribution of AOXs throughout human skin equivalent or 
ex-plant skin. This would be a strong method to visualise the penetrative capacity of THC and 
PTERO and establish if they reach the fibroblasts. This would add substantial merit to the 
protection seen with this combination and monolayer fibroblasts. If the product was to be 
classified as a day cream, consideration for AOX encapsulation would also be worth 
investigating with MALD-MSI. Friedrich et al. (2015) formulated resveratrol and curcumin 
within lipid-core nanocapsules and compared the penetration to ‘free’ compound solutions 
applied to human abdominal skin. Irrespective of encapsulation, resveratrol and curcumin had 
different penetrative profiles, although both penetrated the dermis and entered the fibroblasts. 
Kakkar et al. (2018) substantially increased the bioavailability and penetrative capacity of THC 
by trapping it in lipid nanoparticles and formulating a hydrogel that was tested on porcine ear 
skin. Both studies infer that with the right Physiogel™ formulation, the protective effects seen 
with THC/PTERO combination in fibroblasts could be achieved through product application to 
skin.  
8.5 CELLnTEC medium: an effective commercial tool for producing human skin 
equivalents  
Based on the pilot comparing fibroblasts from different skin regions, it would be highly 
valuable to apply the techniques to a study where donor skin was sourced from multiple body 
sites. This would eliminate inter-donor variability and make an important contribution to the 
field of dermatology.  
It was not possible to repeat the ex-plant/Labskin™ formulation studies with CELLnTEC skin 
equivalents due to technical challenges establishing this batch of skin equivalents. However, an 
evaluation of all pilots was performed in and discussed in chapter 5. Considering the technical 
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recommendations outlined in chapter 5, it is unlikely that this event will reoccur in future 
experiments.  
It is expected that as these skin equivalents are of a similar thickness to thin physiological skin 
(but without additional cell types/organ structures), that the qPCR assay is suited to sensitively 
distinguish between conditions. As such this experiment is worth repeating with future test 
formulations. 
Preliminary work made promising strides in the adaptation of these skin equivalents to represent 
target areas of application (e.g. face). Such skin equivalents are commercially unavailable, and 
the highly proliferative nature of facial keratinocytes suggests the data obtained from 
formulation testing may be different to that from foreskin. Successfully scaling the skin 
equivalents to 24 well size makes it feasible to produce enough skin equivalents from small 
facial skin samples. Furthermore, a valuable resource of (mostly female donor) cryopreserved 
facial keratinocytes remain and could readily be grown into reconstructed human epidermal 
skin equivalents. Another option would be to seed atop dermis constructed from foreskin cell 
fibroblasts, but this is likely to complicate data interpretation. It is worth noting that the age of 
these donors (undergoing Mohs surgery) was typically from older female donors, who are likely 
to have accumulative sun exposure. As skin from older donors does not typically produce robust 
primary cell cultures, this could be a limiting factor to both producing facial skin derived skin 
equivalents and subsequently treating with solar irradiation.  
Commercial media typically has higher levels of vitamins than are found physiologically, and 
both the ingredients and concentration are proprietary. To study AOXs this is an important 
factor to consider. CELLnTEC were co-operative in recognising that this could be detrimental 
to effective AOX dosing and shared the following concentrations as examples to consider: 2µM 
niacinamide, 0.1µM riboflavin, 0.3µM B12, and 0.2µM folic acid. CELLnTEC additionally 
state that their medium is free from phenol/cholera toxin/animal products, and composed of 21 
amino acids, 19 minerals and trace elements (selenium, manganese, zinc), 14 vitamins, 10 other 
ingredients (glucose, pyruvate, buffers), and 6 growth factors/co-factors (insulin, 
hydrocortisone, epidermal growth factor, fibroblast growth factor) -      
https://cellntec.com/products/resources/tech/formulation/. For future work it may be 
worthwhile to perform a literature search of the physiological levels and role of media 
nutritional elements in the blood, hair and skin.  
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8.6 Future work 
8.6.1 Human skin equivalents and organ culture system 
Promising strides were made with the facial skin equivalent trial after optimisation of cell 
isolation and culture methodologies. Whilst it seems feasible that facial keratinocytes would 
readily develop into reconstructed human epidermis (RHE), it would be extremely worthwhile 
to trial the full-thickness skin equivalent in other donors. Given the keratinocytes proliferative 
rate, adaptations to the usual timeline are likely to be required. A contact at CELLnTEC 
communicated that keratinocytes will fail to attach or displace fibroblasts if the dermal layer 
has not established. If feasible, it may be useful to take histological sections of the dermis before 
and after keratinocytes are added.  
To characterise skin equivalent similarity to whole skin, punch-biopsies of reference skin was 
kept for RNA/protein and a custom panel of skin-specific markers was designed. If time had 
allowed, this would have potentially been a powerful publication pertaining to the similarity of 
donor skin and skin equivalents derived from it. In particular, the genes of components from 
metabolic and AOX pathway were included to determine if skin equivalents have the machinery 
to behave in a physiological manner. This would infer how useful they are for elucidating AOX 
mechanisms of action. NanoString technology is an economical intermediary between 
TaqMan™ and RNAseq. As NanoString probes are directly incubated with RNA there is no 
cDNA amplification step, RNA quality is not a limiting factor, and data can be rapidly attained 
at Newcastle University NanoString facility. Functional characterisation has been performed 
on some commercial skin equivalents such as metabolic enzymes in SkinEthic™ (Eilstein et al., 
2014), but they were not compared to donor-matched skin.    
Growth of skin equivalents is a long and expensive process. To better identify the donors most 
suitable for skin equivalents, it would be a worthy trial to begin collecting media samples from 
passage number 0-1 fibroblasts. These would be analysed by protein ELISA for high levels of 
extracellular matrix proteins, as the pilot in Chapter 5 showed that high levels in the media did 
correlate with larger western blot bands (indicative that it will lay down more protein). The aim 
would be to identify the best day to take a media sample and screen a donor for its likelihood 
to be shortlisted for skin equivalents or best used for another purpose. 
In addition, studies pertaining to the stratum corneum are required. Asides from acquiring 
imaging and a lipid profile, MALD-MS imaging could compare Physiogel™ permeation through 
the CELLnTEC skin equivalent and a punch-biopsy of skin from the same donor (using the 
optimised organ culture system) (Mitchell et al. (2016)). Optimisation of a MALDI-MSI 
protocol with these skin equivalents would be highly advantageous for future testing of novel 
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compounds, as there would be visual identification of which layer(s) of skin they permeate and 
provide powerful visual evidence of damage protection for intellectual property and marketing 
purposes.  
A limiting factor in this work was the low sample numbers in some experiments. Future work 
should aim to use statistical power calculations to determine the number of donors to use for 
each experiment, with consideration for grouping of biological age and body site.  
8.6.2 Nuclear DNA (nDNA) protection 
Another area of intended study would involve reanalysis of the DNA samples from this thesis 
for nDNA protection. As the qPCR assay uses mtDNA specific primers and only a very small 
amount of DNA, there is clear opportunity to analyse both genomes within the same sample. 
This would be highly novel and build a comprehensive picture of the AOX role in the 
intracellular space. There is known functional interplay between both genomes, including repair 
mechanisms and autophagy/mitophagy (Fang et al., 2016; Gammage and Frezza, 2019).  A 
technique that could be easily optimised and offer rapid screening would be DNA ELISA for 
biomarkers of UV-induced damage such as 8-hydroxy-2'-deoxyguanosine (8-OHdG) (Cooke et 
al., 2003; Drake et al., 2019). The only limiting factor might be the amount of DNA required 
(ng), which could be reduced by using half-area 96 well plates (as for protein ELISA in this 
thesis). Commercial kits are widely available, but it would be more economical to optimise an 
in-house protocol.  
8.6.3 AOX mechanisms of action  
There are many commercial AOXs of interest, and it is known that strategic combinations are 
key to enhance endogenous cell function (Burke. K.E, 2007; Bogdan and Baumann, 2008; 
Dinkova-Kostova & Abramov, 2015; Burke. K.E, 2018). Collaboration with experts in 
computational predictive modelling could help stratify these for testing in cellular systems. 
When using primary cells (which introduce donor variability), consultation with a Bayesian 
method expert (statistician) could help create a design of experiments (DOE) approach to 
determine the number of donors required for testing, alongside the number of variables and 
replicates required to draw meaningful conclusions (Collins et al., 2009; Holder, D.J. and 
Marino, M.J. (2017); Murray et al., (2017).  
The primary cell AOX studies followed on from pilot in-house data obtained in skin cell lines. 
Dr Matthew Jackson (Newcastle University) pre-incubated HDFn cell lines with THC and 
PTERO for 12 hours before solar irradiation (2.16 SED). The cDNA was analysed with a human 
oxidative stress microarray (Qiagen) to assess the effects on 84 genes related to oxidative stress 
and antioxidant response. This work was preliminary and requires additional validation, but 
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future experiments could expand on the pathways identified (through the up/down-regulated 
genes) in primary skin cells and more complex models. The mechanisms of resveratrol and 
curcumin are propagated throughout the literature, and some studies have extended to their 
synthetically enhanced derivatives PTERO and THC (see sections 1.6.3 and 4.4). These are a 
valued resource to shortlist potential mechanisms worth investigating in our skin equivalent 
systems.  
8.7 Closing summary 
Physiogel™ moisturisers have proven capacity to help dryness, redness and skin irritation 
(Santos-Caetano et al., 2019; Nisbet et al., 2019; Santos-Caetano et al., 2020). These symptoms 
typically present with compromised skin barrier integrity, increasing susceptibility to 
environmental stressors which drive their severity. It is hoped that the sensitive mtDNA assay 
and highly representative human skin equivalent model optimised in this thesis can be used to 
enhance product development and understanding. The data obtained in this thesis pertaining to 
THC/PTERO, in combination with what is known in the literature is highly indicative that these 
active ingredients could contribute anti-inflammatory, anticarcinogenic and AOX properties to 
the product range.   
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Chapter 9:  Appendix 
 PhD publications, presentations and awards 
Portions of this work have resulted in two peer-reviewed publications: 
• Hanna, R., Crowther, J.M., Bulsara, P.A., Wang, X., Moore, D.J. and Birch-Machin, 
M.A. (2019) 'Optimised detection of mitochondrial DNA strand breaks', 
Mitochondrion. 46, pp.172-178.  
• Naidoo, K., Hanna, R. and Birch‐Machin Mark, A. (2018) 'What is the role of 
mitochondrial dysfunction in skin photoaging?', Experimental Dermatology, 27(2), pp. 
124-128 
 
This work has been presented at several conferences: 
• North East Postgraduate Conference: engagement style presentation. Newcastle UK; 9th 
November 2018: oral presentation 
• 8th International Conference on Oxidative Stress in Skin Medicine and Biology, Andros, 
Greece; 6-9th September 2018: oral presentation 
• 11th Annual GSK PhD Science Symposium (Consumer Healthcare: Oral & Skin), 
Weybridge UK; 13-14th June 2018: oral presentation 
• British Society of Investigative Dermatology (BSID) Conference, London UK; 26-28th 
March 2018: travel bursary award and poster presentation 
• DMDG Skin Metabolism Meeting, Sunderland University, UK; 27th-29th November 
2017: networking event 
• Society of Investigative Dermatology (SID) Conference, Portland, OR, USA; 25th-29th 
April 2017: poster presentation 
• Stratified Medicine Category, Director’s Research Day, Institute of Cellular Medicine, 
Newcastle University; 26th June 2017: poster presentation prize            
• Stratified Medicine, Biomarkers and Therapeutics Meeting, Newcastle University; 23rd 
May 2017: poster presentation 
 
This work has been orally presented at internal and collaborative meetings: 
• Institute of Cellular Medicine Seminars, Newcastle University, UK; annual oral 
presentation 2016-2018  
• GSK Project Update Teleconference Calls; 2015-2019; 4-6 week intervals 
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 Supplementary information 
 Composition of EpiLife™ Medium, with 60 µM calcium chloride 
EpiLife™ medium (with 60µM calcium chloride; item MEP1500CA, Thermo Scientific) was 
used to isolate and culture adult foreskin-derived epidermal keratinocytes. The individual 
components are listed in the Table 9.1, but the concentrations are proprietary. The medium was 
additionally supplemented with Human Keratinocyte Growth Serum (HKGS), with the 
composition listed under 9.2.2. The formulation information was sourced from:  
https://www.thermofisher.com/uk/en/home/technical-resources/media-formulation.275.html.  
 
Components Molecular Weight Concentration (g/L) 
Amino Acids     
Glycine 75 confidential 
L-Alanine 89 confidential 
L-Arginine hydrochloride 211 confidential 
L-Asparagine-H2O 150 confidential 
L-Aspartic acid 133 confidential 
L-Cysteine 121 confidential 
L-Glutamic Acid 147 confidential 
L-Glutamine 146 confidential 
L-Histidine hydrochloride-H2O 210 confidential 
L-Isoleucine 131 confidential 
L-Leucine 131 confidential 
L-Lysine hydrochloride 183 confidential 
L-Methionine 149 confidential 
L-Phenylalanine 165 confidential 
L-Proline 115 confidential 
L-Serine 105 confidential 
L-Threonine 119 confidential 
L-Tryptophan 204 confidential 
L-Tyrosine 181 confidential 
L-Valine 117 confidential 
Vitamins     
Choline chloride 140 confidential 
D-Pantothenic Acid 238 confidential 
Folic Acid 441 confidential 
Myo-Inositol 180 confidential 
Niacinamide 122 confidential 
Pyridoxal hydrochloride 206 confidential 
Riboflavin 376 confidential 
Thiamine hydrochloride 337 confidential 
Vitamin B12 1355 confidential 
d-Biotin 244 confidential 
159 
Inorganic Salts     
Ammonium Molybdate 
((NH4)6Mo7O24-4H2O) 1236 confidential 
Ammonium metavanadate 
(NH4VO3) 117 confidential 
Calcium Chloride (CaCl2-
2H2O) 147 confidential 
Cupric sulfate (CuSO4-5H2O) 250 confidential 
Ferric sulfate (FeSO4-7H2O) 278 confidential 
Magnesium Chloride (MgCl2-
6H2O) 203 confidential 
Manganese Sulfate (MnSO4-
H20) 169 confidential 
Nickelous Chloride NiCl2 6H2O 238 confidential 
Potassium Chloride (KCl) 75 confidential 
Sodium Bicarbonate (NaHCO3) 84 confidential 
Sodium Chloride (NaCl) 58 confidential 
Sodium Meta Silicate Na2SiO3 
9H2O 284 confidential 
Sodium Phosphate dibasic 
(Na2HPO4-7H2O) 268 confidential 
Sodium Selenite (Na2SeO3) 173 confidential 
Tin Chloride (SnCl2.2H2O) 226 confidential 
Zinc sulfate (ZnSO4-7H2O) 288 confidential 
Other Components     
Adenine.HCl 172 confidential 
D-Glucose (Dextrose) 180 confidential 
DL-alpha-Lipoic Acid 206 confidential 
Ethanolamine 61 confidential 
HEPES 238 confidential 
O-Phosphorylethanolamine 141 confidential 
Phenol Red 376.4 confidential 
Putrescine 2HCl 161 confidential 
Sodium Pyruvate 110 confidential 
Thymidine 242 confidential 




 Composition of Human Keratinocyte Growth Serum (HKGS; EpiLife™ 
supplement) 
EpiLife™ medium (see 9.2.1) was supplemented with HKGS (item S0015, Thermo Scientific) 
before used in the isolation and culture of adult foreskin-derived epidermal keratinocytes. The 
individual components are listed in the Table 9.2. The information was sourced from:  
https://www.thermofisher.com/order/catalog/product/S0015#/S0015 
 
Components Stock concentration (100X)  Final concentration (1X) 
Proteins     
Human epidermal growth 
factor 200ng/ml 0.2µg/ml 
Human insulin-like growth 
factor-I 1µg/ml 0.01µg/ml 
Bovine transferrin 500µg/ml 5µg/ml 
Other Components     
Bovine pituitary extract 
(BPE) 20% v/v 0.2% v/v 
Hydrocortisone  18µg/ml 0.18µg/ml 
 Composition of Human Keratinocyte Growth Serum (HKGS; EpiLife™ supplement)  
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 Composition of Dulbecco’s Modified Eagle Medium (DMEM) 
DMEM medium was used in the isolation and culture of adult foreskin-derived dermal 
fibroblasts. DMEM was developed in 1969 and is a modification of Basal Medium Eagle 
(BME) that differs from BME and MEM by the following characteristics: 
• Vitamins 4X greater than MEM. Vitamins and amino acids greater than BME. 
• Types and quantities of amino acids greater than MEM and BME 
• Iron (ferric nitrate) 




Components Concentration (g/L) 
Amino Acids   
L-Arginine • HCl 0.084 
L-Cystine • 2HCl 0.0626 
L-Glutamine 0.584 
Glycine 0.03 
L-Histidine • HCl • H2O 0.042 
L-Isoleucine 0.105 
L-Leucine 0.105 






L-Tyrosine • 2Na • 2H2O 0.10379 
L-Valine 0.094 
Vitamins   
Choline Chloride 0.004 
Folic Acid 0.004 
myo-Inositol 0.0072 
Niacinamide 0.004 
D-Pantothenic Acid (hemicalcium) 0.004 
Pyridoxal • HCl 0.004 
Riboflavin 0.0004 
Thiamine • HCl 0.004 
Inorganic Salts   
Calcium Chloride 0.2 
Ferric Nitrate • 9H2O 0.0001 
Magnesium Sulfate (anhydrous) 0.09767 
Potassium Chloride 0.4 
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Sodium Chloride 6.4 
Sodium Phosphate Monobasic 
(anhydrous) 0.109 
Sodium Bicarbonate 3.7 
Other Components   
D-Glucose 4.5 
Phenol Red • Na 0.0159 
Pyruvic Acid • Na 0.11 
 Composition of Dulbecco’s Modified Eagle Medium (DMEM)  
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 Hypothesized ROS production as a result of UV light exposure to PTERO.  
Supplementary information to Chapter 4. Diagram produced by Dr Robert Lucas of 
GlaxoSmithKline, UK. 
 




 Fixative reagent options for immunofluorescence  
Supplementary information to Chapter 5.  
Source: https://www.leica-microsystems.com/science-lab/how-to-prepare-your-specimen-for-
immunofluorescence-microscopy/ 
  Fixative Effect Advantages Disadvantages 
Chemical 
crosslinkers 
Formaldehyde Crosslink proteins via their 
free amino groups  
Preserves well cellular 
morphology. 
Good for already present 
fluorescent proteins. 
Antigens might also be 
crosslinked 
Glutaraldehyde Preserves well cellular 
morphology. 
Good for already present 
fluorescent proteins. 





Methanol Fixation by dehydrogenation 
and protein precipitation. 
Cells will simultaneously 
become permeabilized. 
Good preservation of 
cellular architecture. 
Faster procedure in 
comparison to chemical 
crosslinkers. 
Strong negative effect 
on many epitopes. 
Not suitable for 
fluorescent proteins. 
Soluble and lipid 
components are getting 
lost. 
Acetone Less damaging to 
epitopes. 
Faster procedure 
Not suitable for 
fluorescent proteins. 
Soluble and lipid 
components are getting 
lost. 
 Fixative reagent options for immunofluorescence  
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 Labskin™ construction timeline 
Screenshot of a CELLnTEC conference presentation slide which was publicly available online 
in 2018 but has since been removed. Batch 1910123 used in this study was shipped on day 21 
and received on day 22. After overnight acclimation the experiment was performed on day 3 
after shipping, representing the green zone i.e. skin equivalents in optimal condition/viability.  




 Comparative histological H&E of promotional CELLnTEC skin equivalent 
alongside in-house reconstructed human epidermis and full thickness skin equivalents.  
Skin equivalents grown from foreskin-derived adult keratinocytes and reticular fibroblasts from 
male donors S1073F and S1074F. Measurements (mm) of stratum corneum, epidermis and 
dermis have been calculated using the scale bars for all skin equivalents, alongside the 
CELLnTEC promotional image.  
 
 Comparative histological H&E of promotional CELLnTEC skin equivalent alongside in-house 
reconstructed human epidermis and full thickness skin equivalents. Skin equivalents grown from foreskin-derived and 
donor-matched adult keratinocytes and reticular fibroblasts of S1073F (male – age 65) and S1074F (male – age 28). 
Keratinocytes were also seeded into epidermal skin equivalents as a technical control of cell quality. Skin equivalents have 
formed an anatomically correct keratinised stratified epidermis, attached to a thicker dermal layer. The structural matrix was 
created by the fibroblasts, without artificial scaffold. A dermo-epidermal junction is visible, and fibroblasts are evident within 
the dermal layer. Measurements (mm) of stratum corneum, epidermis and dermis have been calculated using the scale bars for 
both skin equivalents, alongside the CELLnTEC promotional image and three ex-vivo whole foreskin donors (S1141F – male, 
ag 40, S1142F – male, age 17, S1145F – male, age 51; see supplementary Figure 9.4). Reference skin from S1073F and S1074F 
was unavailable. H&E staining was performed on three sections per skin equivalent from each PPFE and OCT block. Images 




 H&E histology of ex-vivo adult foreskin.  Ex-vivo whole foreskin donors: S1141F – male, age 40, S1142F – 




 ELISA standard curves for collagen I, fibronectin and hyaluronan detection in skin 
fibroblast medium. 
 
 ELISA standard curves for collagen I, fibronectin and hyaluronan detection in skin fibroblast medium.    
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